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INTRODUCTION 
Fulminant hepatic necrosis is one of the most dreaded complications in medical practice. 
Although rare, this syndrome carries a mortality of up to 90%, which has not been improved in 
the last 20 years of intensive effort. The principal reason for the employment of treatments of 
great complexity is the accepted significant capacity of the normal liver to regenerate. Hence 
any form of treatment serves to sustain the life of the patient in order that this regenerative 
capacity may have time to manifest itself. 
This study relates to an investigation of one form of treatment of this syndrome - viz. the 
use of an animal liver perfused in isolation with the blood of the patient to provide an extra-
corporeal hepatic assist. Since no form of "artificial liver machine" has yet been devised, this 
bizarre method constitutes an approach to fulfil liver function . 
As an introduction to the study, the problems of the definition and pathogenesis of 
fulminant hepatic necrosis are explored. A precise definition is essential in order that a true 
evaluation of the mortality from the disease may be made. Attempts to define the pathogenesis 
of the neurological syndrome have centred around a defect in the metabolism of ammonia 
since clinical abnormalities of nitrogen metabolism have been noted, and to some extent, the 
syndrome is reproducible experimentally by the administration of ammonia. However, the 
precise pathogenesis is far from certain. 
Considerable difficulty exists in the assessment of when to extend conservative treatment 
to include more radical measures. This emphasizes the necessity for a method of comparison, 
for which the staging of coma has been employed with partial success. The difficulties 
encountered in any form of comparative study are highlighted in a review of the forms of treat-
ment available, with a resume of some world experience. 
Since it appears that the only entity available at present to replace the liver in toto is 
another liver, the design of hepatic assist was explored. As a background to this, the methods 
of assessment of liver function have been elaborated to demonstrate the difficulties involved. 
Methods including total hepatectomy or the establishment of an ischaemic organ have pro-
vided some understanding of liver function but a great volume of work has resulted from isola-
ted liver perfusion studies. Nonetheless, it is well recognised that these results cannot be com-
pared with whole organ function in vivo. The methods chosen for use in this study include a 
wide spectrum of physical and biochemical characteristics selected from the work of a number 
of authors. 
Since large animal liver perfusion constituted a new field of research at this University, the 
establishment of the technique is reported in detail, including selection of animals, pre-opera-
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tive, anaesthetic and operative techniques, and especially the preparation and perfusion of the 
liver. A review of the literature resulted in the circuit design which was the first University of 
Cape Town model, to which various alterations have been made in the course of the develop-
ment of the procedure over three years. 
Initial experiments were designed to evaluate the response of the isolated liver to 
perfusion with homologous porcine blood and to assess the need for additions to improve 
function . Subsequently a study was performed to compare the effects of perfusing the pig liver 
with homologous porcine or heterologous human blood, in order to determine that the 
procedure could be offered with safety as a hepatic assist. 
In the light of the physical and biochemical findings observed in this laboratory and in 
those of many other workers, the isolated pig liver was offered as a form of treatment to four 
patients with acute liver failure. The clinical courses of these patients are outlined in detail to 
provide evidence of the disease under review. 
Although none of these patients survived, an encouraging improvement in the level of 
consciousness was noted. But a feature became apparent which had not been emphasised in 
any other work. This was the thrombocytopenia which constituted a hazard to the recovery of 
these patients. As a result of the severity of this complication, the clinical procedure was dis-
continued while a laboratory programme was undertaken to investigate the nature of, and solu-
tion to the problem . 
The hypothesis was advanced that the decline in platelet levels could be related either to 
the trauma resulting from direct blood/ gas contact in the oxygenator, or to the effect of the 
liver itself. In experiments designed to evaluate the contribution of the circuit in which 
perfusions were performed without livers, it was apparent that there was some decline of plate-
lets related especially to the gas flows in the different oxygenators, but that this could not 
account for the whole problem . The incorporation of a pig liver into a perfusion using porcine 
blood did not result in further fall off in platelet counts, but a striking decline resulted from the 
use of pig liver and human blood. It was observed also that the platelet counts fell markedly 
within the first 30 minutes of perfusion, and that this was a direct effect of the liver. In a further 
evaluation of this phenomenon, the disappearance of platelets was noted to be accompanied 
by reduction in leucocyte counts and the levels of complement and antibody in human blood 
against pig cells. 
Upon review of the literature, it was noted that the heterograft response to interspecies 
transplantation was accompanied by similar features and hence this was invoked as the cause. 
An attempt was made to prevent or reverse this response although little previous success had 
been reported . The attempt took two forms - (a) In homologous perfusions prevention of plate-
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let aggregation to damaged endothelium as a result of poor preservation - i.e. an attempt to 
improve conditions of liver function and (b) in heterologous perfusions prevention of antigen-
antibody complex-induced platelet aggregation by pharmacological means. Single experiments 
in a number of these directions all failed . 
An alternative approach was to find a more compatible animal than the pig . The calf and 
the lamb were also shown to give results similar to those of the pig when the liver was 
perfused with human blood. However, the use of baboon livers from blood group compatible or 
incompatible animals showed a marked improvement. Thus at this time, the use of the baboon 
liver for hepatic assist would be advocated, with the proviso that in an attempt to prevent 
transmission of viruses from these animals to patients or personnel, a period of isolation 
should be completed before use of such animals for clinical purposes. 
Thus the solution to the problem has taken a different direction from that originally 
envisaged. The problem of the heterograft response remains unsolved and poses a number of 
questions which lead to a wide field of research. In addition, considerable improvement needs 
to be made in the technique of liver perfusion as a means of preservation of the numerous func-
tions of this complex organ. 
CHAPTER ONE 
FULMINANT HEPATIC NECROSIS 
i) Definition 
ii) Proposed pathogenesis - with emphasis on hyperammonaemia 
iii) Principles of treatment - general review 
iv) Staging of coma 
v) Treatment - (a) conservative 
(b) exchange transfusion 
(c) cross circulation 
(d) isolated liver perfusion 
vi) Liver regeneration 
vii) A model of hepatic coma 
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i) Definition 
Fulminant hepatic necrosis is a rare but lethal complication of several forms of acute liver 
disease. It carries one of the highest mortality rates of medical diseases (287) and is becoming 
of increasing importance in view of the outbreaks of viral hepatitis in dialysis and transplant 
units (207). Diseases in which acute necrosis may become a complication include (i) hepatitis 
as a result of infection by a virus either of the short- or long-incubation type; (ii) the acute fatty 
liver of pregnancy, and (iii) more recently, drug-induced hepatitis, with especial reference to 
halothane (264). When hepatic coma supervenes in the course of such acute liver failure it 
should be regarded as a most ominous sign and is usually followed by death (19). 
Only since 1950 has there been an increased interest in hepatic coma on the basis of 
acute liver failure, perhaps because more elaborate methods have been advanced since then to 
attempt to halt the course of the disease. The particular biochemical and clinical syndrome 
must be differentiated quite clearly from the derangement accompanying chronic progressive 
dysfunction of the liver as exemplified by the cirrhotic process. A marked difference is oberved 
in the mortality rates of the two forms of coma - 20% of patients die in chronic encephalopathy 
as for example following porta-caval shunts, whereas 80-90% of patients in acute hepatic 
coma succumb (49). In addition, the presentation of the syndrome is different from the 
experimentally induced anhepatic state. 
The disease under review has recently been described as the acute onset of progressive 
jaundice with decrease in size of the liver, foetor hepaticus and hepatic coma. Biochemical 
associations are a decrease in the prothrombin index, and an increase in aspartate 
transaminase, bilirubin, blood ammonia and a amino nitrogen. As a fulminant illness, hepatic 
failure usually results within eight weeks of the onset of the disease (262). 
ii) Proposed pathogenesis 
At this time, the protean nature of the metabolic disturbances (91) consequent upon total 
massive destruction of the liver are only slowly being evaluated. This is not "a discrete, 
aetiologically homogeneous disease (51 )". The nature of the response of the liver cell to 
various forms of assault is not known and hence the biochemical results are poorly understood. 
Probably there are many results of liver destruction which could lead to coma - in contradistinc-
tion to the anhepatic state, since there is absence of liver function plus tissue damage. The 
grim prognosis of the disease is due both to the presence of a host of intermediary metabolic 
defects which cause deficient energy metabolism, acid base imbalance and disordered clotting 
mechanisms, and also to complex associated disorders such as renal failure, gastro-intestinal 
haemorrhage, sepsis and high output cardiac failure (50). 
For many years, a defect in ammonia metabolism has been incriminated as the cause of 
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hepatic coma, and there is considerable evidence to suggest that this may be the case (87). 
Although direct infusion of ammonia solutions of different concentrations and under different 
buffered conditions resulted in coma in dogs (67), there was no relationship between venous 
blood ammonia levels and the production of coma, and the concentrations required to produce 
coma were much higher than are usually observed clinically. The mechanism of ammonia 
toxicity has been postulated to be interference with the cerebral metabolism of ammonia by 
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Figure 1: The biosynthetic pathways of ammonia 
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It is suggested that a oxo-glutarate is removed from the Krebs cycle with resultant de-
creased formation of other members of the cycle and diminution of oxidative phosphorylation 
in the brain (243). However, all these postulates relate the final result - viz, the elevation of 
blood ammonia, to the development of coma. Even if this were proven, the original cause of the 
elevation of blood ammonia is not known, although it is postulated to be a failure of the liver to 
metabolise the nitrogenous products of digestion. Studies of the isolated perfused pig liver 
have shown that the ability of the organ to excrete ammonia is indeed resistant to 30 minutes 
normothermic anoxia (275) and it is supposed that a great number of functions would have 
failed by the time that blood ammonia elevation was noted. Gabuzda (87) states - "Qualified 
acceptance of the role of ammonia in the pathogenesis of hepatic coma is related to such fac-
tors as the limitations of methodology, apparent lack of consistent correlation of blood 
ammonia levels with clinical state, and variations in the degree of elevation associated with 
the clinical syndrome from patient to patient, and in a given patient from time to time". Thus 
the problem is complicated by the tendency to regard hepatic coma and failure as synonymous 
with ammonia intoxication. Other factors which have been incriminated with less certainty 
include changes in the acid base status (110), and cerebral blood flow with disordered 
neurological transmission (204,80). 
iii) The principles of treatment - general review 
Since there are few, if any, metabolic functions in which the liver does not participate 
(223), replacement during its failure is complex, and various approaches have been made. 
Many authors advocate no more than the basic management of coma (19) but others follow the 
principles as outlined by Williams (287) - elimination or neutralisation of the toxic compounds 
thought to be implicated in cerebral toxicity; maintenance of fluid, electrolyte and acid base 
balance; the provision of sufficient caloric intake in the form of glucose infusions; the supply 
of the essential metabolites assumed to be lacking in the condition, and the control of the 
increased bleeding tendency. In a recent extensive review, Hoenig (121) concludes that "most 
forms of liver damage treatment are derived from clinical experience, personal impressions, 
experiments on animals and biochemical considerations rather than from well controlled 
clinical work. That is why polypragmasia has alternated with therapeutic nihilism" . 
Indeed, since the biochemical dysfunction is obscure, the basis of treatment rests on 
sustaining the life of the patient to provide time and the best conditions for the enormous 
capacity of the liver for regeneration to become effective. It is becoming increasingly apparent 
that the commencement of liver regeneration is the governing factor to the success of any form 
of treatment. Stated succinctly - "provided regeneration occurs, the condition is potentially 
reversible" (212). 
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However, in spite of increasing biochemical knowledge, the subject of acute liver necrosis 
and the high mortality rate associated with the condition remain a therapeutic challenge (150). 
Prior to 1951 , it appears that intravenous infusion of glucose was the only form of treatment 
offered. Thereafter, with the advent of corticosteroids, these drugs were given in large doses, 
and for a period of time enjoyed popularity and apparent success in the treatment of some 
patients (133). However, their effectiveness was limited and their use empirical. More 
importantly, the complications of gastro-intestinal haemorrhage in patients with hepatic-in-
duced coagulation defects, and enhanced tendency to infection were recognised. 
Other forms of treatment of chronic encephalopathy with biochemical rationale included 
the use of sodium glutamate (291 ), a combination of threonine, nicotinamide and riboflavin 
(150), ex oxoglutarate and ornithine (202), and ornithine and aspartic acid which have recently 
been proposed to spare the use of ATP in glucose metabolism (96). In addition, Levo-dopa has 
been advocated to improve the presumed disorder of neurological transmission (80,204). 
With the realisation of the diverse complications of liver failure some attempts were made 
to provide an artificial organ (151 ). In broad summary, liver failure represents a deficit of 
excretion and a failure of synthesis, and whilst dialysis and exchange transfusion could supple-
ment the former, another liver is needed for the latter (288). The object of further treatment 
was the same - viz. to provide temporary hepatic support of vital functions whilst regeneration 
occurred. But with the afore-mentioned difficulty in assessment of the cause of coma, and the 
nature of liver dysfunction, it has become apparent that the only means of replacing total liver 
function may be with another liver; nonetheless, on the basis that the coma might be due to 
accumulated toxins which could also hamper regeneration, the use of exchange transfusion 
was suggested (233,261). 
The institution of any form of treatment other than conservative brings with it the 
necessity to select patients and the optimal time at which to employ such procedures. Because 
of the variable nature of the disease, and the absence of controls (212), and because no good 
objective standards exist to predict which patients will survive hepatic coma (153), the 
selection of patients becomes all important. As a result of the extremely high mortality rate 
associated with the disease, it is easy to develop a nihilistic attitude to such patients, especially 
as the main clinical indication of prognosis is the ill-defined conscious state (279). Thus in an 
attempt to provide guidance in the management of such patients, various gradings have been 
made of the stages of coma. 
iv) Staging of coma (Table I) 
This has been a contentious topic since the first definition by Adams and Foley made from 
their numerous observations of patients in chronic hepatic encephalopathy (10). This basis of 
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Table I : A comparison of assessments of hepatic coma 
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assessment was used for many years but more recently a classification directed towards the 
neurological disorders of acute liver necrosis has been evolved by Dr Charles Trey in the course 
of the Fulminant Hepatic Failure Surveillance Study. Subsequently in correlation with the 
electoencephalographic findings, six stages of coma were described by Sherlock (130). These 
various gradings may all be regarded as different stages in the evolution of understanding of 
the neurological deficits resultant upon acute hepatic necrosis, although it was recognised 
early that "the final stage is generally ushered in abruptly by grave nervous manifestations" 
(212). 
v) Treatment (236) 
(a) Conservative 
At this juncture it is important to stress that intensive care may be the most important 
feature of the management of these cases. As the complications of hepatic coma are better 
understood, more success is achieved in the provision of intensive care. At present the follow-
ing scheme is used in the Liver Unit, Groote Schuur Hospital. 
Patients are nursed under isolated conditions and ·staff wear gowns, gloves and masks. 
Rigorous personal hygiene is insisted upon at all times and especially after any contact with 
the patient, blood or excreta; this has been highlighted since the recommendations of the 
Edinburgh group (207) following complications in their renal dialysis unit. 
Complications to which these patients may succumb are legion. Hypoglycaemia is impor-
tant and is treated by continuous infusion of dextrose with hourly monitoring with Dextrostix 
and frequent blood sugar analyses. In at least one patient, this metabolic defect has reached 
major proportions (232). It has recently been observed also that hypothermia may be a 
concomitant of the disease itself, in addition to the comatose state. In one patient, conscious-
ness returned with rewarming after a fall in temperature. Respiratory failure has been 
recognised as a complication which may manifest suddenly, and hence tracheostomy is 
advocated as early as possible - often being performed immediately after an exchange transfu-
sion when coagulation deficits are improved. In regard to this respiratory failure, certain drugs, 
principally Diazepam, seem to be implicated in its precipitation, and thus this form of sedation 
is not given. In a number of instances, death has seemed to be related to administration of 
paraldehyde. For both these drugs, the normal dose constitutes a major excess in the absence 
of liver metabolism. Patients are routinely catheterised to provide monitoring of renal function, 
and intake and output are carefully recorded . Antibiotics are administered only for obvious 
infection except for Neomycin which is given routinely to prevent protein intoxication, as is an 
initial Neomycin enema. 
Many reports exist of various forms of treatment for hepatic failure and some of these are 
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summarised in Table II. The various results will be discussed in the description of each form of 
treatment. In only one of the series describing treatment by conservative measures is a more 
satisfactory survival rate shown (41 ). Perhaps a lesser severity of the disease in these patients 
could be inferred from the fact that liver biopsies could be performed early in the course of the 
disease, suggesting that coagulat ion defects at least, were not as profound as in other patients. 
(b) Exchange transfusion 
This was postulated as a form of treatment (261) wh ich was safe and carried few hazards, 
and was thought to provide a means of removing whatever toxin it was which resulted in 
hepatic coma. As with all forms of treatment, there have been conflicting reports - some in 
favour of the method (23,261), and others showing no success with its use (130). Initially, the 
technique was extended from that used in exchange transfusion of jaundiced infants, and in 
general this method has- been maintained. However, the routes used have been improved by 
the preparation of a Scribner shunt between the radial artery and an available forearm vein, 
which provides direct access to in and outflow. In only one report has the technique been 
rendered more complicated by the incorporation of a hand pump (186) - in this instance, direct 
exchange transfusion was performed from a succession of donors. This has been found un-
necessary in local experience and carries the risk of exposure of an unnecessary number of 
people to the patient with a highly infectious disease. 
In a recent further attempt to remove toxins, a carbon column has been used for the 
removal of bilirubin and alkaline phosphatase (18) and has been shown to clear drugs (227) but 
the problem of trauma to blood elements remains to be solved. 
(c) Cross circulation 
More active treatment has included the use of cross circulation techniques. For this pur-
pose, human "volunteers" have been used in several series (37), but in view of the doubtful 
ethics of this method, a preferable technique has been the use of a non-human primate 
(125,235). Preparation of the animal included almost complete replacement of the blood 
volume with human blood compatible with that of the patient whilst the animal was sustained 
on hypothermic cardio-pulmonary bypass. Subsequent to rewarming of the animal, its circula -
tion was connected to that of a patient via Scribner shunts. In this one instance, it was found 
necessary to incorporate a pump between the patient and the baboon due to the discrepancy in 
size and the danger of overload of the animal by the human circulation . 
The animal prepared in this way has been shown to survive normally for five days before 
any immunological response is noted (134), and this form of treatment has the major 
advantage of attachment of the patient's circulation to a liver under the normal homeostatic 
mechanisms of the animal. However, the virological hazard of the baboon has precluded the 
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Table II Some world exper ience in the management of hepatic necrosis 
Cons. = conservative 
XT = exchange transfusion 
PLP = pig liver perfusion 
cc = cross circulation 
haemo. = haemodialysis 
V = viral 
H = halothane 
s = serum 
D = drug 
chr. = chronic liver disease 
preg. = pregnant 
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No: Aetiology Type of Treatment Survival Rec. consc Ref: 
Conservative 
13 V 4 4 184 
207 various 3 36 24 
61 V ,S,D, 20 20 41 
29 V ,D, 3 3 53 
Exchange Transfusion 
31 V 1 4 223 
7 V,H, 2 3 24 
4 V,H, 259 
V 1 1 23 
7 V,D , 0 2 130 
44 11 11 57 
1 V 1 1 153 
5 V 2 3 267 
Liver Perfusion 
chr 0 1 224 
5 V,D,preg. 2 5 201 
1 V 1 1 277 
5 V,chr. 0 2 240 
8 chr 0 8 71 
Combination etc. 
5 V&chr PLP & cons. 278 
5 V ,H, XT & CC 1 4 37 
7 V,D,H,chr XT & PLP 0 3 49 
preg. XT & haemod. 1 213 
4 V XT direct 1 3 186 
1 chr. XT & PLP 0 1 6 
2 V XT & PLP 0 210 
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further use of this method until adequate isolation facilities have become available. 
(d) Liver perfusion 
In 1958, the pig liver was evaluated in experiments which resulted in the development of 
hepatic assist procedures (70,238) . Initially the liver was perfused in isolation and was found to 
be capable of clearance of ammonia. This fact stimulated investigation of the ability of the liver 
to detoxicate ammonia even when perfused with heterologous blood (155). The removal of 
lactate was also demonstrated. At the outset. and in the absence of any further assessments of 
function, this technique was offered to provide these functions in the absence of an artificial 
organ (71 ). However, this constitutes a major procedure of similar magnitude to the cross-
circulation, and in view of its bizarre nature, has only been offered as a last resort to patients in 
the most terminal phases of the disease. Indeed it has been stated that "such a difficult and 
possibly dangerous procedure, if used at all, should be reserved for massive liver cell necrosis 
from which recovery cannot be expected" (261 ). This attitude has detracted from the potential 
success of treatment but results from the difficulties involved in justification of earlier use of 
such radical methods. 
Liver perfusion enjoyed popularity as a form of treatment in the 1967 / 8 period, but has 
tended to fall into disrepute more recently because of the small success rate. In addition, 
because of the complexity of the procedure, little monitoring has been performed of function of 
the liver during hepatic assist and hence failure of the technique may have related to lack of 
function of the extra -corporeal organ . Livers from pig, (71,73, 115,191,211,279,288), calf 
(26.49) and man (6,241) have been used, and the techniques have fallen into two broad 
categories - either with a simple or a more complex circuit. In the former, a pump has been 
used to deliver blood from the arterial line of the patient directly into the portal vein of the 
hepatic assist liver, and blood returns from the vena cava directly to the patient (71 ). In the 
more complex circuit, a system similar to that used for isolated perfusion is used. The reasons 
advanced for the ·use of the latter relate to the provision of an adequate blood supply to the 
hepatic assist liver in the case of a patient who is a child, or who is hypotensive (49,118). 
There is a great discrepancy in the duration for which livers have been perfused - it is 
stated that such organs will function between 10 and 35 hours (288) but again the question of 
the evaluation of function becomes important. Eiseman has suggested that four hours may 
provide the optimal period of perfusion before the law of diminishing returns becomes 
operational (73). 
One of the most dramatic reports recently has been that of Abouna who has demonstrated 
support of a patient for 72 days by intermittent use of hepatic assist and exchange transfusion 
(6). Whilst difficult to evaluate from the ethical point of view as has been highlighted from the 
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correspondence which followed the report (54), it was shown quite clearly that in that particu -
lar patient. coma was more easily reversed by liver perfusion than by exchange transfusion (6) . 
However, in other patients coma has been reversed by exchange transfusion . and in one 
patient 7 such procedures were required (261 ). These different data are impossible to evaluate 
in view of the fact that to date, no single centre has sufficient experience to show an improve-
ment of survival. This dilemma may only be solved by the development of a suitable laboratory 
model. At present. however, pig liver perfusion continues to be used in patients with terminal 
disease ( 1 52). 
The table shows some of the world experience with the treatment of hepatic coma, mostly 
based on acute hepatic necrosis. The current status of fulminant hepatic necrosis at Groote 
Schuur Hospital and the Red Cross War Memorial Childrens Hospital is as follows:- in the 
period 1963 to 1971, 119 patients in grades Ill and IV coma were seen. Of these, 48 were 
adults and 71 were children. In 20 of each group exchange transfusion was performed; in 
adults, 4 pig liver perfusions and one cross circulation with a baboon were used as additional 
treatment. A total of 1 O adults survived (21 %) and 24 children (31 %) . The difficulty of drawing 
conclusions from these figures has been highlighted in the differences in management and the 
assessment of severity. 
vi) Liver Regeneration 
Although so little is known of the biochemical defects of hepatic coma, probably the most 
important factor in the recovery of these patients is the capacity of the liver to regenerate . 
Hence at this point, a short evaluation of the present knowledge of liver regeneration control is 
pertinent. Numerous studies exist in rats where reproducible models of 68% hepatectomy can 
be produced (35). Whilst the biochemical, morphological and ultrastructur'al results of partial 
hepatectomy are becoming clearer, the humoral control mechanisms are still elusive. The 
present state of knowledge in summary is represented in Figure 2. Observations of altered 
rates of enzyme synthesis have been made within the first hour of partial hepatectomy (229) 
with associated increase in the specific activity of Uridine triphosphate (36) and mitochondrial 
(99) and nuclear DNA (36). Subsequently a pattern of increase in nuclear DNA specific activity 
has been shown, which is accompanied at 18 hours post-operatively by appearance of a factor 
capable of fibroblastic stimulation. This factor is RNA-ase sensitive (92). Growth hormone and 
non-specific surgical stress have been shown to increase the rate of response to the regenera-
tion factor after hepatectomy, but only if administration precedes the operation (174). Further 
experimental studies using para-biotic circulation of rats have demonstrated conclusively that 
the stimulus to regeneration is independent of the liver since total hepatectomy in one partner 
results in stimulation of growth in the other liver (92). However, functional liver mass may be 
necessary for the processing of such a factor. 
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Figure 2 : A composite diagram of the events currently known to follow 
partial hepatectomy in the rat. 
(i) Increase in the specific activity of uridinetriphosphate. 
(ii) Increase in ornithine decarboxylase activity. 
(iii) Increase in mitochondrial DNA specific activity. 
(iv) Increase in lipid. 
(v) Disintegration of endoplasmic reticulum to form polyri-
bosomes, with consequent reformation of endoplasmic 
reticulum. 
(vi) Increase in nuclear histone. 
(vii) Increase in nuclear DNA . 
(vii,) Increase in a factor which stimulates fibroblastic acti-
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These studies emphasise the importance of liver regeneration in this disease and highlight 
at least two questions related to present treatment. One is whether livers damaged by massive 
necrosis in fact have lost the ability to respond to any regenerative stimulus, or whether if it 
could be isolated, administration of the regeneration factor might result in recovery of liver 
function . The second question concerns the validity of attaching such patients to whole livers, 
especially in cross circulation procedures. Indeed it might be proposed that the partners for 
such procedures should undergo partial hepatectomy to increase production of regeneration 
factor. 
vii) A model of hepatic coma 
As discussed in the section evaluating various forms of treatment, the availability of a 
model in which these could be tested is much needed. Numerous attempts have been made, 
but many involve the creation of an irreversible lesion by anatomical disturbances - as for 
example in the three stage operation of Rappaport (220) with ligation of the common .hepatic 
artery with partial Eck fistula formation, followed by total ligation of all portal and hepatic 
arterial radicles. In addition chronic encephalopathy has been induced by the creation of an Eck 
fistula in dogs. 
f 
Whilst these studies provide interesting results as to the biochemical abnormalities of 
chronic liver failure, little contribution is made to acute necrosis. The large number of toxins 
which may induce experimental liver injury is reviewed by Schiff ( 108) but the only report of 
liver necrosis analogous to that seen clinically resulted from the use of galactosamine in rats 
(135). Thus, in general , little useful information in regard to the management of the clinical 
problem has come from the experimental induction of necrosis. The mouse and the dog are the 
only species in which viral hepatitis can be induced at will by infection, and in these cases, the 
disease is widespread and massive, involving many lobules. In addition, for practical purposes 
of biochemical evaluation. the more easily available mouse is too small. 
A recent report by Trey holds more hope (263). A syndrome similar to that seen clinically 
was induced in monkeys by the direct injection of carbon tetrachloride into the mesenteric 
vessels. The technique resulted in fulminant hepatic necrosis analogous biochemically and 
clinically to that caused by the virus in humans, and initial reports showed that there was a 
statistically significantly improved survival rate in animals treated by exchange transfusion 
when compared with their matched controls. This confirmed previous work by Turcotte (267) 
using the anatomical technique of Rappaport, in which an improvement in the neurological 
status but not the survival rate was noted. Exchange transfusion of hepatic failure induced in 
the dog by the canine hepatitis virus resulted in a survival of three animals of thirty-nine, whilst 
none of the controls survived. 
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Initial studies of the value of the perfused liver were performed in dogs in which a porta-
caval shunt had been created (200). The technique reversed the meat intoxication syndrome 
which was induced in these animals. 
The use of the anhepatic animal for assessment of the value of cross circulation provides 
only a limited period of time before irreversible changes, perhaps haemodynamic, supervene 
(253), and attempts to treat such animals in the terminal phases of the experiment were un-
rewarding (132). This raises the question - has the patient with massive liver necrosis reached 
a terminal stage as seen in animals following hepatectomy, when reversal of the final 
syndrome has not been achieved by any form of treatment? The answer almost certainly lies in 
the capacity of the liver to regenerate. 
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Due to its metabolic complexity, the assessment of the function of the liver is extremely 
difficult. No single test represents total hepatic function and indeed it is thought that with 
different degrees and types of damage, different abnormalities manifest. One of the most 
important but indefinable aspects of the assessment of function is the question of the reversibi-
lity of any abnormal features which may be noted. 
In attempts to evaluate the function of the isolated liver, at least three approaches may be 
cited which have contributed to assessment of the perfused liver. These are:- {i) the effects of 
total hepatectomy upon subsequent biochemical patterns; latterly this has been further 
extended during transplantation procedures when a poorly stored liver may be im-
planted. {ii) The assessment of the results of ischaemic liver necrosis and {iii) studies on the 
perfused liver itself - from both rats and larger animals. 
i) The effects of total hepatectomy 
This technique was first investigated from 1920 by Mann, Bollman and Magath in an 
attempt, by total removal of the organ, to analyse the resultant disorders and hence to derive its 
functional ability (164) . Overall, these experiments showed that after total hepatectomy, an 
animal could be kept alive, awake and normal for several hours with the infusion of dextrose. 
Terminally, after some 18 to 36 hours, drowsiness and coma ensued, accompanied by a 
progressive metabolic acidosis which was not reversible by conventional methods. Muscular 
twitchings, hypotension, Cheyne Stokes respiration and diminished urine output were also 
noted. Addition of glucose reversed most of these features for a t ime, and other anti -
hypoglycaemic agents including maltose, galactose, mannose, dextrin and glycogen were also 
effective. However, a number of other substances which relate to glucose metabolism and 
acidosis were found to be ineffective - these including saccharose, lactose, laevulose, insulin, 
sodium chloride, sodium sulphate, sodium bicarbonate and carbonic acid, ethyl alcohol, 
glycerol , lactic acid, acetic acid, hydrochloric acid, pyruvic acid, epinephrine, pituitary extract 
and glycoll (164) . 
In addition to the hypoglycaemia, there was a marked and progressive decline in urea 
levels, provided that the urine output was adequate, and a continued increase in a amino 
nitrogen. There was some excretion of uric acid and bilirubin into the urine but in general these 
substances accumulated in the blood. The animals also lost their ability to detoxicate various 
drugs. 
A more recent evaluation by Drapanas et al (60) has confirmed these observations and 
made a few additions. The most important of these was that there was no further evidence of 
anything other than ammonia for the "toxic" factor responsible for death . They added several 
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observations to the biochemical changes already recognised - viz . - the decline in pH, increase 
in serum potassium and glutamine and in regard to cerebral metabolism, a decreased glucose 
and ex oxoglutarate despite elevated serum levels of the latter. 
At the stage when no further treatment was effective, the use of para-biotic circulation or 
isolated liver perfusion was shown to reverse the syndrome (253,144), thus suggesting that 
the only treatment able to reverse the initial defects resulting from an absent liver was the 
insertion of a liver into the blood circuit. It was confirmed that the liver is entirely responsible 
for protein, urea and glucose synthesis and that there is an integral role in the function of the 
clotting mechanism (164,154). This last important observation has only more recently become 
apparent. Attempts to store the liver with subsequent transplantation have demonstrated 
clearly that the first biosynthetic defect to manifest in a poorly stored organ is a bleeding 
tendency (205). Despite a considerable amount of investigation, the precise cause has not yet 
been defined. It is known that the liver is responsible for synthesis of most of the clotting 
factors (6,281). Also a "scavenging" role has been proposed as Kupffer cells in the liver clear 
the circulation of fibrinogen degradation products and hence prevent the development of 
disseminated intravascular coagulation (89). 
(ii) lschaemia 
(a) \ntroduction 
An approach has been made to investigate liver function by observing the effects of liver 
ischaemia. Again the question of the reversibility of changes arises. In addition, the effects of 
ischaemia are difficult to assess in vivo, although attempts have been made in the dog to pre-
pare a model with isolated vasculature but still under the control of various hormonal mediators 
(95). In the pig, such a study is rendered more difficult by the short length of the hepatic veins 
which drain directly into the inferior vena cava and are inaccessible. Hence it cannot be 
assured that hepatic venous blood sampling is not contaminated with vena caval and thus 
renal effluent. Diversion of the vena caval blood into the jugular vein has been considered, but 
this could be hazardous in the unanaesthetised animal and variations in haemodynamics might 
occur. In addition, the flow of vena caval blood through the liver may be responsible for the 
removal of products of metabolism to the general circulation. Hence the majority of information 
on liver ischaemia has been accumulated from isolated perfusion experiments. Yet it has been 
suggested that such a perfused organ may have been subjected to hypoxia, hypercarbia and 
elevated levels of adrenaline and noradrenaline during hepatectomy (100), and that these 
effects could be carried over into the perfusion experiments. 
(b) The nature and process of biochemical dysfunction 
A number of workers have attempted to define precisely the initial abnormalities which 
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occur. Two phases of response have been suggested - (i) a response of the cell membrane to 
anoxia with release of potassium (252), and (ii) disintegration of the biochemical anatomy with 
freeing of the bound potassium from organic aggregates. 
Following hypoxia, however induced, the sodium pump becomes ineffective. Interference 
with the cellular energy metabolism is proposed to be the prime factor responsible (169). 
Although endogenous substrates such as glucose can supply some energy anaerobically, the 
stored soon become depleted with accumulation of acids and decline in the intracellular pH 
(162). The alteration in ionic strength in the cytoplasm results in the entry of water and swell-
ing of the cells and intracellular organelles. With breakdown of the energy supply to the cell 
wall, the membrane becomes permeable - sodium and potassium enter the cell, and 
magnesium is released (169). The increase of osmotic pressure resultant upon the entry of 
sodium leads to autolysis and an increase of intracellular molecules as synthesis ceases and 
waste particles accumulate (162). Swollen mitochondria are unable to perform oxidative 
phosphorylation after depletion of the respiratory cofactors NAO and ATP, and inorganic 
phosphate accumulates. The final stages of autolysis result from release of lysosomal enzymes, 
precipitation of protein, lysis of cell membranes and release of gylcogen and large intracellular 
particles. 
A major contribution to the further understanding of the process of biochemical disintegra-
tion has come recently from the laboratory of Sir Hans Krebs (33). Original studies had shown 
that the ratio 
13,0H butyrate x a oxoglutarate x NH
4 
acetoacetate x glutamate 
is constant in the normal rat liver. In ischaemia, with the accumulation of ammonia, acetoace-
tate transforms to r, OH butyrate and the pH decreases due to increase in lactate, with 
hydrolysis of ATP leading to the disappearance of bicarbonate and an increase in pC02. Under 
conditions of hypoxia, when the capacity of the urea cycle is impaired, the liver disposes of 
ammonia as follows: 
(i) NH!+ NADPH +Ht~ glutamate+ NADP-H20 
(ii) glutamate and pyruvate ~ a oxoglutarate + alanine. This group of experiments high-
lights the physiological role of a oxoglutarate, which will be noted again in discussion of other 
studies. 
(c) Reversibility 
This most important factor is ill-defined although several attempts have been made. A 
marked suppression of aerobic metabolism in rat liver slices was noted after an interruption of 
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blood flow for 15 minutes (286), but recovery was rapid . Longer periods of interruption led to 
further suppression with a slower recovery. A decrease in pH and loss of potassium (169) were 
also noted after temporary interruption of blood flow, and the release of magnesium and 
13 glucuronidase was noted to precede a rise in aspartate transaminase ( 169). 
In another approach to the problem of reversibility, Dawkins et al (58) attempted to define 
the alterations occurring in the liver during autolysis, and more importantly, investigated the 
value of provision of substrates to protect oxidative phosphorylation. From these experiments 
emerged "a pattern of the complex relationships upon which depended the life and death of 
the liver cell" . The levels of glutathione were shown to be reduced initially, preceding a fall in 
oxidative phosphorylation, and accompanied by a fall in ATP and NAO. Oxidative phosphoryla -
tion had been chosen as the index of viability since it had been shown to decline first during 
autolysis (58). It was found that oxidative phosphorylation could be maintained by the addition 
of a oxoglutarate, and was dependent upon the levels of oxygen and liver glycogen. The 
mechanism of action of oxoglutarate was not well defined since it appeared to act as more than 
a substrate and the activity was not replaced by L-glutamate, pyruvate and lactate. 
Adequate levels of liver glycogen were achieved by continued feeding of the animals up to 
the period of operation . The administration of high concentrations of glucose and oxoglutarate 
were found incapable of substituting for glycogen in the liver cell. 
It was concluded therefore, that there was a complex interplay of factors upon which the 
perfused liver depended. The most important factors were oxygen, adequate levels of ATP, 
glutathione, pyrimidine nucleotides and liver glycogen, and when these were depleted, the 
water and electrolyte balance of the cell and its mitochondria became disturbed. 
(d) The duration of ischaemia and the value of histology 
These factors have been investigated by a number of workers but their observations vary 
widely. Recent evaluation by electron microscopy has extended this range even further. 
The period of maximum tolerated ischaemia has been variously estimated according to the 
species studied and to the type of preparation used (256). A period of 20 minutes normothermic 
ischaemia due to inflow occlusion to the dog liver was found compatible with subsequent 
survival (215) but after 30 minutes, an increase in circulating levels of lysosomal enzymes was 
found, and 60 minutes was reported maximal for reversal of potassium efflux (252). After a half 
hour's normothermic anoxia, the perfused pig liver was found incapable of clearance of 
ammonia or BSP, or the regeneration of ATP (275), yet other workers have noted that "the 
majority of liver functions survive three hours anoxia with almost undiminished efficiency" 
(273), and animals have been found to survive after four hours ischaemia in an autograft model 
(97). 
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The value of histology - The normal morphology of the liver has only recently been more fully 
described with the demonstration of zonal differences to histochemical reactions ( 159). It has 
been suggested that residual enzyme activity may remain despite complete disintegration of 
cellular structures, and that mitochondrial systems may have a more resistant enzymatic 
activity than microsomes (245). 
Significant changes as a result of ischaemia were not noted by light microscopy until after 
4-6 hours (97) and despite the fact that permanent vascular damage resulted from ischaemi.a of 
longer than 60 minutes, no acute changes were seen; a moderate cellular degeneration 
occurred but no peri-portal changes were observed. After 2-4 hours ischaemia, lesions were 
noted in the sinusoids and outflow tracts of the liver, but not in the portal triad . 
However, by electron microscopy, centrilobular loss of glycogen was noted after 45 
minutes' ischaemia and mitochondria were noted to be swollen and poorly stained after 60 
minutes. 
Longer ischaemia resulted in centrilobular fatty degeneration and hydropic changes in 
parenchymal cell cytoplasm, and ultrastructurally, profound changes were noted in the 
sinusoidal epithelium with increase in the size of Kupffer cells and their granules which might 
obliterate the sinusoidal lumina and the space of Disse. Dilatation and vacuolation of the 
endoplasmic reticulum was noted with decrease in the number of heavy aggregates and 
increase in the lighter, with resultant decrease in RNA and protein synthesis. These changes 
were shown to be revers ible after 4 hours (216). 
The temperature under which ischaemia or hypovolaemia is sustained is critical. In 
perfusion studies (58) it was shown that between 35 and 43°C, there existed an optimal 
temperature for oxidative phosphorylation in the rat liver. There also appeared to be a direct 
correlation between temperature and the rate of accumulation of calcium, which was also 
related to the decline in oxidative phosphorylation - for example, glutathione levels were better 
sustained at 35 than 38°C. Hypothermia to 30°C resulted in release of potassium without 
glucose, whilst with further reduction to 15° both were liberated (101 ). In studies using the 
slowly cooling liver to evaluate the effects of temperature, van Wyk et al (275) showed that 
even a slight decrease in temperature afforded a marked protection to function as assessed by 
perfusion. Reduced blood flow also accompanies cooling (149). 
iii) Methods chosen in this study 
Introduction 
It is difficult to compare the physical and biochemical characteristics noted by other 
workers. This is compounded by the fact that, in many experiments, human blood has been 
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used without comparison with homologous perfusions. In addition, few studies exist in which 
the function of the isolated organ has been compared w ith that of the intact animal (74,268). 
and hence evaluation is valid only when comparing one perfused liver with another, and one 
series with another, but not when comparing physiological values relating to the intact animal. 
The few studies comparing liver function in vivo and in vitro demonstrate a major deficit in the 
function of the isolated liver. 
A great deal has been written concerning the assessment of function of the perfused 
organ, especially in regard to the rat liver (9), but the studies reported here have been directed 
towards the clinical problem of hepatic assist. Hence, a range of functions has been used to 
give a broad spectrum for assessment. These have been used with varying frequency during 
perfusion and hence will be briefly described prior to the presentation of each group of experi-
ments. After this presentation, reasons will be given for alterations in assessment. Based on 
the information outlined above, the experiments to be described have been assessed as 
follows: 
(a) Physical characteristics 
(i) Resistance - the ratio of pressure either in cm H20 for the portal system or mm Hg for the 
arterial system, divided by the flow rate in ml / g/ min for each system provides a better index of 
the response of the liver to the flow offered, than do pressure or flow alone. The results are 
expressed in arbitrary peripheral resistance units for which the quoted maximal values are 
0,02 in the portal system and 1,0 in the arterial system (192) . Factors influencing resistance 
have been carefully evaluated in the dog liver and include histamine, endotoxin, acidosis, 
adrenaline, noradrenaline, temperature and hypoxia (69). However, the mode of action of most 
of these substances is thought to be via the " outflow block" which bedevils experiments with 
the dog liver where spasm of prominent sphincters in the hepatic veins results in total cessa-
tion of flow (69). These sphinters are poorly developed in the species under review and hence 
most of these factors do not interfere with perfusion. 
(ii) Total flow - It has been suggested that the optimal flow rates for the liver are from 0,5 to 
1,0 ml / g/ min (61) but that these may be reduced if flow takes place through both the portal 
and arterial systems (61 ). The total flow rate to the liver has been variously calculated (268). In 
experiments using direct cannulation of the vessels with the liver still in situ, and with minimal 
anoxic time, flow rates of 0,6 ml / g/ min were obtained without excessive pressures (168). A 
factor of great importance is the inherent regulation of flow for example after digestion. 
Certa inly it has been demonstrated in studies of the isolated frog or rat liver, that individual 
areas of the liver are not all perfused simultaneously, but that regulation by sphincters results 
in intermittent filling and emptying. It has been suggested that intermittent changes in size of 
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the reticulo-endothelial cells are the basis of this regulation of blood flow (185). Further 
regulation of sinusoidal distension may be achieved by outflow vascular resistance which is 
thought to promote maximal blood/ hepatocyte contact (274). In the experimental design, this 
may be achieved by siting of the vena caval catheter so that intermittent filling and emptying of 
the liver results. However, the pressure in the vena cava must be monitored carefully, since in 
some instances, high resistance to caval drainage resulted in the development of outflow 
block. In the same experiments it was felt that a positive outflow pressure improved bile flow 
rate (56) . Certainly it is generally accepted that increased outflow tract pressure increases the 
rate of ascites formation (190). 
It has been questioned whether a pulse is needed in the arterial system - indeed, whether 
perfusion of the arterial system is necessary at all. In the absence of pulsation, an increase in 
pressure and reduction of flow into the hepatic artery was noted (187), whilst in the total 
absence of arterial supply, it has been observed that biliary secretion rate drops (65) and that 
citrate cycle metabolism is less effective (271 ). 
Optimal division of the flow rates has been quoted to be 0,32 ml / g/ min through the 
arterial system, and 0,65 ml / g/ min through the portal system, this latter being 85-90% 
saturated with oxygen (129). 
(iii) Pressures - Arbitrarily, but based on observations made in random animals during 
anaesthesia and prior to dissection of the liver, the maximal pressures accepted in this study 
were 15 cm H20 in the portal system and 100 mm Hg in the arterial system. 
(iv) Bile flow rate - In the experiments to be described, initial studies were performed to 
evaluate the rate of flow and the trend in secretion rate during perfusion without the addition of 
any form of choleretic. Thereafter, since biliary secretion rate in the pig has been shown to be 
dependent upon bile salt load, the circulating secret in level and neurogenic stimuli (104) and 
since the action of the former substances lasts only 1 Vi to 2 hours unless replenished, arbitrary 
amounts of bile salt and secretin were added to perfusions as a continuous drip infusion. The 
bile salt selected was deoxycholate which . is the principal acid secreted in the pig bile 
(105); this was obtained as the intravenous preparation of the sodium salt - Decholin (BDH). 
Bile flow may also be stimulated by cholic acid (289). 
Investigation of the effect of hypertonic solutions upon bile secretion (44) has resulted in 
the proposal of two mechanisms of secretion - osmotic activity leading to water and electrolyte 
excretion, and active secretion of bilirubin and bile acids. It is also suggested that the action of 
secretin has been to produce a fluid rich in bicarbonate and poor in chloride, or a fluid with 
fixed electrolye composition unrelated to ion exchange or reabsorption within the biliary tree 
(102). The bile salts are supposed to act as osmotic diuretics with reduced chloride and 
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bicarbonate levels (104). As a result of this confusion surrounding biliary secretion, a great deal 
of work is necessary to elucidate precise mechanisms (76). From the numerous regulatory 
mechanisms however, it is obvious that the measurement of bile flow alone without evaluation 
of the quality and composition of the secreted fluid, is not an indication of function but rather of 
substrate availability. Similarly the wide ranges of flow rate reported from different centres 
may relate to the added use of choleretics. 
Haemobilia as a result of arterial pressure greater than 150 mm Hg or a total flow greater 
than 1,0 ml/ g/ min, clearly indicates gross damage (61 ). 
(b) Biochemical characteristics 
Many tests have been suggested for the function of the perfused liver (3,2). In this study, 
functions were chosen which gave evidence of - cell membrane integrity, viz. electrolytes and 
oncotic pressure; - the provision of energy from glucose and lactate metabolism; - the acid 
base status and oxygen consumption; - damage to liver parenchyma. 
- The evaluation of cell membrane integrity has been made in relation to the known factors in 
ischaemia and necrosis as described previously. Elevation of plasma potassium and increase in 
osmolality were taken to suggest greater membrane permeability with leakage. More recently, 
direct measurement of membrane potential has been suggested by Lambotte (147,148) in 
which maintenance of the mean potential difference resultant upon passage of a probe 
through at least 50 cell membranes has shown good correlation with results of reimplantation 
of such organs. 
- Interpretation of the metabolism of glucose has been complicated by lack of knowledge of 
the in vivo and perfusion relationships. The results of study of glucose metabolism are 
conflicting - many workers propose that a rise in perfusate level during experiments indicates 
synthesis of glucose ( 136), perhaps from gylcogen or lactate. Other workers report uptake of 
glucose by the liver (198) but the interpretation of these conflicting results is uncertain. 
Contributing facts may be (a) different conditions of starvation preceding the procedure; (b) a 
wide range of perfusate glucose levels; and (c) the reduction of levels of insulin and glucagon 
in the perfusate due to the short half-lives of these hormones, and to their destruction by the 
trauma of oxygenating systems (163). Again two divergent reports exist concerning insulin 
metabolism - one suggesting no significant effect of insulin on glucose metabolism by the 
perfused liver (183) and another in fact demonstrating an effect if transhepatic measurements 
were made (126). Regulation of glucose metabolism has been shown to be dependent upon the 
breakdown of glycogen into glucose, the entry of glucose into the cell under the influence of 
insulin, and the availability or high energy phosphate to catalyse anaerobic phosphorylation of 
glucose to intermediary compounds and pyruvate. Thereafter aerobic oxidation occurs of 
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pyruvate via the Krebs cycle with transfer of electrons by respiratory chain enzymes within 
mitochondria for oxygen consumption. In addition, the liver can synthesize glycogen or glucose 
by reversal of lactate/ pyruvate metabolism (60). 
- Lactate/ pyruvate metabolism has been measured according to the recommendations of 
Huckabee (123,124) since the ratio gives a better index of cellular oxidation and aerobic 
metabolism as the reaction is coupled to the redox status of the NAD/ NADH 2 system by the 
action of lactate dehydrogenase. Assessment of lactate metabolism in the intact dog showed a 
negligible rate in the resting state (95) but variations with different oxygen saturations have 
been noted (129) - 0, 11 ml/ g/ min with 100% saturated blood, and 0,22 ml/ g/ min with 50% 
saturated blood. The clearance of lactate has been proposed as a sensitive index of the 
adequacy of perfusion and since a oxoglutarate has been noted to rise with the administration 
of lactate, a maximal rate of metabolism has been postulated (270). 
- The isolated liver should provide an admirable basis for the study of the role of the organ in 
acid base metabolism, but since no comparative in vivo studies are available, the significance 
of alterations in acid base status is unknown. The pH of the perfusate is maintained arbitrarily 
at 7,4 by the addition of sodium bicarbonate since a trend towards acidosis has been 
associated with increase in circulatory resistance (5). It may be that a slow trend towards 
acidosis should represent accumulation of organic acids resulting from metabolism, but the 
buffering capacity of the liver is not known. 
- Oxygen consumption has been proposed to be a single, reliable guide to function (3), but 
when the blood flow is slow or static, the rates of consumption may be falsely elevated due to 
the longer availability of blood for extraction of the oxygen. 
- Damage to liver parenchyma has been assessed by the measurement of aspartate 
transaminase which has not been used much by other workers, presumably because of the 
associated damage to red blood cells in oxygenation and pumping, with release of the enzyme. 
However, in these studies, the plasma haemoglobin level has always been related to changes 
in enzyme level. Damage to the liver has been reported to occur during hepatectomy (12,193), 
but this accumulation should be rinsed out during flushing . In addition, an intra-operative 
period of recovery from "unconventional ischaemia" has been proposed by Abouna (3), and it 
has been suggested that adequate perfusion may reverse damage which has occurred during 
hepatectomy (103). However, during perfusion, no extra-hepatic regulation can occur of the 
mechanical pumping of arterial flow into the liver and overperfusion and damage are likely to 
occur. 
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(c) Biliary secretion 
Apart from the observation of flow rate, plasma alkaline phosphatase and cholesterol, 
biliary electrolytes and osmolality were also measured. However, the relationship of biliary 
electrolytes and osmolality to those of the plasma is not known. Whilst the integrity of cell 
membranes could again be invoked to explain differences in electrolyte levels, the role of active 
transport and secretion has yet to be elucidated for the biliary system as has been expounded 
for the renal system . 
Plasma alkaline phosphatase and cholesterol were selected as having clinical significance 
and should be of value at least in confirming evidence of biliary stasis. However, in perfusions 
of this short duration, alterations were small and insignificant. 
(iv) Excretory characteristics and clearance 
These have not been evaluated in this series of perfusions. In other work, indocyanine 
green, Rose Bengal (289), bilirubin and BSP (156), have been used to determine clearance . 
BSP has not been used by some workers as a single bolus dose (156), since it was found to be 
rapidly removed before adequate mixing could take place. Although isolated liver physiology 
has been evaluated by the use of BSP (42), neither BSP nor ammonia clearance was found as 
sensitive to changes in temperature as lactate clearance (257). More recently, however, it has 
been suggested that the BSP transporting ability is a more sensitive index of liver cell damage 
than the pure measurement of BSP retention (3) and the isolated organ is ideal for this 
measurement since there is ready access to the bile. 
Further evaluation of the mechanism of clearance has suggested that a functional division 
may exist (79) - parenchymal clearance of galactose and lactate, hepatobiliary clearance of 
BSP, bilirubin and Rose Bengal, and mesenchymal clearance through the Kupffer cells of 
various particles. It is now thought that there are two components to clearance - removal of 
the substance by the liver, and storage within the cells with subsequent release (284). 
Galactose elimination has been suggested to be independent of bile and blood flow and to be 
representative of functional cell mass (128). 
(v) Synthetic ability 
Sir Hans Krebs has recently stated that the only true means of evaluation of the function of 
the liver is in the study of its synthetic ability ( 145) and indeed sophisticated studies in the rat 
liver have been performed in that laboratory (111 ), and by Exton and Park (77) and many 
others, but these belong to the realm of the physiologist. The studies to be described benefit 
from the results of these sophisticated investigations, but in the interests of practicability, such 
work does not have direct application in this clinically directed programme. 
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(vi) Reimplantation 
Reimplantation , however, constitutes the only true method of assessment of total liver 
function, but due to the complexity of the procedure, only a few such studies have been per-
formed. Kestens (136) has reported survival after perfusion at normal temperatures for periods 
of 6-8 hours. This technique holds the key to the solution of the coagulation problem, since in 
the perfusion system due to the presence of heparin, few adequate studies have been made of 
coagulation factors. 
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A. PREPARATION OF THE LIVER 
Probably the most important and least studied contribution to the success of liver perfusion 
lies in the selection and surgical preparation of the donor animals. Hence, the following section 
is dealt with in detail. 
i) Animals 
In the original design of the study, it was decided to commence the investigation using 
pigs. The porcine liver had been used in the majority of clinical hepatic assist procedures repor-
ted, and hence seemed suitable. In addition, recent knowledge and experience in the handling 
of the animal had been obtained by one member of the Liver Research Group. 
Pigs have generally been selected for use in such programmes because they are cheap and 
easy to maintain (64); the liver is free from bacteria, and, perhaps the most important factor, 
they do not manifest the "outflow block" which has complicated research using the dog liver. 
The response of hepatic vein sphincters which are poorly developed in the pig, is practically 
never seen, although it is suggested that in isolation, some venous obstruction may result in 
the presence of acidosis (274). Perhaps the only disadvantage to the use of the pig liver is the 
lack of biochemical information available especially for the age of animals used. Hence a study 
was made during initial experiments in a transplantation programme, in which normal bio-
chemical, haematological and organ weight values were collected (116,119). 
With subsequent extension of the perfusion project, it was decided to use baboons, calves 
and lambs. Little work has been published on perfusion of the isolated baboon liver since the 
animals are not readily available in other countries; sheep livers have been used in a variety of 
physiological studies (156) and the calf liver has been used both for physiological and clinical 
application (26). 
Pigs were obtained from two farms in the Western Cape from the general market stock. 
They were transported aged about four weeks just after weaning, and were not castrated . The 
breeds used were Landrace, and cross Landrace/ Large White. The optimal weight for handling 
was 15-20 Kg, and such animals provided livers weighing between 540 and 720 grams, which 
were suitable for the design of the circuit and the priming volumes used. 
Lambs and calves were obtained from farms at random and were selected to be as small 
as possible to provide comparable organ weights. 
Baboons (of the Cape Chacma type, Papio ursinus ursinus) were obtained by courtesy of 
the University of Stellenbosch Primate Facility at the Karl Bremer Hospital. These were used 
according to available size - ranging from 7 to 15 Kg. 
All animals were maintained on standard rations for the duration of their stay - pigs 
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received a commercial ration (Creep meal) which contained recommended ratios of 
carbohydrate, fat and protein with supplementary vitamins and minerals. Calves and lambs, 
being very young, were procured the day before use and hence needed little feeding . Baboons 
rece ived a standard vegetable diet. 
ii) Preparation 
(a) Pre-operative: Except in experiments where otherwise stated, all animals were starved 
for 24 hours prior to surgery. This was of particular importance in regard to the pig where the 
bowel occupies a large area in the abdominal cavity and renders dissection and retrattion 
almost impossible if filled with solid pultaceous faeces. The pig also appears to have a slow 
gastric emptying time and hence required starvation for the minimum of 24 hours. Animals 
were offered 5% dextrose water but in general did not take this. Further investigation of the 
possibility of feeding a liquid diet is necessary since it has been clearly shown that various 
aspects of liver function are protected in livers in which there is an adequate store of glycogen 
(58). 
In animals which were to be used for clinical hepatic assist, antibiotics were given -
chloromycetin, penicillin and streptomycin which covered the flora cultured at random in the 
laboratory. If insufficient time was available before the dissection was undertaken, penicillin 
and rolitetracycline (Reverin) were given intravenously during removal of the liver. 
(b) Anaesthetic techniques: These varied with the different animals used. 
Pigs: Initially halothane anaesthesia was used with great success, but after interruption of 
the programme by the complication of malignant hyperpyrexia which occurred in 25% of the 
Landrace pigs used ( 107), this drug was abandoned in favour of the injection of sodium 
Pentothal into an ear vein. No premedication or sedation was used and during injection the pig 
was manually restrained . Usually 10-15 ml of a 0,5% solution injected over 2-3 minutes 
allowed ample time for weighing and positioning of the animal on its back for insertion of an 
endotracheal tube. This was achieved under direct vision by standard techniques (260) using a 
Magill laryngoscope with xylocaine spray to the vocal cords. Anoxia was encountered on only 
two occasions and tracheostomy was never employed. A wide bore Ryle's tube was passed 
also under direct vision, to provide drainage of any residual fluid in the stomach. 
The endotracheal tube was connected immediately to a mechanical (Cyclator) ventilator 
with a closed Magill-type circuit. Pressure and rate of ventilation were adjusted to those 
observed in the animal and were controlled by blood gas analysis. Initially, attempts were 
made to continue the abdominal operation under nitrous oxide/ oxygen anaesthesia alone, but 
the muscular relaxation was inadequate, and 5 tubocurarine 1,5 mg was injected as soon as an 
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intravenous line was established. This relaxant was sufficient for the duration of the operation 
and was not reversed; however the drug was not used in preparations for clinical procedures. 
Baboons: These animals were immobilised in a "squeeze cage" and sedated with an intra-
muscular injection of Ketamine 5mg/ kg. The duration of action of this drug was 20-30 
minutes, but within 10 to 15 minutes, the animal was relaxed and could not bite. An 
endotracheal tube was passed under direct vision and initial anaesthesia was maintained with 
nitrous oxide, oxygen and halothane. As soon as the intravenous route was established a simi-
lar dose of curare was injected. In general a stomach tube was not required. 
Calves and lambs: These animals were induced with halothane administered through a nose 
cone, and anaesthesia was subsequently maintained with nitrous oxide, oxygen and 
halothane. Relaxation with curare was also employed. 
(c) Intra-operative fluid: Replacement fluid took the form of 10% Invert Sugar in Ringer lac-
tate - 300 to 500 ml being given during the procedure according to the size of the animal and 
the blood loss. In addition, in later experiments, as soon as the intravenous route was 
established, 25g of dextrose was given to restore hepatic glycogen stores after depletion by 
starvation, and to prevent total depletion by the effects of adrenaline stimulated during surgery. 
Total body heparinisation was achieved by the administration of 2mg/ kg just prior to final 
removal of the liver. 
iii) Operative technique 
In general the operative procedure was similar in all animals, but certain differences will 
be highlighted. 
The internal jugular vein was cannulated with a Portex umbilical feeding tube (Fg 9) as an 
initial procedure to provide an intravenous route for drug administration. This was particularly 
important in the pig which has small peripheral vessels. For convenience an arterial pressure 
line was established through the same incision, in the common carotid artery. This consisted of 
a short length of intravenous infusion tubing attached directly to a "Tycos" pressure 
gauge; this line could be filled and flushed with heparinised saline and resulted in a very 
efficient monitoring apparatus. 
A midline abdominal incision was chosen as the most practicable although the possibility 
of a subcostal transverse incision was also explored. This latter resulted in considerable blood 
loss and did not materially improve the exposure. As these animals all have long narrow chest 
cavities, the livers tend to be high up under the costal margin, and when necessary, the chest 
was opened. 
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Dissection commenced around the left diaphragmatic border of the liver with incision of 
the triangular ligament and incision into the lesser sac. The hepatic artery of the pig lies to the 
left of the portal vein and hence can easily be felt and dissected (see Figure 3). The first branch 
to the stomach was ligated and the dissection continued down to the pancreatico-duodenal 
branch of the coeliac which was also ligated. During this and subsequent dissection, it was 
found important to incise and leave open any lymphatics. The pig periportal and peri-hepatic 
arterial tissue is particularly rich in lymphatics and it was found that ligation or cautery of these 
resulted in oedema of the porta hepatis which often became gross and was thought to contri-
bute to oedema around the intra hepatic portal radicles with resultant rise in portal pressure. At 
this stage of the procedure, the peri-portal tissues were approached and freed from surround-
ing structures. The bile duct was identified and dissected from the junction of the cystic and 
hepatic ducts down to the entry into the duodenum, which in the pig is only a few millimetres 
distal to the pylorus (247). The duct was ligated just above the duodenum and a catheter 4mm 
in diameter was inserted for drainage of bile as an intra-operative collection. This sample was 
drained for an hour and served as the pre-perfusion control. The cystic duct was immediately 
dissected and ligated to prevent drainage from the gall bladder. The cystic artery was pre-
served. In further dissection of the portal vein, a large constant lymph node was found on the 
right side and was removed with a number of smaller inconstant nodes which seemed more 
prevalent in younger pigs. The pancreatico-duodenal tributaries of the portal vein were ligated 
and the portal vein was dissected free down to the confluence of the superior mesenteric and 
splenic veins. At this point it was possible to palpate the hepatic artery dorsal to and on the left 
of the portal vein and access to it could be more easily obtained by retraction of the vein to the 
left. Hence the artery could be freed from the branches of the coeliac axis. Depending on the 
calibre of the vessel, dissection was limited to the provision of an adequate length for cannula-
tion. In the baboon, it was necessary to include a segment of aorta in dissection, since the 
calibre of the hepatic artery was insufficient for effective cannulation. 
Attention was next directed to the dorsal surface of the liver. In the pig, the infra-hepatic 
cava is extremely short before it is covered by a tongue of liver, and hence careful dissection 
has to be made of the liver from the diaphragm. However, the liver is much less adherent to the 
diaphragm than that of the baboon. This adherence was more marked in the younger animals 
and resulted in difficulty with the baboon liver which seemed more friable. 
The phrenic veins were next ligated and the liver was totally free of all attachments except 
a full vascular supply. At this stage the animal was heparinised and a short recovery period of 
30-45 minutes was allowed while the circuit was primed and blood and diluting solution were 
mixed and warmed, and while blood gas analyses were performed. Final removal of the liver 
commenced with ligation of the portal vein above its origin, and insertion of a length of Silastic 
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Figure 3 : The hepatic arterial anatomy of the pig, calf and lamb. The 
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tubing 6mm diameter. Through this catheter infusion of the cooling and flushing solution was 
begun. As infusion continued, the infra-hepatic vena cava was clamped and the diaphragm 
around the supra-hepatic vena cava was incised. The supra-hepatic cava was traced up to-
wards the right atrium and was clamped as high as possible. The cava was incised to release 
the infusion fluid which had accumulated in the liver. If large enough, the hepatic artery was 
cannulated directly with a Portex umbilical feeding tube (Fg 9), and infusion commenced 
immediately. If too small, the artery was closed with a bulldog clamp and the segment of aorta 
was removed. The lower cava was cut and the liver was removed to a bowl for collection of the 
flushing solution and cannulation of the remaining vessels. The vena cava above and below the 
liver was cannulated with a Y-shaped tube since it had been found beneficial to drain both ends 
of the cava; if the lower end were tied or included a thermometer probe, the small caudate lobe 
became markedly distended. These cannulae were inserted allowing a short segment of vessel 
free above the exit to allow the intermittent filling and emptying which was thought to simulate 
cardiac action and the intermittent negative pressure on the sinusoids. If the hepatic artery had 
not been cannulated in the animal, the aortic segment was ligated and all air excluded by 
infusion of fluid through the Portex umbilical feeding tube which was then tied into the vessel 
and the bulldog clamp released to allow flushing of the hepatic artery which was continued 
under slight pressure from the intravenous infusion set. 
The liver was then transported to the perfusion laboratory where it was inserted into the 
circuit after initial preperfusion samples had been taken. In all cannulating procedures and 
with connection into the circuit. great care was taken to eliminate air since this resulted in 
extremely high resistance particularly in the hepatic arterial system. The final temperature of 
the organ was recorded just prior to the institution of perfusion. When the perfusate 
temperature was 4°C, the liver arrived in the laboratory at a mean temperature of approxima-
tely 12°C, whereas when-the perfusate temperature was 37°C, the final recording was approxi -
mately 26°C. 
Dissection of the calf or lamb liver differed slightly in that the organ lay entirely to the right 
of the abdominal cavity being displaced from the left by the stomach (see Figure 3). The portal 
vein was short and covered by the pancreas, with many small pancreatic tributaries which 
hindered dissection . The portal vein was directed towards the left at the porta hepatis as the 
left gastric vein formed a large tributary. The intra-hepatic cava was more inaccessible than in 
the pig as the whole plane of the liver was tilted towards the right hence covering the area of 
dissection. In addition, the vena cava was more retro-peritoneal than in the pig and required 
more dissection. 
iv) Blood and blood grouping 
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Pigs - have a number of blood groups of the minor type (179). Following much experience with 
a transplantation programme in the pig, it became evident that no cross-matching of blood 
between these animals was necessary. No allergic response was ever seen in the numerous 
instances of infusion of abattoir blood to liver transplant recipient animals. However, it has 
been shown that pig erythrocytes cross react with human sera and that the pig can thus be 
"grouped" into A. Band Ohuman types . For the purposes of the experiments to be described, 
only the A grouping was made since the preparation of the anti-B test serum requires a project 
of its own. Animals were thus designated A or O according to the reaction of erythrocytes with 
a specific human anti-A serum, prepared according to the method of Lockyer (157) by absorp-
tion of heterophile antibodies with pig group O erythrocytes. 
Porcine blood for homologous perfusions was obtained fresh on the morning of the experi-
ment from the abattoir. Animals among the general market stock were initially stunned and 
then hoisted by a chain around the hind limb on to a conveyor belt. Whilst the animal was thus 
suspended, the throat was slashed and the blood was collected directly into a 5 litre plastic 
container through a plastic funnel. Although this was relatively clean, no attempt could be 
made to collect blood under sterile conditions. 
Baboons - secrete in the saliva and other secretions, substances analogous to the human 
blood group substances, and hence these animals were grouped as humans into groups A. B 
and AB. Blood group O does not appear to exist in baboons (176,285). 
Calves and lambs - Since little information could be found concerning the _blood groups of 
these animals, they were used ungrouped. 
Human blood for heterologous perfusion was obtained fresh from the Blood Transfusion 
Service on the morning of the experiment. Initially collection was made into glass bottles, and 
the subsequent change to plastic packs seemed not to alter the P.latelet counts nor their 
response in perfusion. 
v) Anticoagulants 
Since citrate metabolism has been shown to be impaired in the presence of poor liver 
function (271 ), it was originally decided in the clinical management of patients with massive 
liver cell necrosis to select heparin as anticoagulant. Hence all experiments were performed 
with heparinised blood. While the standardisation of the dose added to human blood was easy 
(22,5mg/ 500ml), it was more complicated for the blood to be collected from the abattoir. 
However, it was felt important to ensure adequate heparinisation and hence 250mg was 
injected into the container which usually held 2-2,5 litres of blood. This final concentration of 
0,4mg/ ml was ten times that in the human blood. 
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In regard to the analysis of perfusion samples, the use of heparin was a complication in 
that fibrinogen cannot be measured in the presence of heparin, and high concentrations of the 
drug can interfere with the measurement of complement (90). However, the concentration 
used in any one experiment was constant as far as is known, and comparison was made of 
data within each experimental group. 
B. THE PERFUSION CIRCUIT 
i) General 
The circuit was designed with the principal objective that it should be compact and 
portable for clinical application. In addition , with the original plan that such procedures might 
be applied in the ward beside the patient's bed, all parts of the apparatus were adjustable in 
height (F igure 4). 
A single trolley was designed on which were carried the pumps, and the perfusion 
chamber, and which also provided electrical connections. As will be seen from the diagram, 
the pumps were sited to one side of the trolley with the oxygenator supported on adjustable 
rods which could be inserted into rings welded onto the base of the trolley. The chamber, 15" x 
1 O" oblong and 1 O" deep had a sloping base down to an exit tube. The chamber was closed 
with a lid of glass and steel so that closed observation of the liver could be made. Holes drilled 
in the sides of the chamber allowed exit of catheters, and the lower exit tube drained ascites or 
any blood leakage. Bile was collected in a graduated tube within the chamber in order that the 
length of the draining catheter should not provide too great a resistance to bile flow. The liver 
was supported within the chamber on a diaphragm of soft fibre-glass gauze which was 
attached w ithin the chamber by elastic hooks from each corner. Mobil ity was ach ieved in later 
experiments by attachment to a small motor with an eccentric wheel and adjustable speed 
(Figure 5). The excursion provided to the diaphragm was 5cm/ cycle and the rate was set at 16-
20 cycles per minute. Although no definite studies were performed, it seemed that this move-
ment resulted in better perfusion of the posterior surface of the liver. 
ii) Oxygenator (Figure 6) 
In the original investigation of the available types of oxygenator, the bubble type was selec-
ted. The disc type, whilst perhaps superior in regard to its trauma to blood, was tedious to clean 
and expensive in requiring new discs to be obtained if damaged during use. The membrane 
oxygenator. whilst probably superior was both unavailable in the country and prohibit ively 
expensive to import. The disposable bubble type (Rygg Kyvsgaard) was freely available and had 
been used for clinical and experimental work so that much experience was available. The 
smallest "Infant" type was used. A priming volume of 2Vi litres was needed to continue a four-
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hour perfusion during which a gas flow of 500-1 OOOml/ min was needed. Subsequent studies 
reported in more detail in a later chapter resulted in the use of a smaller oxygenator - the 
Travenol Miniprime bag wh ich required a lesser priming volume of only 1,5 litres and a gas 
flow of 300-400 ml / min. 
iii) Gas 
In previous descriptions of perfusion circuitry, a 95% oxygen 5% CO 2 mixture was used. 
However, it was found that pure oxygen and carbon dioxide were more readily available locally 
than mixtures which had to be transported 1 300Km with inevitable delays. Hence a rota meter 
block was obtained by courtesy of the Anaesthetic Department, Groote Schuur Hospital , 'and 
individual gas rates could be used. A final oxygen rate of 300-350 ml/ min and carbon dioxide 
rate of 30-50 ml/ min were used, giving a final concentration of 91 % 0 2 and 9% CO 2 . Final 
adjustments were made according to the blood gas analyses when the flow rates had been 
determined. 
iv) Pumps 
Individual Sarns roller pumps were chosen for their ability to provide relatively non-
traumatic pulsatile flow. Although several workers have claimed successful perfusion with 
portal supply only, or with an arterial infusion by gravity from the main portal line (61 ), in this 
experimental model, as physiological a preparation as possible was sought, and hence the 
hepatic artery was perfused individually and under pulsatile conditions. Each pump was set at 
optimal calibration of rollers (recommended occlusion such that a column of fluid 36" high 
should fall less than 1" in 1 minute), and the individual stroke volumes were calculated accord-
ing to the tubing used. These were measured at a number of different speeds and the results 
graphed. Subsequent flow volumes were calculated direct from the pump speed. 
v) Tubing 
In view of the diverse application of the perfusion model, it was· thought preferable to use 
silicone rubber rubing (Silastic) throughout the circuit. All except the segment through the 
hepatic arterial pump was 0,625 cm internal diameter, and the arterial section was 0,25 cm 
internal diameter; this bore was selected to allow a smaller volume to be delivered by a 
relatively fast pump speed. For experimental perfusions, tubing was rinsed in cold water and 
then soaked overnight in warm Lux flakes. It was then left to dry. A Dow Corning medical grade 
si licone spray was applied to all non-tubing portions of the circuit after every 5 or 6 perfusions. 
In clinical hepatic assist procedures, as much disposable apparatus as possible was used and 
discarded, including tubing and connectors. 
vi) Other 
Connectors were limited in number in the circuit and were made of polypropylene (Portex). 
42 








Figure 6 : Diagrams of the Rygg-Kyvsgaard and Travenol oxygenators. 
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A specific cannula for the double vena caval drainage was constructed with a T-piece and a Y 
(Figure 7). 
Figure 7 : The Y-piece inserted into the supra- and infra-hepatic vena 
cavae. 
Heat Exchangers were constructed of highly polished stainless steel on the design of 
Brown Harrison (88) and heating water was delivered to the outside jacket by a thermostati-
cally controlled laboratory water circulating unit at a maximum of 5 litres/ min. 
The final circuit is shown in comparison with that used for clinical perfusions (Figure 8). It 
was decided to use a similar circuit for clinical hepatic assist purposes for several 
reasons. (i) The technique when applied clinically is time-consuming and requires complete 
familiarity with the mechanics and circuitry and hence it seemed preferable to use the routine 
laboratory circuit. (ii) In the majority of clinical perfusions described by other workers, there 
has not been an oxygenator in the circuit, as the patient was connected directly to the liver and 
his own system was relied upon to provide oxygenation. However, it was felt that this 
technique was too hazardous in a patient with a failing circulation, or in a child with a small 
blood volume, and it was decided to incorporate an oxygenator into the circuit to ensure that an 
adequate volume of blood was available to supply the liver at all times. A similar inclusion is 
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being described more frequently in perfusion techniques. The c ircuit is shown provided the 
security of being able to isolate the liver and the patient with only two clamps without 
jeopardising either. However, as will be discussed later, the inclusion of the oxygenator could 
be questioned in the light of subsequent results . 
In most previously described perfusions, there has been little measurement of the flow 
rate obtained from the patient, which rendered particularly difficult the assessment of the 
volume to be returned from the liver outflow. It was thus decided to allow the patient's blood to 
drain directly into a reservoir sited above the draining into the oxygenator, in which the flow 
rate could be measured. A Y-connection from the venous return line via a bubble trap and pump 
provided return to the patient. In this manner, the haemodynamic state of the patient could be 
more easily balanced. 
vii) Sterility 
Experimental liver perfusions were not performed under sterile conditions but for hepatic 
assist procedures, the system was boiled, autoclaved or gas sterilised, and the animals were 
given antibiotics. 
viii) LiverWeight 
For the pig, the weight of the liver. upon which the flow rate was dependent, was assessed 
as 3,64g/ 1 OOg total body weight (live). Since any method of direct weighing involved the 
estimation of fluid retained within the organ, and cannulae as inserted, it was felt to be as 
accurate to estimate the organ weight from the total body weight. These weights had been 
obtained during the transplant programme (119) when the livers from recipients were dis-
carded to the sink and allowed to drain for 15 minutes before weighing. This weight was then 
related to the total body weight of the animal just after anaesthesia and a mean of fifty estima-
tions was used in the perfusion programme. It has been noted, in justification of the use of this 
mean, that the pig liver can more than double its empty weight when maximally distended 
(292). The calf and lamb livers were assessed at 1-2% total bodyweight (247). 
ix) Technique 
Perfusion was commenced approximately 40 minutes after initial devascularisation of the 
liver, after pre-perfusion samples had been taken and the Astrup corrected. The priming blood 
was warmed to 38°C before insertion of the liver into the circuit; some authors prefer to warm 
blood and liver simultaneously (156), but it was felt that this might give rise to some problems 
of haemolysis. 
Factors considered during initiation of the perfusion were (i) the weight of the liver, 
and (ii) arbitrary perfusion pressure maxima of 15 cm H
20 in the portal system and 100 mm 
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Figure 8 : Diagrams of the circuits used for experimental and clinical 
perfusions. 
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Hg in the arterial system. Perfusion was commenced simultaneously through both pumps 
adjusted to flow rates which resulted in these pressures. Over the course of the first 30-45 
minutes, in most cases, the flow rate could be increased gradually as the liver rewarmed and 
the intravascular resistance declined. It was hoped in all cases to achieve a total flow rate of 
1,0.ml / g/ min with a distribution of 70-80% flow through the portal vein. Resistance reduced 
rapidly as the temperature approached 35-36°C, after which rewarming proceeded more 
slowly. After achieving the estimated total flow, this was not diminished unless gross elevation 
of pressures occurred. In general, it was preferred to observe subsequent alterations of 
pressure at the chosen flow rate. 
A negative pressure was maintained in the venous return line by positioning of the 
catheter as detailed previously. Bile samples were collected hourly, and the ascites which 
flowed from the liver surface and the incised lymphatics was returned to the prime. 
In perfusions using the Rygg bag oxygenator especially, an additional line was taken from 
the venous return reservoir to the portal system to allow the admixture of venous and arterial 
blood in order to achieve partial saturation of the portal supply. Flow through this line was 
adjusted by a screw clamp according to the oxygen saturation measurements in the portal 
blood. This technique was similar to that of Kestens et al (136), but they are the on ly other 
perfusion group to use this attempt at a more physiological system. 
x) Flushing of the liver 
Preparation of the liver prior to perfusion is an extremely important stage in the experi-
ment. yet very little study has been made of the subject. The objects of flushing the liver are 
short term preservation, and the removal of blood elements from the organ. Four features of 
the procedure will be discussed - the constitution, temperature, volume and pressure of inflow. 
(a) Constitution 
In most instances, initial rinsing of the liver has been performed with Ringer lactate which 
had been found satisfactory for preservation of the kidney. However, in a study of the effects of 
various solutions upon aspects of function of the perfused liver, Abouna (2) has shown clearly 
that Ringer lactate results in more damage than other solutions. It is suggested that the simple 
electrolyte solution without colloid osmotic pressure and deficient in energy substrates with a 
low pH is quite unsuitable (7). From his evaluation, he preferred to use a solution containing 
high levels of potassium and magnesium, with Dextran, insulin, heparin and procaine. Subse-
quently Abouna has shown further that a solution with high potassium levels as advocated for 
long term kidney storage (47) is not effective as a preserving solution for the liver. Indeed, he 
concludes that while most mammalian cells share common needs and undergo similar trans-
membrane shifts during hypothermic preservation, there appear to be important differences in 
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the metabolic requ irements and in preservation conditions among different organs. This is an 
aspect which requires a great deal of further study. 
In the study to be described, several different fluids were assessed (Table Ill). The first was 
the commercial preparation - TisUsol - which has the advantage of added sulphate and 
phosphate; the in itial pH of this fluid was corrected to 7,4 with the addition of 10 to 15 mEq/ 1 
of 4,2% sodium bicarbonate. A second solution which was used was the 
plasma/ bicarbonate/ dextrose solution of Schalm (237) with which livers had been success-
fully preserved for periods up to 10 hours (250). The third solution used was a modified Krebs 
Ringer Bicarbonate solution with which isolated rat l ivers had been successfully perfused (58). 
(b) Pressure 
Little attention has been paid to the pressure under which flushing, especially of the portal 
system, has been performed, and a remarkably wide range has been reported. In the experi -
ments under review, the bottle conta ining the flushing solution was hung no higher than 20 cm 
H20 above the porta hepatis. The arterial system was flushed with a fluid from a bottle hung 1 
metre above the porta hepatis, and intermittent increase in this pressure was achieved by 
pressure on the " pump" of the intravenous infusion set. During flushing, the venous return line 
was intermittently clamped to clear the furthest edges of the liver. 
(c) Volume 
The volume selected for rinsing of the liver should probably be related to the weight of the 
organ since the object of flushing is the removal of blood. However, usually a standard volume 
was used which was selected by experience~f the appearance of the liver. The organ cannot in 
fact be completely rid of blood, and flushing was continued until the effluent was clear. 
Arbitrary volumes used initially were 1,0 litres through the portal vein and 0,25 litres through 
the artery. Later this was increased to 1,75 litres through the portal vein and 0,25 litres 
through the artery. In clinical perfusions, this volume was increased .to a total of 3 litres, but it 
cannot be said that the appearance of the l iver was different. A wide range of volumes has 
been used by other workers, with a maximum of 10 litres, and a study of this aspect is much 
needed, probably with histological control of the flushed livers to assess the presence of red 
cells after flushing . 
(d) Temperature 
It is claimed that the liver can withstand only 4 minutes of warm ischaemia, but few 
studies exist of this fact (256). As was detailed previously, the reports concerning the results of 
ischaemia to the liver are varied and in most instances it has been preferred to cool the organ 
before institution of perfusion . Initially, thus the livers were flushed with solution at 4°C. Later, 
it seemed that a better flush might be achieved if there were no vasospasm as a result of the 
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Table Ill Balanced salt solutions used for flushing and perfusion of the 
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cold perfusion, and hence the solution was kept first at room temperature, and then at 38°C 
just prior to infusion . With this last solution, the liver appeared to rewarm much more rapidly 
with the re-institution of perfusion, and the overall diffusion was more even. 
xi) Priming solutions and additives 
Initially the circuit was primed with the same solution as was used for flushing viz. TisUsol 
or Krebs Ringer bicarbonate, but later an attempt was made to improve and sustain function by 
the use of a tissue culture medium for priming and various additives as constant infusion. The 
tissue culture medium selected was McCoys 5A (see constitution). Whilst this was used be-
cause of the wide range of substances available in it. there is no documented evidence of its 
value in the perfusion of isolated organs. In addition. it is not known whether the concentra-
tions of amino acids are optimal, especially for the liver. In some rat liver experiments, various 
alterations in amino acid levels have been shown which are thought to inhibit some aspects of 
function (198). However, it was noted that with the use of this medium.an improved rate of 
synthesis of urea occurred, which might be interpreted as an indication of improved function . 
An additional advantage observed with the use of the medium was that the phenol red included 
as an indicator of pH was actively excreted in the bile and could perhaps be used as a valuable 
indicator of biliary secretion and transport. 
During the course of various perfusions, several additives were given both by single injec-
tion and by constant infusion. Where relevant to a small series of experiments, these will be 
individually described before the presentation of the experiment, but in several instances, addi-
tions were made to a large number of perfusions. In an attempt to provide substrate and 
stimulus for biliary excretion dehydrocholic acid and secretin were added, and insulin was 
given for its role in maintenance of the intracellular potassium and glucose levels. These three 
substances were given in a "cocktail" prepared with arbitrary concentrations - soluble insulin 
(pork) 100 units, dehydrocholate (Boots, England) 100 mg, and secretin 21 units, - in 100 ml 5% 
dextrose water to provide a constant infusion of dextrose. This was given over the four hour 
period of perfusion. (Initially these substances were given as single hourly injections, but on 
realisation that the insulin particularly would have a half life of a few minutes before destruc-
tion in the liver, it was preferred later to give a constant infusion.) 
Sodium bicarbonate 4 ,2% (0,5 mEq/ ml) was added arbitrarily at the rate of 1 mEq/ 1 per 
hour. In addition, 3g dextrose per litre of perfusate was added at the commencement of 
perfusion. 
In order to evaluate function, a load of sodium lactate of 3,5g (70% solution B.D.H .) and of 
ammonium citrate 2g was added before the last hour of perfusion and samples were taken at 5, 
15, 30, 45 and 60 minutes thereafter to assess the peak and clearance rate. 
56 
When McCoys medium SA was used as prime, half of the commercial powder requ ired to 
prepare a litre of solution was dissolved in 250 ml distilled water for the prime whilst the 
remaining half was dissolved in 50 ml distilled water and was added to the infusion. 
As a result of the work of Dawkins et al demonstrating the value of a oxoglutarate in pre-
serving the function of isolated rat livers (58), 15 mM each was added to the flushing solution, 
the prime and the infusion solution. This was made up in distilled water and the pH corrected to 
7,0with sodium hydroxide. 
CHAPTER FOUR 
EXPERIMENTS 








C - Phase Ill - clinical application 
i) Design 
ii) Case Reports 
iii) Interpretation 
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A - PHASE I 
i) Design 
In order to provide a control basis for experimentation, a series of 23 pig livers was 
perfused with pig blood for a period of six hours. The purpose of these experiments was to ob-
serve the changes in physical and biochemical properties as measured, in order that subse-
quent modifications could be made to prevent adverse changes. 
In this series of experiments 
(a) animals were starved for at least 24 hours pre-operatively, and intra-operatively 50g 
glucose was given in Ringer lactate. 
(b) the liver was flushed through the portal vein with 100 ml TisUsol corrected to pH 7,4, and 
through the hepatic artery with 150 ml 0,9% saline. The temperature of both these solutions 
was between 10 and 15°C when infused. 
(c) the duration of dissection was 60-90 minutes and the liver was removed immediately 
thereafter with a warm ischaemic interval of 2-3 minutes. 
(d) the priming solution was TisUsol plus fresh abattoir pig blood, heparinised and corrected 
to pH 7,4 with sodium bicarbonate. The final haematocrit was 24%. 
(e) partially desaturated blood (70-80% 0 2 ) was circulated through the portal system as 
described. 
(f) the diaphragm was immobile. 
The physical characteristics measured included: 
The portal, arterial and vena caval pressures, the total flow and percentage portal component 
and the biliary secretion rate at hourly intervals. 
The biochemical investigations made were: 
At hourly intervals, the pH, pC02, base excess, plasma aspartate transaminase and plasma 
haemoglobin, lactate/ pyruvate ratio and oxygen consumption, plasma osmolality and total 
protein and albumin. In samples taken pre and post perfusion, sodium, chloride, potassium, 
urea, glucose plasma alkaline phosphatase and cholesterol. 
ii) Results 
The results of these experiments are presented in Figures 9-16: 
In Figure 9 it appears that the initial portal pressure of 12,2 cm H 20 remained constant for 
the first three hours and thereafter rose to a final mean of 19 cm. Simultaneously, the hepatic 
arterial pressure which commenced at a mean of 76 mm Hg also rose at the three hour period 
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to a mean of 108 mm Hg. At this stage of experimentation, the bile flow was measured accord-
ing to the number of seconds required for 0,03 ml of bile to be formed , and hence an increase 
in the number of seconds represents a slowing in the flow rate . Figure 9 shows clearly that 
there was a considerable reduction in flow rate from the 21/2 hour period. 
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Figure 9 : A graph of the pressures in portal vein, hepatic artery and 
vena cava, and the bile flow rate. 
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Figure 10 shows the changes which occurred in pH, which declined initially and thereafter 
remained within the range 7,40 to 7,43; there was a negligible increase in plasma 
haemoglobin from 25 to 55 mg / 100 ml over the course of perfusion, and in regard to the flow 
rates, the total flow was increased within the first hour from 0,7 ml / g/ min to a final 0,9 
ml / g/ min which was maintained for the remainder of the perfusion. Of this, the percentage 
flow through the portal system remained between 83 and 84 for the whole period. 
Figure 11 shows the mean values of sodium, potassium and chloride as measured in 
samples taken pre-perfusion and at 6 hours. There was a significant rise in sodium levels from 
152 to 161 mEq/ l(p< 0,001) which was attributed to the addition of sodium bicarbonate to 
correct the pH . In addition, there may have been some concentration with increase of 
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decreased from 6,4 to 5,6 mEq/ 1, and whilst not significant, it was felt that this represented 
intracellular conservation of potassium. 
A mentioned, standardisation of the amount of glucose present in the priming fluid was 
complicated by differing levels in the donor blood. An amount of 0,56 mol per litre was added 
but nonetheless wide standard deviations were observed in the mean values as shown in 
Figure 12. There was a rise in the glucose levels from 7,5 to 9,9 mMol/ 1 which was not signifi-
cantly different on account of these high standard deviations. However, histological evaluation 
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Figure 12 : The glucose levels before and after perfusion, and the 
lactate/pyruvate ratio and oxygen consumption. 
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As also shown in Figure 12, the ratio of lactate to pyruvate declined slightly although not 
significantly. The oxygen consumption was maintained within levels reported to be normal for 
the isolated perfused liver (3), and the liver in vivo (240), but showed a tendency to increase at 
the end of perfusion, concurrent with the rise in portal pressure. These combined observations 
could be interpreted as indicative o( a rise in intra-hepatic resistance with reduction in flow 
rate through the liver. 
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Figure 13 shows the changes in plasma osmolality and total protein and albumin values 
during perfusion. The significant rise in osmolality from a mean of 298 to 339 mOsm/ 1 was 
attributed in part to the increase in electrolytes and glucose as already shown and to urea and 
other substances which were not measured. The rise might also confirm the concentration 
which was postulated previously with shift of fluid into the cells. There was no significant 
difference in protein or albumin levels but the hypoalbuminaemia resultant upon initial 


























Figure 13 : The plasma osmolality, total protein and albumin and urea 
levels during perfusion. 
Figure 14 shows the acid base status in more detail and shows that the downward trend of 
pH during the first hour could be attributed to the rise in PC02 since the standard bicarbonate 
remained stable. The slow subsequent rise in pH was probably due to the continued addition of 
sodium bicarbonate at hourly intervals. However, no marked decline in pH occurred which 
would have been suggestive of major tissue damage. 
Figure 15 shows the changes in plasma aspartate transaminase which was taken as the 
index of liver damage. Comparison is made with plasma haemoglobin levels over the same 
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standard 
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Figure 15 : The levels ot aspartate transaminase and plasma haemo-
globin during perfusion. 
64 
period to indicate that there was negligible damage to erythrocytes and thus little contribution 
to the levels of aspartate transaminase by enzyme released from erythrocytes. The rise in 
aspartate transaminase was significant from 32 to 165 Karmen units. 
In Figure 16, a further representation of the biliary secretion rate is given, as ml / hour, and 
in conjunction with the levels of plasma alkaline phosphatase and cholesterol, and biliary 
osmolality. The minimal decreases in alkaline phosphatase and cholesterol which were not at 
a significant level could perhaps be attributed to excretion in the bile. The rise in biliary . 
osmolality seemed to parallel that observed in the plasma and probably also represented the in-
creased excretion of sodium in the bile, and concentration of the bile as the flow rate 
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Figure 16 : The biliary flow rate during perfusion. and the plasma 
alkaline phosphatase and cholesterol levels before and after 
perfusion. 
iii) Interpretation 
Overall , these results were interpreted as follows: 
(a) A stable preparation of perfusion for six hours appeared to have been achieved. The most 
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striking alterations in the physical characteristics were the slow progressive rise in portal 
pressure after three hours perfusion, and the rapid decline in biliary excret ion rate . A sim ilar 
rise occurring later in perfusion had been noted by Abouna (5) who attributed it to accumulation 
in the vasculature of cellular debris resultant upon oxygenator trauma. Such debris was noted 
in 2 biopsies as described later. The biliary secretion rate was never as rapid as that recorded 
by others, although the same decline in rate had been previously observed, and no reason 
for this could be suggested other than an inadequate substrate and hormonal level. 
(b) In regard to the biochemical observations, it was thought that the electrolyte levels, 
especially the constant or slightly declining potassium values suggested maintenance of 
integrity of the cell membrane ionic pump, and the maintenance of levels of lactate and 
pyruvate and the acid base status has been interpreted as evidence of metabolism during the 
period of perfusion. The sustained "normal" levels of oxygen consumption were thought to con-
firm this, with the reservation of the development of stasis terminally. 
The small rise in osmolality which occurred during perfusion suggested that some fluid 
shifted from the plasma to the intracellular space and a minimal mean increase in the weight 
of the livers was observed. This was also related to the venous stasis which resulted from 
inadequate immobile mechanical support of the liver with kinking of the vessels. In addition, a 
contribution to oedema was probably made by the use of hypoalbuminaemic blood. The slight 
rise in levels of urea was thought to represent the metabolism of ammonia and other 
nitrogenous substances, and also perhaps to be the result of gluconeogenesis. The rate would 
however, also be substrate dependent. 
Some evidence of hepatic parenchymal and red cell damage was noted but both compare 
favourably with other published data (156). In regard to the biliary secretary mechanism, the 
osmolality appeared to follow the trend of the plasma, and the minimal fall in alkaline 
phosphatase and cholesterol was attributed to biliary excretion. 
B - PHASE II 
After the initial evaluation of liver function when perfused with homologous pig blood, a 
series of experiments was performed to validate the use of such a liver for the clinical hepatic 
assist. 
i) Design 
Twenty-one experiments were performed - in 8, pig livers were perfused with fresh 
heparinised abattoir pig blood; in the remaining 13, 4 pig livers were perfused with human 
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blood of group 0 , and 3 each with human blood of groups A, B and AB. Homologous perfusions 
with pig blood were continued for 6 hours, and heterologous perfusions with human blood 
were only continued for 4 hours, the period arbitrarily selected for the performance of clinical 
hepatic assist. 
In addition to the features described for phase I, certain modifications were made on the 
basis of the observations from those experiments. 
(a) Human blood was collected on the morning of the experiment, but since this could be 
obtained only a little later than the abattoir porcine blood, a period of 30 to 60 minutes was 
allowed following dissection of all livers in phase II. 
(b) In an attempt to improve the substrate levels and the level of albumin, the final mean 
haematocrit was increased to 29%. 
(c) The response of the liver to the blood flow offered was monitored by the use of resistance 
to relate pressure and flow. 
(d) Evaluation was made of the capacity of the liver to handle ammonia and lactate, two sub-
stances known to be increased in concentration in hepatic coma (25,221). In homologous 
perfusions, a load of sodium lactate (3,5g) and ammonium citrate (2g) was administered at one 
and five hours after the commencement of perfusion. Measurement of urea, and 
lactate/ pyruvate ratios was made at quarter hour intervals for the hour after administration of 
the load. The ability of the liver to return elevated levels to those prior to infusion was 
measured within the arbitrary period of this hour. In heterologous perfusions, a single load was 
given three hours after the commencement of perfusion, and clearance was similarly moni-
tored. 
(e) Biliary bilirubin levels were measured hourly but were expressed as a total hourly 
excretion per gram of liver weight to compare with the excretion rate measured in the intact 
animal during the operation. 
(f) Detailed histological assessment of pre- and post-perfusion biopsies was made. 
ii) Results 
Due to the large number of tests performed, only those in which a striking difference was 
noted will be presented in detail. The remainder are shown in summary in Table VI. 
Physical characteristics 
Table IV shows that a markedly lesser total flow rate could be achieved through the portal 
vein in perfusions with group AB blood, than in perfusions with other blood. Table V shows the 
actual values for mean pressure recordings in the portal vein and hepatic artery for the three 
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Blood Type Hours of perfusion 
0 2 3 4 5 
Group 1 
ml / g/ min 0,45 0,84 0 ,88 0,88 0,88 0,81 
% 82,6 83,8 83 ,8 83,8 83 ,5 83 ,3 
Group 11 
ml / g/ min 0,32 0,80 0,80 0,80 0,80 
% 66,0 84,0 87 ,0 86 ,0 86 ,0 
Group 111-A 
ml / g/ min 0,40 0,70 0,70 0,80 0,80 
% 82,0 83,0 81,0 83,0 83 ,0 
Group 111-B 
ml / g/ min 0,30 0,80 0,90 0,90 0,90 
% 78,0 84,0 82 ,0 82,0 82,0 
Group 11-AB 
ml / g/ min 0,30 0,50 0,60 0,60 0,60 
% 72,0 71,0 72 ,0 72,0 72 ,0 
Table IV : The mean total flow rates and percentage portal flow in per-




groups of experiment. The significance of these results is more striking when the individual 
resistances are calculated. 
Resistance - (Figure 17) - In the portal system, not only is there a marked difference in the 
actual resistances measured, but the levels show a different pattern . In both groups using 
human blood (II and Ill), the resistance was very high initially. This tended to decline after the 
first hour although remaining almost entirely above that of perfusions with pig blood (group I). 
This pattern was most pronounced when blood of group AB was used. No comparison could be 
made of resistance after four hours since heterologous perfusions were not continued beyond 
this time, but the work of Abouna in which a rise occurred after longer periods of perfusion was 
performed with human blood (5). 
Resistance values in the hepatic arterial system showed no particular pattern due probably 
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to the fact that this blood was pumped under pressure. 
A similar pattern of biliary excretion (Figure 18) was seen in all groups as had been noted 
in perfusions in phase I - viz. a rise in the first hour of perfusion and a gradual decline there-
after. 
The results of analysis of serum potassium are shown in Table V. A mean fall of 0,3 mEq/ 1 
occurred in group I perfusions with pig blood, whereas a mean rise occurred in all perfusions 
with human blood - in group II of 2 , 1 mEq/ 1, in group Ill-A of 2,3 mEq/ 1, group 111-B of o; 1 mEq/ 1 
and in group Ill-AB of 3,9 mEq/ 1. The initial potassium levels in human blood were consistently 
lower than levels in porcine blood probably related to trauma to erythrocytes during collection 














































































Table V : The mean pressures in the portal and a;terial systems in 
perfusions with porcine and human blood. 
Differences in changes in sodium levels were less marked and were related in general to 
the administration of sodium lactate. 
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In Figure 19 it may be seen that there was an increase in plasma haemoglobin levels in all 
perfusions; this was more obvious in the final hours of group Ill. However, a much more 
striking picture was observed in comparison of the levels of aspartate transaminase . There was 
a considerable difference between the levels during homologous and heterologous perfusion, 
and the difference in perfusions with group AB blood was particularly marked. 
An unexpected observation resulted from the measurement of plasma bilirubin (Table VI) . 
In groups I and .II, pre- and post-perfusion plasma bilirubin values were less than 0,5 mg/ 100 
ml. In group 111, bilirubin increased in both the total and conjugated fractions, the latter forming 
about two thirds of the total. This increase was greatest in perfusions with group A blood. 
Estimatio.n of the total bilirubin excreted in the bile over the course of the perfusion, was com-
pared with the excretion in a sample of bile collected during one hour of operation. The 
perfusion results per hour were expressed as a percentage of the intraoperative collection. In 
group I, there was a mean excretion of 50%; in group II, 22%; in group Ill-A, 16%; in group 111-
8, 55%; and in group Ill-AB, 28%. No reason can be advanced for these differences except per-
haps that the numbers are too small to draw any significant observations. However, it appears 
interesting that there was the least excretion in group Ill-A in which the conjugated hyper-
bilirubinaemia was noted. 
Estimation Group 1 Group 11 Group 111 
A B 
Sodium mEq/ 1 29+ 24+ 1 o+ 9+ 
Potassium mEq/ 1 0,3- 2,1+ 2,3+ 0,1+ 
Chloride mEq/ 1 3+ 2+ 4- 4+ 
Glucose mM/ q 3,9+ 4,9+ 5,2+ 2,1+ 
Plasma Osm. mOsm/ 1 71+ 41+ 81+ 80+ 
Bi le Osm. mOsm/ 1 72+ 30+ 70+ 42+ 
Bile sodium mEq/ 1 6- 11- 4- 6-
Bi le potassium mEq/ 1 1,2- 1,0+ 2,2+ 3,2+ 
Alkaline phos. units 0,9- 0,3+ 1,0+ 0,5+ 
Cholesterol mg/ 100 ml 2,0+ 2,0+ 17+ 7+ 
Bilirubin mg/ 100 ml 
total 4,1+ 1,9+ 
conjugated 3,2+ 1,0+ 
Table VI : Mean biochemical observations made during perfusion of 
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Figure 17 : The resistance in the portal systems of livers perfused with 
porcine or human blood. 
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Figure 19 : The levels of plasma haemoglobin and aspartate transa-
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Figure 20 : The lactate/ pyruvate ratios and urea levels during perfusion 
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Whilst levels of plasma alkaline phosphatase fell during perfusion with porcine blood, 
there was a slight increase in groups II and Ill with human blood (see Table VI). A similar 
pattern was not as obvious when comparing the values for cholesterol, but the actual levels 
throughout were higher in the human blood. In group I, the biliary potassium fell, but in groups 
11 and Ill the levels increased during perfusion. This was similar to the pattern seen in the 
plasma. Biliary sodium levels declined in all groups. 
Lactate and ammonia metabolism following a loading dose: (Figure 20). 
In most groups the first administered load of sodium lactate was cleared well according to 
the arbitrary criteria - i.e. to pre-load levels within one hour of administration. Only in group Ill-
AB did the clearance appear slightly less efficient. In group I, the second load of sodium lactate 
at 5 hours was cleared less completely during the remaining hour of perfusion. 
During perfusion with homologous blood, urea increased from 14 mg/ 100 ml to 54 
mg/ 100 ml; the majority of this increase occurred after the initial addition of ammonium 
citrate. In perfusions of groups II and Ill, there was an increase in urea following the infusion of 
ammonium citrate, which was similar to that following the first addition during homologous 
perfusion. No significant differences could be detected as the changes are small. 
Other analyses (Table Vi) 
Plasma glucose levels increased to a variable degree in all groups. There was no marked 
difference in the levels of oxygen consumption in the three groups, the increases being con-
current with the administration and metabolism of the sodium lactate load. In none of the 
groups was there a marked alteration in the pH or pC0 2 - in all cases, with the administration 
of 1 mEq/ 1/ hr of 4,2% sodium bicarbonate, the pH remained above 7,4 units. 
The initial mean leveis of albumin were higher in the human blood, being 2,4g/ 100 ml, as 
compared with 1,6g/ 100 ml in homologous blood, these levels representing dilution with 
priming solution to a mean haematocrit of 30%. The total protein and albumin levels altered 
little throughout the course of perfusions. Electrophoretograms were performed to seek an 
alteration in gamma globulin levels, but there was no marked difference. 
In all groups, the increase in plasma osmolality could be attributed to the addition of 
sodium in the lactate load, and to the addition of sodium bicarbonate. Increases of bile 
osmolality probably occurred for the same reason, in addition to stasis and concentration of the 
bile. 
Histology 
In biopsies of the livers in group I, a variable degree of sinusoidal congestion and portal 
tract oedema was seen after perfusion; in three sections, there was evidence of haemorrhage 
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into the interlobular septa. Biopsis from livers in groups II and Ill showed similar features of 
portal tract oedema, but less sinusoidal congestion than in biopsies of group I. In addition, a 
polymorphonuclear infiltrate was seen which appeared to be migrating from the portal tracts to 
the sinusoids. In two biopsies from group 111, a few intravascular eosinophilic masses were 
seen, similar to those described by Abouna (5), but these were not wide-spread . 
iii) Interpretation 
This study was undertaken with two objects - (a) to evaluate the nature and degree of 
damage which resulted from perfusion of the pig liver with human blood and (b) to assess the 
ability of the liver to metabolise lactate and ammonia, both of which are elevated in hepatic 
coma. 
(a) Evidence of damage 
Several factors combined to form a pattern indicating damage to the liver. The initial 
increase in vascular resistance offered by the portal system to perfusion with heterologous as 
compared with homologous blood, suggests a vascular component in the response to 
heterologous perfusion. The effect was less marked in the arterial system, where a pulsatile 
flow would overcome small alterations in resistance. 
In heterologous perfusions, Abouna has shown that resistance increases over the course 
of perfusion, and has suggested that this is due to the deposition of intravascular debris 
resulting probably from trauma to blood and parenchymal cells by the pump oxygenator system 
(5). This has been an occasional finding in this series, but most biopsies showed evidence of 
stasis which would also contribute towards an increase, particularly in portal pressure. In the 
homologous perfusions, which continued two hours longer, a slow progressive increase in 
resistance was noted during the fifth and sixth hours. 
When considering the histology, sinusoidal congestion, which was demonstrated particu-
larly in homologous perfusions, could perhaps be attributed to over-perfusion . It has been 
shown that in the intact liver in situ, there is a variable flow through portions of the hepatic 
parenchyma at any instant (185,242). Factors which contribute to this are the intermittent 
negative pressure in the venous return to the vena cava, the diaphragmatic movement and the 
intra-abdominal pressure. Of these, only the intermittent negative pressure in the venous 
return is simulated in the perfusion situation. Positioning of the vena caval reservoir results in 
intermittent filling and emptying of the liver, but no other regulation occurs. The use as a 
chamber with intermittent positive pressure movement of a diaphragm as described by Abouna 
(4) or Eiseman (68) might improve this venous stasis . 
However, the immobility of the liver and the potential development of stasis and liver 
damage were similar in perfusions with homologous or heterologous blood and could not alone 
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be incriminated as the cause of the major liver damage which occurred in the heterologous 
perfusions. 
Evidence for this damage lies principally in the loss of integrity of the cell membrane ionic 
pump, revealed by the leakage of potassium. There is additional evidence of the release of intra-
cellular constituents in the increase of aspartate transaminase. These increases are only partly 
related to the increase in plasma haemoglobin which was greater in the last hours of 
heterologous perfusion. 
A marked difference was observed in biliary secretion. In heterologous perfusions, a bio-
chemical profile of biliary obstruction was shown in the slightly slower flow rates, and the 
elevation of plasma alkaline phosphatase as compared with homologous perfusions. The 
biliary potassium levels mirrored those in the plasma. 
The suggestion of obstruction is confirmed in the heterologous perfusions of group Ill 
where a conjugated hyperbilirubinaemia developed over the course of perfusion. This occurred 
in association with an apparently reduced excretion of bilirubin in the bile. Only in group 111-B 
was there an apparently adequate excretion (when compared with homologous perfusion) 
whereas in group Ill-A, impaired excretion of bilirubin in the bile resulted in a marked increase 
in plasma bilirubin . There was a higher circulating plasma haemaglobin in perfusions of group 
Ill which might have provided a load of bilirubin in excess of the transport maximum, especially 
being heterologous bilirubin. In a subsequent series of experiments utilising human blood with 
continuous infusion of bile salts and secretin as choleretics, bilirubin levels still rose but in 
many instances the rise appeared concurrent with the administration of sodium lactate and 
ammonium citrate . Some competition between the excretion of bilirubin and sodium might be 
postulated. 
(b) Clearance of lactate and ammonia 
The metabolism of the administered load of sodium lactate and ammonium citrate shows 
no marked difference in the rates of clearance in the three groups of perfusion. Clearance 
appeared to be performed as efficiently in heterologous perfusions at three hours as in 
homologous perfusions at one hour, although this latter may not be optimal. In addition, the 
numbers of experiments are too small to draw any but the broadest conclusions. 
(c) Other measurements 
None of the other biochemical measurements showed any marked difference in the three 
groups of perfusion . In all cases, plasma glucose levels rose but whether this reflects 
gluconeogenesis or release of glucose from damaged cells is not clear. There was no obvious 
difference in the acid base status of the three groups, since the pH could be maintained above 
7,4 units with addition of only one mEq/ 1/ hr of sodium bicarbonate. The pC02 remained within 
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physiological limits, while the oxygen consumption commenced at higher levels than has been 
reported as normal, confirming the stasis which was shown histologically. In all cases, there 
was an increase in oxygen consumption in relation to the metabolism of lactate and ammonia . 
Although albumin levels were higher in the human blood initially, the patterns of protein 
values and the osmolality of plasma and bile were similar in the three groups. The addition of 
sodium lactate and bicarbonate probably contributed much to the rise in osmolality. 
C - PHASE Ill 
As a result of the observations made in phase 11, it was decided to offer clinical hepatic 
assist to patients in deep hepatic coma, with the following reservations. 
i) No relationship between observed function and human blood groups could be noted so no 
particular selection of the pig could be made. 
ii) Despite the initial rise in portal resistance, this appeared to resolve during the first hour of 
perfusion. 
iii) These livers, when perfused with human blood, appeared capable after three hours of 
clearing lactate and ammonia in a manner similar to that during the first hour of homologous 
perfusion. 
iv) A greater degree of hepatic damage was noted in regard to levels of plasma aspartate 
transaminase. 
v) In interpretation of the biliary secretion rates, plasma alkaline phosphatase and 
cholesterol, and the appearance of conjugated hyperbilirubinaemia, a biliary stasis related to 
heterologous perfusion was observed. In clinical hepatic assist, elevated levels of bile acids 
stored in the patient with liver necrosis, are said to act as cholinergics during assist procedures 
(4,84), and hence no further secretory stimuli were added . . 
vi) It should be borne in mind that this constitutes a heterograft procedure with its attendant 
hazards. 
Hepatic assist by attachment to the pig liver was thus offered to four patients whose clini-
cal courses will be described in detail to allow estimation of the severity of the disease. 
Design 
For hepatic assist procedures, the preparations of the liver were more prolonged due to the 
co-ordination of this complex procedure. 
i) These procedures were often performad at night when laboratory facilities were sub-
optimal. 
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ii) Livers were flushed with 3 litres TisUsol and 150 ml sodium chloride to attempt to clear 
most pig blood and protein. 
iii) After removal, livers were transported to the hospital submerged in a volume of TisUsol at 
4°C. A period of 30 to 45 minutes was allowed for stabilisation of the liver in the circuit before 
clinical attachment was made. 
iv) The condition of these patients was monitored during perfusion by a senior anaesthetist, 
and by a senior physician, in order that full attention could be devoted to the perfusion. 
Case 1: 
M.K., an African male of 11 years presented to the Frere Hospital, East London, with mild 
jaundice 2 weeks before admission to the Groote Schuur Hospital. He was otherwise well and 
bed-rest was advised. Three days later he was seen to be more jaundiced, and on the same day 
became drowsy, dizzy and ataxic. He was admitted to the Frere Hospital and exchange transfu-
sion was performed. During the procedure he developed urticaria. There was no improvement 
in his level of consciousness and for the next 4 days, exchange transfusions were performed at 
24-hour intervals. On the 5th day, he answered his name and his level of consciousness was 
thought to be improving. However, despite further exchange transfusions, no further improve-
ment occurred. After 8 exchange transfusions, he was transferred to Groote Schuur Hospital 
for further management. On admission he was assessed to be in deep hepatic coma with doll's 
eye movements and extension of the arms and legs. A sluggish response to pain was observed 
in the form of decerebrate movements of the limbs. The plantar reflexes were extensor. He was 
deeply jaundiced and a 2,5 cm liver could be percussed. There were no signs of chronic liver 
disease. 
Preparations were made for pig liver perfusion, but during this time the patient suffered a 
respiratory arrest which was treated by tracheostomy and intermittent positive pressure 
respiration with a Bird respirator . 
Perfusion was commenced 6 hours after admission and was continued for 3Y2 hours. 
There was a flow of 250 to 300 ml / min from the patient into the perfusion circuit and no 
haemodynamic difficulties were encountered. One hour after the commencement of perfusion, 
spontaneous respiration resumed, but the assisted ventilation was maintained. Perfusion was 
discontinued when oozing of fresh blood was noted from the shunt site and the buccal mucosa. 
A further exchange transfusion was performed immediately after the perfusion in an attempt to 
remove, at least partially, any heterologous substances transferred from the pig liver. After the 
perfusion, there was an alteration in the patient's condition in that the reflexes were less brisk 
and the doll's eye movements could no longer be elicited. The plantars remained extensor. 
Twenty-four hours later another exchange transfusion was performed, but the plantars 
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remained extensor and fixed dilated pupils were noted. The patient became hypothermic with a 
temperature of 95°C. Later he became hypotensive and died following gastro-intestinal 
haemorrhage. 
At autopsy the liver weighed 534 grams. There was gross collapse of the periphery of the 
right lobe and the whole of the left lobe. A small regenerative nodule was noted on the anterior 
surface. An indistinct lobular area of regeneration in the centre of the right lobe 5-6cm in 
diameter was noted but not well demarcated. The remainder of the tissue was bile-stained and 
necrotic. Histology revealed massive necrosis with disappearance of hepatic cells, stromal 
collapse, infiltration by inflammatory cells and much proliferation of bile ducts. There were 
surviving islands of regenerative activity in the central zones with ragged vacuolated degenera-
ted cells at the periphery. The kidneys were bile-stained and friable and contained abundant 
bile stained casts. In the spleen, which was soft and rubbery, there were numerous large 
monocytic reticulum cells and it was thought that these could be the result of viral infection. 
Some of the biochemical and haematological findings in this patient are shown in Figure 21 . 
Because of the danger of exaggerating the haemorrhagic tendency in these patients, 
heparinisation was kept to a minimum but clumps of cells and strands of fibrin were noted in 
several of the blood samples and hence heparinisation was increased in the second hepatic 
assist by the addition of 10mg per hour to the perfusate. 
Case 2: 
M.A., a Coloured female of 34 years was admitted to the Groote Schuur Hospital with a 3-
week history of malaise and lethargy. Four days before admission she noted jaundice and dark 
urine. Hepatomegaly was detected and she was treated with bed-rest. Two days before admis-
sion she became confused. There was a past-history of possible ethanolic excess. On 
admission, she had asterixis and was assessed to be in light stupor, responding to her name 
and to painful stimuli . Twelve hours later there was no percussible liver dullness, she was 
hypertonic and the plantar reflexes were flexor . Later she became deeply comatose and an 
exchange transfusion was performed. Thereafter, the right plantar became extensor, and 
reflexes were brisker on the right side. Electroencephalogram showed slowing predominantly 
on the left side with periodic sharp waves. As there was no improvement in the next 24 hours, 
a pig liver perfusion was performed. Twenty minutes after the commencement of perfusion, the 
patient recovered consciousness completely and remained lucid and oriented for 20 minutes. 
Thereafter, she lapsed back into coma . Perfusion was discontinued after one and a half hours, 
due to oozing of fresh blood from puncture sites. During the course of the subsequent exchange 
transfusion, the patient again had a period of lucidity lasting 15 minutes. During the next 2 
days, she developed haematemesis and melaena and was treated with two further exchange 
84 
Figure 21 The clinical course of patient M .K. 
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transfusions. A picture of consumptive coagulopathy was noted haematologically (see Figure 
22). Eight packs of platelet rich plasma were given. Twelve hours later she was awake and talk-
ing, and the electroencephalogram showed a marked improvement. During the next two days, 
she became confused, waves became evident on the EEG and haematemesis continued. An 
area of liver dullness could be percussed. Despite this, the level of consciousness declined 
further, the patient became anuric and she died following haematemesis with inhalation. In 
retrospect, this patient should have had a tracheostomy to prevent this complication. 
At autopsy, the liver weighed 905 grams and was soft and pliable. Brightly jaundiced 
regenerating parenchyma contrasted sharply with deep red areas of necrosis. The 
regenerating liver was also necrotic and was very soft. The capsular surface was slightly 
wrinkled suggesting the gross loss of liver tissue which had occurred. Histologically, there was 
a varied picture with regeneration and centrilobular necrosis with bile plugs and lakes. There 
was no evidence of pre-existing disease. The stomach contained altered blood and 2 sub-acute 
ulcers were noted at the cardio-oesophageal junction. The kidneys were oedematous and 
jaundiced. Some sub-capsular haemorrhage and bile-stained casts were evident. A 
chromophobe adenoma was noted on section of the pituitary. 
Some biochemical and haematological data are shown in Figure 22. 
During perfusion of this patient a marked fall occurred in fibrinogen levels and in platelets. 
However, these were improved by intravenous administration, and it was decided to give both 
these elements during the course of the next perfusion. 
Case 3: 
V.M ., an African female of 26 years was admitted noisy and unco-operative with a 5-day 
history of anorexia and vomiting. On admission she was noted to be markedly jaundiced and 
confused. Both plantar reflexes were extensor but no other abnormal neurological features 
were noted. A 3-4cm smooth liver was palpated. There were no signs of chronic liver disease. 
Some 6 hours later she was in deep coma and an exchange transfusion was per-
formed; immediately thereafter a tracheostomy was done. Twelve hours later, she was noted 
to respond to painful stimuli with decorticate movements of the limbs, and treatment with pig 
liver perfusion was instituted. This was continued for 2 hours and was stopped due to oozing 
from the shunt site. An exchange transfusion followed the procedure. The next day, her 
response to painful stimuli took the form of opisthotonus and another pig liver perfusion was 
performed. This lasted two hours and was again discontinued because of bleeding. After a 
subsequent exchange transfusion there was no alteration in her level of consciousness, but a 3-
4cm area of liver dullness could be percussed. Another exchange transfusion was performed, 
and thereafter the patient's level of consciousness began to improve. Over the course of the 
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next two days, she became fully conscious. However, 5 days later the liver was still impalpable. 
She lapsed back into coma over one night when she became hypothermic, but she responded 
to rewarming. During the course of the next 3 days, ascites became evident and melaena 
developed. She lapsed back into deep coma, possibly due to haemorrhage, and another 
exchange transfusion improved her level of consciousness to one of mild confusion . She was 
transfused because of continued gastro-intestinal haemorrhage and the liver edge became just 
palpable. Two days before death, she developed menorrhagia and required further transfusion . 
Terminally, she had a massive haematemesis and was thought to have aspirated despite 
tracheostomy. 
At autopsy, there was evidence of pulmonary oedema and inhalation. A florid pneumonia 
was present and an early lung abscess with associated fungal colonies was seen. Culture 
yielded a pure growth of Klebsiella pneumoniae. The liver weighed 970 grams and showed 
three areas of regeneration in the left lobe. The right lobe was flabby, and on histology, there 
was total necrosis of all liver cells with stromal collapse and aggregation of bile ducts near 
former portal tracts. There was some evidence of pre-existing fatty change. A bleeding 
tendency was evidenced by multiple petechial haemorrhages, massive bilateral haemorrhage 
into the broad ligaments and peri-vesical tissues and a sub-arachnoid haemorrhage over both 
occipital lobes and part of the upper surface of the cerebellum. The bone marrow showed 
normal erythrocyte and myeloid series and megakaryocytes. 
Some of the biochemical and haematological features of the case are shown in Figure 23. 
As a result of the apparently profound effect of perfusion upon the platelet counts, a 
decision was already in hand to withdraw the procedure until further evaluation could be made 
in the laboratory. However, with the condition of the fourth patient appearing terminal, she 
was treated by hepatic assist. 
Case 4: 
J . v.d. M., a Caucasian female of 17 years had been ill for 5 weeks before admission with 
dark urine and jaundice. Two days before admission the jaundice deepened, she became 
stuporose and then lapsed into coma. On arrival in hospital, she was noted to be markedly 
jaundiced and was making involuntary movements of her limbs of decorticate type. She was in 
deep coma with decorticate response to painful stimuli. An exchange transfusion was 
performed six hours later, and there was marginal improvement. A tracheostomy was done 
and after a 24-hour interval, another exchange transfusion was performed. Although she was 
again assessed to be slightly improved neurologically, the EEG was isoelectric. Altered blood 
appeared in the naso-gastric tube. She suffered two generalised convulsions. The next day, 
while preparations were being made for pig liver perfusion, the patient suffered a respiratory 
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Figure 22 : The clinical course of patient M .A. 
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Figure 24 : The clinical course of patient J. v.d. M. 
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arrest complicated by cardiac arrest from which she was resuscitated. She became areflexic 
and suffered another cardiac arrest from which she was again resuscitated. Assisted respira-
tion was commenced. Pig liver perfusion began four hours later and continued for 2 hours 
being discontinued again because of bleeding from the shunt site. A subsequent exchange 
transfusion was performed but there was no alteration in the lev':!I of consciousness or general 
condition of the patient. The EEG remained isoelectric and she died 48 hours later. 
At autopsy, bile stained effusions were noted in the pleural and peritoneal cavities. The 
major bronchi were filled with a blood stained mucoid material. The pulmonary parenchyma 
was oedematous with areas of frank haemorrhage into the lung substance. The liver weighed 
999 grams and showed early coarse nodularity. The capsule was wrinkled and thickened. The 
cut surface showed islands of heavily bile-stained surviving, perhaps regenerating, liver cells 
with a preponderance of dead rather pale liver stroma. Histology confirmed islands of 
regenerating cells scattered in a matrix of loose fibrous stroma with a few chronic inflamma-
tory cells. Numerous bile ductules and islands of bile duct epithelium were present in the 
stroma. Regenerated hepatocytes were represented as eosinophilic "ghost" cells. The spleen 
was enlarged (weight 423 grams) and the cut surface was dark purple and bulging . There was 
coffee ground material but no ulceration in the stomach. In the pituitary there was an area of 
recent infarction. A nodule (0,3cm diameter) of adenomatous hyperplasia of the chromophobe 
type was seen on section of the pituitary. 
The biochemical and haematological data for this case are shown in Figure 24. 
Assessment of the livers used for hepatic assist 
During perfusion, the livers appeared to function the same as the isolated preparation as 
described previously. Bile production tended to fall over the course of the perfusions but 
bilirubin was seen to be excreted in the ascitic fluid exuding from the surface of the liver. 
Due to the complexity of the procedure, little monitoring of the liver was performed except 
for the flow rates and pressure recordings, and the maintenance of acid base balance. Bio-
chemical analyses of the effluent from the liver showed equilibration of the prime with the 
patient's blood in all cases within the first half hour of link up. No trans-hepatic studies were 
performed. 
Coagulation studies 
Figure 25 shows the results in two of the cases (2 and 3) of heparinisation of the patient in 
addition to the circuit as compared with case 1 where only the circuit was heparinised. In cases 
2 and 3 fibrinogen was also given. For comparison, the results in 9 perfusions of the isolated 
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Figure 25 : The levels of fibrinogen and fibrinogen split products during 
clinical hepatic assist compared with experimental results. 
these experiments, nor did split products of fibrinogen appear as they did in the clinical 
situation. 
Although none of these patients survived, the response in improved levels of conscious-
ness in two of the patients which might be related to treatment by the isolated liver, has pro-
vided sufficient stimulus to initiate a full investigation of the cause, nature and prevention of 
the thrombocytopenia which complicated these clinical procedures. 

CHAPTER FIVE 
THE HYPOTHESIS - that either the circuit or the liver, or a combination of the effects of both , 
was responsible for the thrombocytopenia which occurred during clin ical 
assist. 
A review of the literature:-
a) The circuit 
b) The liver - (i) experimental studies 
(ii) clinical hepatic assist 
(a) - haematological studies 
(b) - immunological studies 
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THE HYPOTHESIS 
The hypothesis was proposed that there are at least two possible causes for the disap-
pearance of platelets during clinical perfusion, and as this problem had not been highlighted in 
other descriptions of hepatic assist procedures, an attempt was made to determine the nature 
of the complication. It was thought that either the circuit, or the liver could be responsible for 
the thrombocytopenia, or a combination of both these entities. 
a) The Circuit 
Trauma to the cellular and protein elements of the blood is known to accompany mechani-
cal pumping procedures (29). The disappearance of platelets is especially related to trauma at 
the blood-gas interphase of the bubble-oxygenator (15) and damage to leucocytes and 
erythrocytes has also been noted, with denaturation of protein (293). A great volume of litera-
ture has been reviewed in a standard text on heart-lung bypass (88) in order to assess the 
importance of these changes in patients following cardiac surgery. Whilst thrombocytopenia is 
noted in such patients, in general it does not constitute a major problem and platelet levels 
return slowly to normal. However, in the patient submitted to hepatic assist, a number of 
coagulation defects exist - the failure of the liver to synthesize fibrinogen, and prothrombin 
(278), and other clotting factors (281 ), the disordered calcium metabolism (202), and in particu-
lar, the spontaneous thrombocytopenia which has been noted in patients with massive 
necrosis before any form of therapy is undertaken (217,254). This has been ascribed to con-
sumptive coagulopathy and fibrinolysis following major tissue damage. The addition to such a 
disordered coagulation mechanism of major platelet destruction could well have precipitated 
the bleeding disorders which were manifest. 
b) The Liver 
As mentioned in the review of the assessment of function of the liver, a great deal of work 
has been performed using heterologous blood but in none of these studies has haematological 
assessment been performed. 
(i) In experimental hepatic assist procedures some immunological investigations have been 
performed, mostly involving the use of the dog. In those experiments in which pigs were used 
as the divergent species, dogs were noted to collapse with acidosis when connected to a pig 
liver (98) and other animals were sustained during the procedure, but responded with 
anaphylactic shock to a subsequent injection of porcine protein . During perfusions, an increase 
in vascular resistance and decrease in pH were noted (26). 
(ii) In clinial procedures a few reports exist in which the results are divergent in regard to the 
haematological and immunological observations. 
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(a) Haematological 
In only a small percentage of the clinical assist reports is mention made of thrombo-
cytopenia, or allusion made to any bleeding problems (49,202), but in none of these instances 
was the problem highlighted and in no case was a report made of perfusion termination for this 
reason. Indeed, in several reports, no mention was made of thrombocytopenia or haemorrhage 
(50,73, 191,211,241). Abouna, especially, has not reported major fall-off even in the long-term 
multiple species perfusion which was described (6). More recently he has documented 10 
patients treated by hepatic assist, of whom 8 suffered acute hepatic necrosis, 5 recovered 
consciousness and 2 survived (1 ). He emphasizes the bleeding problems encountered by other 
workers and attributes his own lack of this complication to the ability of the livers he perfuses 
to synthesize clotting factors. The synthesis of factors II , V and IX had been reported in a 
previous series (6). Since an immunological response may be associated with platelet aggrega -
tion, and due to the heterograft nature of this procedure evidence was sought of immunological 
responses in many of the patients reported . 
(b) Immunological 
In one patient, a temporary hypersensitivity-like reaction occurred with a generalised 
erythematous rash, diarrhoea, hypotension and vasoconstriction (280). "Considerable 
bleeding troubles" and thrombocytopenia with increased prothrombin time were noted during 
and shortly after perfusion. Subsequently antibody activity was detected against the 
parenchymal cells of human, pig and rat liver, and human kidney (106). However, in view of the 
major differences of opinion which exist in the interpretation of the presence of such anti-
bodies in many patients with liver disease (213), the significance of these observations is 
difficult to assess. 
In another series of perfusions, it was noted that in the patients' plasma, a decline 
occurred in a and !3 globulin, and 19s protein, with a subsequent increase in porcine albumin, 
a 1 and a2 globulin. The ascites exuding from the surface of the livers wheri perfused represen-
ted an ultrafiltrate of the patients' plasma and contained little porcine protein, and in the bile, 
all protein detected was of human origin (194). In some cases, no porcine protein has been 
detected immunoelectrophoretically or by immunodiffusion (61 ), but in others, cytotoxic and 
anti-pig serum antibodies were noted to develop after perfusion (6). 
As a result of this review, it was clearly necessary to perform studies to evaluate the 
various roles of the circuit and the liver in the thrombocytopenia which had complicated the 
clinical application of this procedure. In the course of investigation, it was hoped to find a 
means of preventing this complication. 

CHAPTER SIX 
A. INVESTIGATION OF THE HYPOTHESIS 
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8. THE NATURE OF THE RESPONSE 
1 . The nature of the heterograft response 
2. Platelet aggregation 
3. The role of the liver - the reticulo-endothelial system 
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- coagulation 
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A. INVESTIGATION OF THE HYPOTHESIS 
PHASE IV 
The effects of the circuit (particularly the oxygenator) upon platelet levels and red cell 
damage were investigated. 
(i) Design: 
i) Four experiments were performed without a liver, to provide a control series of observa-
tions of the platelet counts, plasma haemoglobin and plasma aspartate transaminase. 
ii) Four experiments were performed without a liver, with the addition of the detergent 
Pluronic F68 to the perfusate. This substance had been used experimentally to reduce 
oxygenator trauma in cardiopulmonary bypass studies on dogs where haemolysis is a 
major complication (199). In addition it had been used experimentally (55) and indus-
trially as an effective surface-tension reducing agent, and it was thought that this proper-
ty might prevent the aggregation of platelets which results from direct contact of blood 
and gas. 
iii) Four experiments were performed without a liver in which the oxygenator was first 
rinsed through with fresh pig plasma in an attempt to cover surfaces which might pro-
mote platelet adherence. 
iv) In four experiments, the low molecular weight plasma expander, Rheomacrodex was 
added to the perfusate in arbitrary clinical doses. This substance reduced sludging of 
blood ( 120) and it was used in an attempt to prevent platelet aggregation ( 161 ). 
v) Platelet aggregation has been noted to be associated with the removal of ATP (30) and 
hence this substance was added to the perfusate in three experiments without a liver 
vi) In all the above experiments, the Rygg Kyvsgaard oxygenator was used. 
vii) Since none of these additives appeared to be effective, except for the Pluronic F68 of 
which no clinical application could be found in the literature, a different oxygenator was 
used. It was not felt justified to embark upon use of a disc-type, especially as the im-
provement in blood trauma resulting from use of this apparatus is not highly significant 
(18). Membrane oxygenators are reputed to cause less trauma to all blood elements 
especially over prolonged periods and have been used to sustain completely the oxy-
genation of small animals for several days (142). These oxygenators were not available. 
A single experiment was performed with the Temptrol oxygenator which combines a 
heat-exchanging apparatus with the oxygenator. A complication in the use of this 
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type of oxygenator was the larger priming volume required as a result of the increased 
area occupied by the heat exchanger. 
viii) Finally, the Travenol miniprime 1 LF infant oxygenator w as selected because of its les-
ser priming volume of 1.5 litres which required a slower gas flow to achieve adequate 
oxygenation. The reduction in gas flow should be associated with less blood trauma . 
Four experiments were performed without a liver but us ing this type of oxygenator. 
ix) Platelets were counted in a haemocytometer using ammonium oxalate as diluent, as 
described by Brecher (32). 
x) All non-silicone rubber portions of the circuit were re-siliconised at the commencement 
of each group of experiments. 
(ii) Results: 
Table VII shows the mean results and standard deviations from each of the experiments 
described above. It may be seen that within the first hour in control group i, there was a fall in 
platelets to 50% of original levels, but that thereafter there was a less rapid decline over the 
remaining 3 hours. No improvement was noted with the use of plasma, Rheomacrodiex, or 
ATP, in fact these levels appeared to be lower, but these differences are not statistically signifi -
cant. 
In the single experiment with the Temptrol oxygenator, the rate of decline was a little 
slower than in the control experiments. 
The use of the Travenol bag in the circuit alone resulted in an improved terminal platelet 
count. There was virtually no fall in the platelet level within the first hour, and thereafter a 
decline was noted at the rate of 10% per hour. 
The use of Pluronic F68 resulted in a marked improvement in the platelet fall-off, there 
being only a 10% decrease in the first hour and a final fall of only 30% over the four hour 
period. This remained an interesting observation only, because the nature of the effect on plate-
lets and blood elements is not defined and no clinical experience has been reported. It was felt 
unjustifiable to use this substance without some previous clinical use, especially in view of the 
possibility that the platelets which had not aggregated in the perfusion circuit, might show 
altered properties when returned to the patient - either with a continued failure to aggregate, 
or a rebound leading to thrombosis after the drug had been excreted. Whilst it was known that 
the drug could be measured in the urine (112), neither the route of excretion nor the role of the 
liver in its metabolism were known . 
A lesser rise in plasma haemoglobin and aspartate transaminase in experiments using 
Pluronic F68 and the Travenol bag confirmed the reduction in trauma to erythrocytes. In addi-
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Table VII : Mean values (with± 1 S.D.) for platelets, plasma haemoglobin 
and aspartate transaminase in perfusions performed to 





































































































































































































































































































































































































































tion, Rheomacrodex seemed to prevent damage to these elements although no effect on plate-
lets was noted. 
(iii) Interpretation: 
The conclusion drawn from these experiments was that the Travenol oxygenator proved 
superior in regard to platelet damage in the circuit alone. 
PHASE Va: 
The effect of the addition of the liver to the circuit was then investigated. 
(i) Design: 
In 5 experiments, the pig liver was prepared as has been previously described, and was 
perfused using the Travenol oxygenator. Platelet counts were performed half an hour after 
commencement of perfusion and at hourly intervals thereafter. 
(ii) Results: 
It may be seen from Table VII that there was only a slightly greater fall-off in platelets 
when the liver was added into the circuit. The final count after 4 hours' perfusion was 52% of 
the original, and there was no significant difference in the other factors recorded . Assessment 
of the function of the liver as previously described showed no difference with the use of the 
Travenol oxygenator. 
(iii) Interpretation: 
It appeared that the trauma resultant upon oxygenation might have contributed 
considerably to the clinical problem of thrombocytopenia . 
Thus a series of experiments was begun to demonstrate that the effect of reducing 
oxygenator trauma was sustained during perfusions with human blood. 
PHASE Vb: 
In the first experiment using human blood to perfuse a pig liver under identical conditions 
to those descr ibed, very few platelets could be demonstrated in the first half hour sample 
taken, and no increase occurred during the further course of perfusion. In view of this observa-
tion, it was necessary to perform a series of experiments with human blood in which particular 
attention was directed to the first half hour of perfusion, and to the ~ole of the liver by 
measurement of trans-hepatic differences in platelet counts. 
(i) Design: 
i) Six pig livers were perfused with human blood for one hour. No attempt was made to 
match pig and human blood groups and the human blood was used at random as sup-
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plied by the Transfusion service; by chance, all blood used was of group A. 
ii) Platelets were counted in the perfusate before commencement of perfusion and there-
after at one, five, fifteen and thirty minutes. These samples were taken from the portal 
reservoir which was representative of the total inflow, and from the venous return which 
represented the post-hepatic sample. 
iii) In order to improve the biliary flow rate which had been found inadequate during the pre-
vious perfusions with human blood, the "cocktail" of insulin, secretin and decholin was 
added by continuous infusion throughout the perfusion. 
iv) In three control experiments, pig livers were perfused with pig blood for comparison of 
the fall-off in platelet counts during the first half hour, and the effect of addition of the 
"cocktail" upon biliary excretion. 
v) Additional studies included the rapidity of rewarming, the portal resistance, the total 
flow, plasma potassium, aspartate transaminase and plasma haemoglobin. The biliary 
flow rate under the influence of choleretics was noted in conjunction with the biliary 
electrolytes and osmolality. 
(ii) Results: 
The rate of transhepatic decrease in platelets is shown in Figure 26. Homologous 
perfusion of the pig liver with pig blood resulted in a slow transhepatic decrease in platelets 
which never exceeded 5% of the original. In perfusions of the pig liver with human blood, the 
transhepatic decrease in platelets was greatest (26%) between 5 and 15 minutes, and resulted 
in a final circulating count of 30% of the original value. This difference was highly significant. 
The other factors measured are shown in Table VIII. The portal resistance was slightly less 
in homologous perfusions and the total flow rate was slightly greater. The biliary flow rates 
were similar in both groups of perfusion and were markedly increased in comparison with 
previous work. Under the influence of added insulin, the plasma potassium was noted to fall 
slightly in heterologous perfusion, and considerably in homologous perfusion. Although the 
aspartate transaminase increased similarly in both groups, a greater rise was noted in plasma 
haemoglobin in heterologous perfusions. 
(iii) Interpretation: 
These results show clearly that while the circuit and oxygenator may have played some 
role in the clinical thrombocytopenia, the most marked response seemed to result from 
perfusion of the pig liver with human blood in the same time interval, little biochemical 
difference was observed. The results seemed to emphasise the role of the liver in the 
phenomenon of thrombocytopenia, and hence a search was made of the relevant literature to 
l>. -1:!. p ·-· 90 
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Figure 26 : The mean trans-hepatic levels of platelets in perfusions 
with porcine or human blood. 
P indicates the use of porcine blood 
H indicates the use of human blood. 
p indicates portal blood 
h indicates hepatic venous blood. 
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Pig Human 
0 - 1 hr 0 - 1 hr 
1 ) Aspartate transaminase units +27 (10-50) 35-90 
( 5-25) 
+15 20-35 
2) Plasma osmolality mosm/ 1 +21 (268-302) 284-321 
+24(195-330) 
273-387 
3) Plasma haemoglobin mq/ 100 ml +15 ( 13-16) 20-45 
( 5-50 ) +28 21-184 
4) Plasma potassium mEq/ 1 -2 ,5(3 ,7-6 ,5) 
2.4-6.7 
-0 4(6 ,5-7 ,2) 
• 3,5-5 ,8 
5) Biliary sodium mEq/ 1 +14(138-168) 122-158 
+ 8 (156-164) - 146-150 
6) Biliary potassium mEq/ 1 -0 .9€,7-9,0) ,8-9,8 
+1 .2~ ,2-5,7) 
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Table VIII : A comparison of mean values of the factors studied during 
one hour perfusion of the pig liver with pig blood (3 experi-
ments) and human blood (5 experiments). In determinations 
1 - 7, the mean difference over 1 hour is shown - + indi-
cates a rise and - indicates a fall. 
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determine the possible nature of the response. 
B. THE NATURE OF THE RESPONSE: 
Several factors were thought to be inter-acting in provoking this response. 
1) The pig liver perfused with human blood constituted a heterograft preparation albeit only for 
a short period. 
2) The circuit itself contributed some degree of platelet destruction although this was a minor 
component of the response. 
3) The liver, apart from being the antigen in the immunological response, has two other 
relevant roles - one in the process of coagulation and the other in the large phagocytic area of 
the reticulo-endothelial system formed by the Kupffer cells. 
There is a great overlap in all aspects of these factors, but they will be arbitrarily discussed 
according to the above tenuous division. 
1) The nature of the heterograft response: (222) 
Since the first description of the Forss man antigen, it has been known that "heterophile" 
antigens occur widely in micro-organisms and animal tissue and their existence may be due 
partly to accidental correspondence of immunogenic and haptenic determinants in cells and 
tissues that would otherwise have no close systematic relationship" (63). The antibodies of the 
human ABO system are thought to result from exposure to a variety of cross-reacting antigens 
(219). Hence heterophile phenomena have been described in one instance as immunological 
reactions in which the interaction of antigen and antibody is seemingly non-specific (34). 
"The strength and nature of the immune response which may result in damage to or death 
of the transplant are determined in part by the chemical nature of the surface configurations, 
the degree of disparity from those of the host, their concentration and distribution on the outer 
and inner cell membranes and whether or not they are expressed on all cells comprising the 
graft. The effect of the immune response on the graft is a function of the physicochemical 
- characteristics of the antibody, the ratio of cellular immunity to serum antibody and the degree 
of heterogeneity of the combining sites of antibody or immunocompetent cell. The nature and 
intensity of the host response will also be influenced by any prior immunisation of the host to 
antigens present in the graft" (59). 
Attempts to clarify the complexity of the transplant phenomenon between animals of 
different species have included the use of the terminology "closely related or widely divergent" 
(208), or more recently by Caine (39) "concordant or discordant" species. 
There has been some debate as to whether the response to antigen in the presence of pre-
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formed antibody constitutes a reaction of the Arthus or the Schwartzmann phenomenon type, 
or a combination of both . In kidneys, it has been postulated to be the Schwartzmann 
phenomenon (140) and in the generalised Schwartzmann phenomenon, there is evidence that 
platelets are involved (201 ). But, from the general description of the Arthus reaction, this would 
appear more apposite to the observations made. In this reaction (45), following deposition of 
antigen/ antibody precipitates on vessel walls, complement is bound and neutrophils and plate-
lets accumulate. Severe injury occurs to the vessel wall, with disruption of the basement 
membrane, oedema and haemorrhage. Invading neutrophils are said to engulf and degrade 
antigen/ antibody complexes. Mechanisms involved in the localisation of immune complexes 
in blood vessels include - (i) phagocytosis by endothel ial cells especially if the reticulo-endo-
thelial system is already saturated by phagocytosed complexes; (ii) attachment by affinity for 
vessel wall structures especially if electrostatic conditions are favourable, and (iii) entrapment 
in the vessel wall as a result of increased permeability induced by these complexes, and their 
results (46) (see Figure 27). 
Circulating Antigen/ antibody complexes 
l 
Release of vase-active amines 
l 
Increase in vascular permeability 
I 
V 
Localisation of complexes 19s along vascular membranes 
I 
non-polymorphonuc I ear 






activation of C' through 
C'5 - 7 
1 
Accumulation of polymorphonuclear leucocytes 
and platelets. 
\ 
(mast eel I rupturing agents in lyso-
somes (MCF )- i.e. release vaso-
active amines from mast cells and 
platelets. 
Figure 27 : A hypothetical scheme to represent the effects of circulating 
antigen-antibody complexes. 
C' indicates the fractions of complement. 
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Once complexes localise, complement is rapidly fixed, polymorphonuclear leucocytes and 
platelets are attracted and damage ensues. In immune lysis by complement, small holes are 
formed in cell membranes which allow ions but not large molecules to diffuse through. This 
results in equilibration of ionic contents across the cell membrane (201 ). Since some platelet 
granules are lysosomes, these also result in tissue injury when platelets become degranulated. 
The results of experimental heterotransplants have been described frequently. It has been 
apparent that the liver plays a major role in the reaction to anaphylaxis resultant upon the 
challenge of a pre-sensitised animal. As early as 1923, in pre-sensitised dogs, the injection of 
antigen resulted in increased perfusion resistance and decreased flow in the portal system 
(165). In addition, the effect of anaphylaxis upon platelet counts in the heterograft 
phenomenon, has been known since 1941 (143). 
In this laboratory, (259) the baboon liver and kidney were transplanted into individual 
recipient pigs. The observation was made that while the kidney was obviously rejected within 
30 minutes, becoming turgid, and black with gross proteinuria, the liver continued to perfuse 
for a much longer period of time. Recipients of these livers recovered consciousness and were 
alert for up to 18 hours; thereafter they succumbed with a metabolic acidosis which could not 
be reversed. This syndrome was reminiscent of the totally hepatectomised animal which also 
survived for a similar period of time, and in which the terminal syndrome also could not be 
reversed. Histological evidence of damage to the heterografted liver occurred within the first 
30 minutes, with sinusoidal congestion and the presence of polymorphs within the sinusoids. 
Fine non-lipid vacuolation of cells was also seen, with hyaline intracytoplasmic inclusions. 
There was some nuclear pyknosis and cytoplasmic shrinkage characteristic of parenchymal 
cell damage. 
The association of decreased platelet and polymorphonuclear leucocyte levels in the 
heterograft process has been frequently described in heterotransplants and heterogeneic 
perfusions of the kidney (48,168,210) and follows the pattern as described for the localisation 
of immune complexes (Figure 27). Little work has been performed on the platelet responses to 
liver heterografts but the few reports record a similar pattern of the sharp decline in platelets 
within a few minutes of commencement of perfusion. The decline was associated with a fall in 
leucocytes, complement and cytotoxic antibody (27). 
2) Platelet aggregation: 
Platelet function and the phenomenon of platelet aggregation have been exhaustively 
reviewed (167,170) in attempts to elucidate the problems of normal and abnormal blood 
coagulation. For the purpose of this study only the selected references of direct importance will 
be cited. 
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Platelet functions have been classified as the support of endothelium; aggregation and the 
promotion of coagulation; and the activation of prothrombin complex to thrombin (282). Also, 
the mechanism of aggregation has been widely studied. Aggregation appears to be dependent 
upon ADP released from erythrocytes (86) which is dependent upon the availability of glucose 
(139). It is thought that the reduction of ATP to ADP on the surface of platelets and red cells 
results in a negative charge which increases the tendency to adhere (30). Aggregation may be 
induced by ADP, adrenaline, 5-hydroxytryptamine, thrombin, collagen and fatty acids in vitro 
(171 ), and the ultrastructure of the changes involved has been recently described (251 ). 
Of greatest significance to this study are the reports of platelet adherence to collagen 
(158,201), to vascular endothelium (180), and the involvement of platelets in the formation of 
immune complexes (206). This will be cited in more detail in the next section. Upon aggrega-
tion of platelets, various factors are released - histamine, serotonin and lysosomal enzymes, 
which aggravate endothelial and cellular damage and establish a vicious cycle (131 ). Local 
release of adrenaline activates the mechanism by further release of ADP (197). 
3) The role of the liver 
a) The reticulo-endothelial system - It has recently been observed that homologous platelet 
aggregates could be cleared from the circulation by attachment to an isolated perfused liver, 
thereby preventing pulmonary damage (195). Clearance of fibrin aggregates has also been 
noted (89). This highlights the "scavenging" and protecting effect of the R-E system in the liver 
- the major physiological host defence system (230). In the problem of removal of platelets and 
immune complexes, the fact that the liver has this large area of macrophages may be signifi-
cant. While the Kupffer cells have been noted to enhance the action of weak antigens, their 
role in the immune response is less clearly defined (290). However, in a review of the functions 
of the R-E system and studies of suppression of phagocytosis by colloidal carbon (276) the 
question arises whether the role of platelets is indeed to surround foreign particles and 
transport them to the R-E system hence being phagocytosed themselves. 
Overall, the role of the R-E system in regard to the Kupffer cells has been suggested to be 
(i) phagocytosis of colloidal particles, red cells, viruses, bacteria, lipids and cholesterol, and (ii) 
the removal of immune complexes and the clearance of antigen. In addition to this role of the 
Kupffer cells, endothelial cells of the portal and hepatic veins and the hepatocytes are also 
capable of these clearance functions (21 ). 
b) Endothelial surfaces and tissue factors - .Damage to the vascular endothelium specifically 
has been of interest to those investigating the nature of thrombogenesis, but in the case of 
perfusion or transplantation (127) of the liver, where damage to vascular linings may result 
from inefficient preservation, ischaemia or the mechanical trauma of perfusion or flushing, it 
114 
may play an important role in the development of thrombocytopenia. The phenomenon has 
been described as platelet cohesion to each other, but adherence to connective tissue (249), 
and different physicochemical properties are involved. Contact with sub-endothelial tissues 
has been thought to lead to the activation of prothrombin (17). In recent studies it has been 
shown that it is contact only with collagen and connective tissue from organs with high oxida-
tive phosphorylation ratios (e.g. liver, brain, kidney and muscle) which leads to aggregation of 
platelets. Contact with tissue homogenates of a number of other organs did not have this effect 
(265). The resultant aggregation is probably still mediated through ADP, the tissue specific 
inducer (266); calcium is also required . Repeated leakage of ADP and collagen from disrupted, 
ischaemic or intoxicated tissues could result in persistence of platelet thrombi, stasis and the 
development of a vicious cycle (266). 
As mentioned previously, it has been suggested that the platelets have a role in 
"nurturing" the endothelium (94). This has been demonstrated in perfusions of rat thyroid with 
platelet rich media, using apparatus which was entirely silicone rubber and therefore non-
traumatic. In addition, it has been suggested that platelets enter to block endothelial gaps, but 
that as repair takes place, this attachment of platelets is reversed (83). 
c) Coagulation - The liver is reported to play a role in fibrinolysis which may become defective 
with inadequate preservation as evidenced upon transplantation. Its role has been postulated 
to be to compensate particularly for the increased fibrinolytic activity after trauma (11 ). This is 
confirmed by studies after total hepatectomy in dogs in which an increase in proteolytic activity 
was noted in the blood with breakdown of fibrinogen to fibrin degredation products with conse-
quent disseminated intravascular coagulation (258). 
As mentioned previously, the liver has been supposed to synthesise many of the coagula-
tion factors (283) and in isolation has been shown to remove fibrin deposits from the circula-
tion in its "scavenging" role. In addition, the l iver is thought to be the primary site of synthesis 
of the C'3 fraction of complement ( 14). Most of these activities are revealed in patients with 
liver disease, especially in massive liver necrosis (278). 
d) Another role of the pig liver which has been shown by the allo-transpantation experiments 
of Caine (40), is the suggested immunological effect by which it may protect other transplanted 
organs from rejection . 
PHASE VI: 
Consequent upon this review, a study was designed to investigate the association of other 
features of the heterograft phenomenon with the already observed thrombocytopenia . 
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(i) Design: 
i) Four experiments were performed with human blood circulating through the circuit 
alone. 
ii) Four experiments were performed with the pig liver perfused with pig blood, and 
iii) Seven experiments were performed with the pig liver perfused with human blood of 
various groups - A (2); B (2); AB (3). 
iv) The liver was "massaged" by movement of the diaphragm which was mobilised by the 
motor shown in Figure 5. This pr~cedure was commenced in an attempt to reduce stasis 
on the dependent surface of the liver which had been noted during previous perfusions. 
v) Since these were the first experiments with human blood using the Travenol oxygenator 
for four hours, a full biochemical evaluation was performed as described in experiments 
in phase II. 
vi) Platelets were counted in samples taken from the portal inflow and the venous return. 
The results were corrected for the small changes in haematocrit, and were expressed 
as a percentage of the original pre-perfusion count. The difference between in and 
outflow platelet counts was designated the transhepatic difference. 
vii) Lymphocytes and leucocytes for cytotoxic tests were generally obtained from the donor 
of the liver, but in a few instances, multiple results were obtained with the cells of a 
single donor. Lymphocytotoxic antibodies were sought using the microtechnique of 
Van Rood (272) and leucocyte aggregating antibodies by the techniques of Kissmeyer 
Nielsen and Kjersbye (141 ). Heterophile antibodies were measured in pig plasma 
against human, baboon, rat, sheep and guinea-pig erythrocytes, and in human plasma 
against pig, rat, sheep and guinea pig erythrocytes by standard techniques (see Appen-
dix of Methods reference 18). 
(ii) Results: 
a) Physical and biochemical 
In Figure 28 the portal resistance, total flow rates and rate of bile flow in perfusions of the 
pig liver with pig blood or human blood are shown. There was no marked difference between 
the two groups in the resistances, although the readings in the human group remained a little 
higher than those in the pig group. Bile flow rate was similar in both groups and was higher 
than in previous perfusions due to the addition of choleretics, but in 3 of the 7 perfusions with 
human blood, bilirubin accumulated in the plasma after one hour of perfusion. 
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Figure 28 : The portal resistance, total flow rates and rate of bile flow 
in perfusions with porcine or human blood. 
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In Figure 29 the levels of plasma and biliary potassium are compared, and although the 
levels in pig blood were higher, the patterns appear similar. In Figure 30 the highly significant 
rise of aspartate transaminase in perfusions with human blood may be seen (p(0,001) the 
clearance of the lactate administered at three hours appears similar in both groups although 
the initial lactate/ pyruvate ratios were higher in perfusions with human blood. The rates of 
clearance of ammonia and increase in plasma urea are shown in Figure 31 from which it may 
be seen that there is a greater increase in urea levels in perfusions with pig blood, and a more 
rapid clearance, at least within half an hour, of the administered load. 
The appearance of the liver is impossible to quantitate, but it is noted that livers perfused 
with human blood tended to be blotchy and to develop small black areas of ischaemia after four 
hours' perfusion which were not seen in the livers perfused with pig blood. 
b) Haematological and Immunological 
From Figure 32 it may be seen that there was no significant decrease in platelets during 
perfusion of human blood through the circuit alone. During homologous perfusion of the pig 
liver with pig blood, the maximum mean transhepatic decrease (6-8%) occurred at 1 and 5 
minutes, and between 15 and 30 minutes there was a reversal of the levels. This was pre-
sumed to be due to release of platelets after initial adherence within the liver. 
During heterologous perfusion with human blood, the mean transhepatic decrease in 
platelets increased from 24% at one minute to a peak of 57% at 5 minutes. This resulted in a 
final total circulating level of 20% of the original value at 30 minutes, which was highly signifi-
cantly different from the level of 60% obtained in homologous perfusions. No subsequent 
increase of circulating platelets was noted in the remaining 3Vi hours of perfusion. A similar 
observation was made in the leucocyte counts. In homologous perfusions, a mean trans-
hepatic decrease of 9% and 3% was noted at one and f ive minutes, and an increase of 20% and 
3% at 15 and 30 minutes. In heterologous perfusions, the mean trans-hepatic decrease 
increased from 15% at one minute to 39% at 5 minutes with a final total circulating level of 
15%. 
The levels of complement fell to 94% of the initial value in perfusions of human blood 
alone; to 95% in perfusions of the pig liver with pig blood, and significantly to 72% in 
perfusions of the pig l iver with human blood (p(0,001 ). The levels of plasma haemoglobin 
increased in all perfusions, with a greater increase in human blood perfusing pig livers. 
Lymphocytotoxic, leucoagglutinating and heterophile antibodies in human blood 
diminished with in five minutes and were almost totally absent after 30 minutes of perfusion 
through the pig liver. No alteration of these antibodies occurred in the human blood when 
perfused through the circuit alone, nor in pig blood perfused through the pig liver. 
119 
c) Histology 
Histological features were similar to those reported in the comparison of livers perfused 
with porcine or human blood in phase II of these experiments. Whilst the architecture seemed 
reasonably well preserved after four hours' perfusion with porcine blood, with only occasional 
evidence of sinusoidal congestion and haemorrhage, these features were marked in livers 
perfused with human blood. In two sections, frank total cell necrosis was seen in areas. 
(iii) Interpretation: 
One observation made in these experiments was that there appeared to have been a reduc-
tion in the levels of portal resistance in perfusions with human blood as compared with experi-
ments in phase II. No reasons could be advanced for this observation except that the total flow 
in these experiments was also greater than in phase II; this observation may only reflect the 
lesser resistance rather than explain it. The differences in the experimental design of this 
group and phase II lay in the oxygenators, and in the infusion of the "cocktail". It could be 
postulated that less damage occurred to the human blood when passed through the Travenol 
oxygenator, with fewer small particles to lodge in the portal vasculature, or that the infusion 
acted as a vaso-dilator. Bile acids are known to have vasodilatory properties, but it is likely that 
there would have been some obvious effect upon the homologous resistance in addition to that 
in heterologous experiments. These results were the mean of 7 perfusions with different blood 
groups - of these, only 3 were of group AB, which had been previously noted to cause the 
greatest rise in portal resistance and aspartate transaminase. Hence the lower resistances 
may be evidence of random use of blood groups and the result of taking mean values. 
The levels of potassium in perfusions with human blood were reduced over the course of 
the experiments as compared with observations in phase II. This difference might also be 
attributed to the use of insulin, and could perhaps indicate that the release of potassium which 
occurred in the first perfusions with human blood was reversible by infusion of insulin. 
Nonetheless there was still evidence of greater liver damage in organs perfused with 
human blood, there being a highly significant increase in the levels of aspartate transaminase. 
It should be noted also that there was a lesser increase in perfusions with pig blood in these 
experiments than had been observed in perfusions in phase II. This might be attributed to the 
improved perfusion of the liver as a result of the diaphragmatic movement, which prevented 
obvious stasis. 
As in phase 11, there was clearance of the administered load of lactate and ammonia within 
one hour of infusion. Livers perfused with pig blood appeared to synthesise more urea during 
the first three hours of perfusion, but in response to the load, the levels of plasma urea 
increased equally in both groups within the hour tested. 
120 
Figure 29 : The levels of plasma and biliary potassium in perfusions 
with porcine or human blood. 
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Figure 30 : The levels of aspartate transaminase and the clearance of 
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Figure 31 : The rates of clearance of ammonia and increase in urea 
in perfusions with porcine or human blood. 
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Figure 32 : The levels of platelets, complement, plasma haemoglobin 
and human anti-pig antibodies during perfusions with por-
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Hence there was evidence of liver damage in the perfusions with human blood in both 
phases II and VI. In phase VI a reversal of potassium leakage occurred probably as a result of 
the add ition of insulin, and a change in the pattern of the portal resistance which was attribu-
ted to the infused " cocktail " or to the various blood groups used. The overall appearance and 
perfusion of the liver was markedly improved by the use of the diaphragm. 
The patterns of platelet and leucocyte decrease across the liver and the decline in the 
levels of complement and antibodies confirmed the proposed heterograft nature of this 
response. 
Subsequent investigations were made in an attempt to prevent this response . 
CHAPTER SEVEN 
ATIEMPTS TO PREVENTTHROMBOCYTOPENIA 
Introduction (1) Prevention through the mechanism of the aggregating process - drugs 
- calcium 
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(3) Attempted prevention in the heterograft model 
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(g) Colloidal carbon 
(h) KRB + KG 
(i) (h) + heparin 
(j) (h) + EDTA 
(k) KRB + KG + McCoys 5A 
(I) Human blood, and plasma flushes 
(m) 2 pig livers successively 
Justification of design 
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A wide variety of methods has been employed in an attempt to prevent platelet 
aggregation in vitro and in vivo. Many of these have been successful in vitro, but have failed in 
the in vivo heterograft. 
( 1) Prevention through the mechanism of the aggregating process 
Two principal features in platelet aggregation are the release of ADP, and the requirement 
for calcium. Many attempts at prevention of aggregation have been directed at these two 
factors . (Few reports exist of each of these methods and hence a number of references will be 
cited . An attempt has been made however to select methods with a possible clinical 
application). 
Drugs which have been used to inhibit aggregation include anti-ADP enzymes, local 
anaesthetics, antihistamines, tranquillizers and anti-depressant drugs (171 ). Adenosine 
monophosphate has been used in its role of replacement of ADP (30). Since the energy of 
oxidative phosphorylation is necessary for ADP-induced aggregation, the effect of removal of 
glucose has been explored. Antimycin, oligomycin and 2-4 dinitrophenol have been used (139) 
for prevention of the synthesis of enzymes involved in oxidative phosphorylation . Acetyl 
salicylic acid is thought to be effective by causing the incorporation of a_cetate into the 
metabolic pathway (13). The pyrimido-pyrimidine compound RA-233 has been used to inhibit 
calcium and ADP-induced aggregation and to decrease the release of platelet factor 3 by kaolin 
(109), whilst the related drug, Dipyridamole (Persantin) has been found to slow the disappear-
ance of adenosine (75). Arginine methyl esters have also been used empirically to prevent 
platelet aggregation (182). Sulfinpyrazone and butazolidine have caused an alteration of the 
response of platelets to surface stimulation, by blocking the aggregating action of collagen, 
antigen/ antibody complexes and y-globulin coated surfaces on platelets. This is also one of the 
multiple functions of prostaglandin E 1 in vitro ( 138). 
Calcium plays a vital role in clotting, and aggregation of platelets has been suggested to be 
independent of any other clotting factors except perhaps thrombin (15). The release of 
histamine from rabbit platelets has been used as an indicator of platelet aggregation or its 
prevention . This reaction has been found to be dependent upon specific levels of calcium and 
the pH . The range of pH has been found in vitro to be narrow - between 6,2 and 7,8, and 
absolute removal of calcium by chelation with EDTA or citrate has resulted in inhibition of 
platelet aggregation (172). 
(2) Prevention with colloidal or particulate matter 
Infusion of long-chain fatty acids has been shown to lead to thrombosis (52), but unsatura-
ted fatty acids were noted to be less active (294) and mixture with serum before injection also 
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seemed to decrease the effect. Other lipids - e.g. ethyl esters of oleic and stearic acid seem 
capable of blocking aggregation (21,255). Colloidal carbon has been used to block the reticulo-
endothelial system but with incomplete blockade, compensation occurs by the remaining 
unblocked areas of the macrophages (21 ). However, it has also been suggested that since plate-
lets are required for the transport of colloidal particles to the reticulo-endothelial system (276), 
the apparent blockade occurs as a result of thrombocyopenia or inefficient action of platelets. 
(3) Attempted prevention in the heterograft model 
Heparin and aspirin have been used for their anticomplementary effect and reversal of 
platelet aggregation in attempts to prevent rejection of the heterografted kidney (160), and a 
large number of other drugs has been explored (166). The use of anti-lymphocyte serum, blood 
grouping and cross matching or pre-treatment with donor antibody has been found ineffective 
in such experiments (208). Cyproheptadine (Periactin) has been used with success in pre-
venting platelet aggregation and vasculitis in heterografted kidneys (38), but the anti-
fibrinolytic and anticomplementary effects of Arvin and heparin, and the use of anti -platelet 
serum were ineffective. However, in these same experiments, the perfusion of the recipient's 
blood through an isolated liver resulted in reduction of platelet and cytotoxic antibody levels 
and prolongation of the heterograft survival (248). In vitro studies with human platelets and 
heterologous anti-platelet antiserum have shown that the sulfhydryl reducing agents 
monoiodoacetate and N-ethyl maleimide prevented aggregation of platelets (182). 
In a more recently described technique, some success has been reported with mechanical 
separation of plasma fractions. The attachment of the circulation of animals to a forced flow 
electrophoresis apparatus resulted in the removal of substantial amounts of antibody and 
caused prolonged survival of heterologous kidney grafts (27,244). 
In the following experimental approach to this problem, two directions were taken . 
(i) Attempts were made to reduce the endothelial damage by manipulation of the method of 
short-term preservation of the liver after removal, and its flushing . The experiments of 
Dawkins et al (58) as previously reported, were taken as a basis for these studies. 
(ii) Several of the means detailed above were selected in an attempt to prevent the platelet 
response following heterologous exposure. 
PHASE VII 
(i) Design 
A - Attempts to reduce endothelial damage in homologous perfusions 
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a) Variations were made in the temperature of the flushing solution - temperatures of 4, 20 
and 38°C were used. In the last instance, the liver lost heat during transport to the per-
fusion laboratory and before commencement of perfusion when the mean temperature 
was 26°C. Livers which had been perfused with the 4°C solution as before, gained heat 
to a mean of 10°C. The livers perfused at 20°C tended not to change temperature since 
this was approximately the ambient temperature. 
b) Variations were made in the constitution of the flushing solution and the solutions used 
to prime the circuit and to infuse during perfusion. Following the work of Dawkins (58), 
a modified Krebs Ringer bicarbonate solution (see Table Ill) was used to flush the liver 
and to prime the circuit, and several substrates were added to the flushing solution, the 
prime and the infusing solution. These substrates included fumarate, pyruvate and 
glutamate in one experiment, and in several experiments, a -oxoglutarate which had 
been found the most effective by Dawkins in the preservation of oxidative phosphoryla -
tion . The concentration of a -oxoglutarate chosen was 15mM being divided equally 
between the flushing solution, the prime and the infused fluid, and the substrate was 
added both to TisUsol and the Krebs Ringer bicarbonate. 
A further attempt to improve substrate levels was made with the use of the tissue cul-
ture medium McCoys 5A. This had been used for preservation of the isolated spleen (66), 
and contained "physiological" amounts of numerous amino acids, vitamins and electro-
lytes. 
c) A few of the drugs described above were used. 
Heparin - in addition to the 45mg/ l present in the human blood as obtained from the 
Transfusion Service, a further 250mg was added initially to the 1,5 litre perfusate, and 
250mg was added by continuous infusion over the 4 hours' perfusion. An additional 
amount of 250mg was added to the flushing solution. 
Ethylene-diamine-tetra-acetate (EDTA) was added to deplete the perfusate of calcium, 
the dose used being 1,0mg/ 1. 
Adenosine (0,001 M) was added in an attempt to block the aggregating effect of ADP. 
d) The pig donating the liver was unstarved in an attempt to ensure adequate pre-operative 
levels of glycogen in the liver. This lack of starvation made dissection a little more difficult 
but no obvious additional trauma resulted to the liver. 
B - Attempts to prevent platelet aggregation on the basis of trauma, ADP release, or the 
immunological phenomenon in heterologous perfusions 
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a) Hydrocortisone - 1 OOmg/ 1,5 litres was added to the perfusate just prior to commence-
ment of perfusion. 
b) Trasylol - 75 000 units/ 1,5 litres was used as an antifibrinolytic agent and has also been 
reported to have effect in the prolongation of heterografts. 
c) Cyproheptadine (Periactin) was used in the dose 160mg/ 1,5 litres. The tablets were 
dissolved in water and the pH corrected to 7,0 with 0, 1 N hydrochloric acid. The final 
suspension was filtered to remove the agents used in preparation of the tablet form . 
d) The temperature of the perfusion was reduced to 10-15°C to investigate whether the 
platelet aggregation was temperature dependent. 
e) Heparin was added as in A(c). 
f) Dipyridamole (Persantin) was used in the dose of 200mg/ 1,5 litres. 
g) A suspension of colloidal carbon was prepared in TisUsol in a concentration of 4mg/ ml 
as had been described (131 ). This was used to flush the liver prior to perfusion. 
After evaluation of the results of the experiments in section A, the most efficient 
combinations were chosen and were used in the heterograft procedure in combination with 
other pharmacological manoeuvres. 
h) The modified Krebs Ringer bicarbonate solution was used as a flushing solution and 
prime, with added a -oxoglutarate as described in A(b). 
i) As 2h with added Heparin as in A(c). 
j) As 2h with added EDTA as in A(c). 
k) Krebs Ringer bicarbonate flushing solution with McCoys medium 5A as priming solution 
and as addition to the infusion solution. a -oxoglutarate as used in A(b) was added. 
I) In two different groups of experiments, attempts were made to block the antibody-
binding sites within the liver by prior exposure of the liver to human blood or plasma con-
ta ining such antibody. Hence, livers were flushed either with fresh human blood com-
patible with that to be used for priming the circuit, or with reconstituted dried plasma. 
m) In a further attempt to remove antibody from the human blood, two livers were used, after 
both had been dissected. The first was inserted into the circuit and allowed to perfuse 
for 15 minutes while samples were taken, and thereafter, the second liver was inserted 
into the circuit and the perfusion continued for 4 hours. In this experiment, in retrospect, 
it was realised that the platelets would disappear with the initial perfusion and might be 
present in too few numbers to show a significant alteration in the second part of the 
perfusion . 
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Except where otherwise stated, all drug additions were made to the perfusate before 
commencement. 
In all additions of drugs, the dose chosen was the greatest which might be used in a 
clinical procedure. 
The first half hour of perfusion was studied in more detail in a number of the above 
experiments in an attempt to define more clearly the occurrences during the first hour 
of perfusion in which most of the radical changes take place. The factors reviewed were 
the portal resistance, the total flow rate, and the rate of increase in the temperature, the 
plasma potassium and haemoglobin, and the aspartate transaminase. 
Justification of Design: 
In all experiments, especially those performed with human blood, but also in those using 
pig blood, only a single experiment of each type was performed unless otherwise stated. If any 
procedure had appeared to result in a marked difference in the decline of platelets which was 
taken as the prime objective, further studies would have been made after the safe clinical 
application had been thoroughly explored. This policy was adopted due to the expense involved 
in each experiment, and in an attempt to prevent over-use of human blood. No statistical 
conclusions could be drawn, but provided that experimental conditions were kept constant, a 
technique was excluded if no improvement resulted in trans-hepatic platelet differences. This 
applied especially in the pharmacological group in which other workers have reached a similar 
conclusion in heterograft experiments. 
(ii) Results 
A - Attempts to reduce endothelial damage in homologous perfusions 
The results obtained in 13 groups of perfusions are shown in Table IX where the platelets 
and leucocyte counts for the first half hour are recorded . The mean changes in potassium, 
plasma haemoglobin and aspartate transaminase at thirty minutes and four hours after 
perfusion appear. and the mean total flow rate, portal resistance and changes in temperature 
with time are also recorded. 
a) Effect of increasing the temperature of the flushing solution: 
Comparison of the control changes in platelets with those occurring after flushing with 
TisUsol at 20°C and 38°C shows a marked improvement with the latter two temperatures. The 
same effect is noted when Krebs Ringer bicarbonate was used at 4°C and 38°C. A greater 
increase of aspartate transaminase over four hours occurred with either TisUsol or KRB at 4°C, 
than when the solution was warmer. With KRB at 38°C a lower total flow rate was achieved. 
The improvement in perfusion after flushing with warm solution was much more obvious 
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Table IX : The mean values for temperature change, and for portal resis-
tance and total flow rate during the first 30 minutes of 
homologous perfusion. 
Table IX : The mean values for aspartate transaminase, plasma haemo-
globin and plasma potassium at 30 and 240 minutes of per-
fusion with homologous blood. 
Table IX The mean values of leucocytes in homologous perfusions using 
methods to prevent endothelial damage. 
Table IX : The mean values of platelets in homologous perfusions using 
methods to prevent endothelial damage. 
(Initial Temp) Temp . change at Resistance at : Tota l flow at: 
O" 1" 5" 30" 1" 5" 30" 1" 5 " 30" 
TisUsol 20°c (20) 8 13 17 0.10 0.029 0.023 0.27 0.83 1,06 
TisUsol 38°C (30) 0 1 7 0.14 0.050 0.032 0.31 0.60 0.91 
KRB 4°C (24 ) 7 10 13 0,069 0,037 0,026 0,33 0,55 0,72 
KRB 38°C (27 ) 2 5 9 0,160 0,190 0, 120 0,29 0,32 0,43 
TisUsol + ex KG (28) 0 4 8 0,10 0,040 0,026 0,36 0,44 0,56 
Fumar/ pyruv/ glut. (25) 6 9 12 0, 11 0,110 0,060 0,44 0,74 0,99 
KRB t EDTA ( 16) 12 22 22 0, 123 0,091 0,048 0,49 0,38 1,01 
KRB t ex KG at 38°C (23) 7 12 14 0,094 0,068 0,052 0,36 0,53 0,65 
KRB t ex KG t Heparin (28) 2 6 14 0,107 0,085 0,037 0,38 0,80 0,92 
KRB+ ex KG+EDTA (23) 7 9 14 0,092 0,091 0,042 0 ,31 0,60 0,76 
Unstarved pig (18) 8 10 19 0,130 0,174 0,043 0,27 0,26 0,73 
KRB t ex KG t McCoys (25) 6 10 12 0,050 0,050 0,040 0,73 0,73 0,96 
KRB t ex KG t Adenosi ne (24) 9 12 13 0,085 0,037 0,048 0,43 0,94 0,94 
Asp.T/ sam Plasma Hb Plasma Kt 
30" 240" 30" 240' ' 30" 240" 
Ti sUsol 20°C 5 35 0 20 1.6 3.7 
TisUsol 38°C 0 15 2 30 0,8 2,8 
KRB 4°C 5 15 0 25 1,6 6,4 
KRB 38°C 30 90 40 70 1,0 3,0 
TisUsol t ex KG 10 25 0 5 0,6 0,6 
• Fumar / pyruv / glut. 0 10 0 55 0,7 4,2 
KRB + EDTA 15 50 3 60 0,5 1,5 
KRB t ex KG at 38°C ( 6 ) 0 15 3 30 0 2,4 
KRB t ex KG+ Heparin ( 2) 0 30 4 12 0 3,8 
KRB t ex KG t EDTA ( 2) 10 50 5 75 0 1,8 
Unstarved pig 15 80 10 50 1,0 2,0 
KRB t ex KG t McCoys 10 30 0 20 1,3 2, 1 
l<RB t a KG t adenos i ne 5 40 30 60 1,7 1,9 
Control 25 15 0,9 
Leucocytes % PV / HV 
1" 5" 15" 30" 180" 
TisUsol 20°C 107/ 18 74/ 23 67 / 32 35/29 
Ti sUsol 38°C 71 / 58 76/ 12 71/29 29 / 18 43 
KRB 4°C 110/27 75/21 63/ 26 37/ 25 19 
KRB 38°C 108/ 15 100/ 27 38/ 25 33/ 22 11 
TisUsolt exKG 84/ 26 87/ 36 62/ 43 39/ 33 24 
Fumar/ pyruv/ glut. 100/ 55 89/ 28 85 / 27 47/ 33 13 
KRB t ex KG at 38°C (6) 84/ 55 83/ 33 62/ 36 48/ 40 40 
KRB + EDTA 87/ 37 94/ 19 45/ 29 25 / 34 16 
KRB t ex KG + Heparin ( 2) 101 / 52 101/25 70/25 36/ 33 25 
KRB t ex KG t EDTA (2) 67/ 40 63/ 38 50/ 50 2G/ 42 29 
Un starved pig 86/28 82/ 23 71 / 31 45/ 25 18 
KRB t ex KG t McCoys 102; 20 108/ 16 68/ 30 45/ 36 30 
KRB + ex KG t adenosi ne 83/74 72/ 19 57/ 40 40/ 40 19 
Platelets % PV / HV 
-
1 " 5" 15" 30" 180 ' ' 
Ti sUso I 20° C 99/ 91 110/ 110 117/ 114 90 / 104 
TisUsol 38° C 65/ 67 65/ 53 65 / 59 61 / 58 53 
KRB 4° C 110/ 58 80/ 63 66/ 56 58/ 55 50 
KRB 38° C 90/ 54 94/ 90 83/ 80 86/ 81 26 
TisUsol + ex KG 109/ 73 108/ 99 112/ 98 93/ 115 67 
Fumarate/ pyruvate/ glutamate 83 / 67 93/75 98/73 74 / 70 56 
KRB t EDTA 106/ 58 91 / 65 51 / 82 56/ 98 30 
KRB + ex KG at 38° C (6) 78/ 68 83/71 81 / 82 70/ 86 75 
KRB + ex KG t Heparin (2) 109/ 60 87/ 83 88/ 86 83/75 62 
KRB t ex KG t EDTA (2) 98/ 68 88/ 82 93/ 107 57 / 107 72 
Unstarved pig 65/ 57 66/ 56 64/ 60 47/ 48 47 
KRB + ex KG t McCoys 84 / 76 106/ 88 84 / 92 86/ 96 71 
KRB t <>< KG t Adenosi ne 91 / 55 69/ 93 60/ 126 93/ 115 67 
Control 90/ 95 83/ 82 64/ 63 59/ 61 45 
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in the appearance of the livers. The organs which had been flushed with a warm solution were 
a homogenous beige colour whereas the livers perfused with cold solution often showed small 
red areas which looked like bruising . In the first few m inutes of perfusion, blood spread 
diffusely and evenly through the warm-flushed livers whereas there were areas of patchy 
perfusion for the first hour in livers which had been flushed cold . 
b) Effect of changing the constitution of the flushing solution/ pr ime: 
It is striking that in all experiments in which -oxoglutarate was added, the platelet count 
after 3 hours was between 62 and 75%, contrasting with the control level of 45%. The levels of 
leucocytes at 3 hours also tended to be higher, being between 19 and 40%, whereas most of 
the other readings, except where warm TisUsol was used, were less than 19%. Although no 
obvious differences were present in any of the other features measured, the improved platelet 
and leucocyte levels justified the attempted use of cx- oxoglutarate in the heterologous perfusion. 
c) Effect of added drugs: 
The use of Heparin in the doses planned seemed to result in add itional haemorrhage with-
in the liver during perfusion . No obvious improvement was noted in the three hour platelet or 
leucocyte counts. Addition of EDTA seemed to result in elevat ion of the aspartate transaminase 
and potassium levels but not in improvement of the cell counts. Adenosine was added only in 
the presence of ex KG and no improvement was observed. 
Non-starvation of the animal made little difference. 
Interpretation: 
The conclusions drawn from these experiments were that the use of a warm flushing solu-
tion containing ex KG appeared to result in improvement of the platelet and leucocyte counts, 
and in the appearance of more even perfusion. 
The use of McCoys medium 5A was found to have a major advantage in regard to the 
phenol red which is used as an indicator. This substance was readily excreted in bile and its 
clearance from plasma and appearance in bile was obvious. In the early minutes of perfusion, 
this may provide evidence that bile is being secreted rather than being a mere transudate of 
oedema fluid across the biliary membranes. In these homologous perfusions, there was an 
interval of 3-5 minutes between obvious reduction in plasma levels of dye and the appearance 
of colour in the bile. This observation should be followed by quantitative colorimetric determina-
tion, with the performance of formal clearance studies. 
Movement of the diaphragm resulted in improved perfusion of the dependent surface of 
the liver with absence of the black areas of stasis which had appeared routinely when the 
diaphragm was immobile. 
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Table X : The mean values for temperature change, and for portal 
resistance and total flow rate during the first 30 minutes of 
heterologous perfusion. 
Table X : The mean values for aspartate transaminase, plasma haemo-
globin and plasma potassium at 30 and 240 minutes of per-
fusion with heterologous blood. 
Table X The mean values of platelets in heterologous perfusions using 
methods to prevent aggregation or the immune response. 
Table X The mean values of leucocytes in heterologous perfusions using 

















































































































































































































































































































































































































































































































































































































B - Attempts to prevent platelet aggregation in heterologous perfusion 
In Table X, the same factors as described above are judged in the results of 11 groups of 
perfusions with human blood. 
The use of Trasylol, Periactin, cold perfusion, Heparin, and Persantin did not result in any 
improvement in platelet and leycocyte levels. Addition of colloidal carbon not only made no 
difference to the cell counts, but resulted in a marked increase in portal resistance with the 
production of large amounts of ascites from the liver surface. 
The use of Hydrocortisone, EDTA or the flushing with human blood or plasma, and the 
addition ofaKG improved the fall in cell counts a little, but no major improvement was noted. 
No difference was made by any of these techniques to the presence of antibodies, nor to 
the decrease in complement levels. 
Interpretation: 
As a result of the experiments, it was concluded that the pig liver could not be used aga in 
for clinical perfusion with safety before a means was available of removal of antibody with 
associated improvement in trans-hepatic platelet differences. The use of forced flow electro-
phoresis in the separation of antibody has been shown to result in prolongation of heterograft 
survival, and could be of great value. However, at present it remains an experimental tool and 
requires full investigation before more general use. 
Another possible means of avoiding the thrombocytopenia lay in the choice of another 
animal for donation of the liver. Experiments in this direction are described in chapter Eight. 

CHAPTER EIGHT 





(a) Calf with human blood 
(b) Lamb with human blood 
(c) Baboon with compatible human blood 
(d) (i) Baboon with human blood of Group 0 
(ii) Baboon with incompatible human blood 
2) Other conditions 











Livers from calves had been used for clinical assist purposes (50) and sheep livers had 
been used for physiological studies (156). No haematological investigations were performed in 
either of these two groups of experiments. Since calves and sheep were readily available it was 
decided to investigate their use and the effect upon platelet counts of perfusion of these livers 
with human blood. Although the relationship of the heterograft response under review to all 
pre-formed antibodies is not completely defined, the observation that human blood appeared to 
possess a lower titre of heterophile antibodies against sheep cells, also encouraged the use of 
this animal for experiments . 
The baboon had been used in this Unit (235) and elsewhere (125) as a cross circulation 
partner for patients in hepatic coma . In other centres though , the animal has not been used for 
experiments due to its unavailability. The use of the baboon was investigated in this study 
especially because of the similarity of the blood group substances which are secreted by these 
animals, to those carried on human cells. In addition, heterophile antibodies had not been 




(a) Three livers from young calves were perfused for four hours with human blood of random 
groups. 
(b) The livers from three lambs were perfused with human blood of random groups. 
(c) Four baboon livers were perfused with compatible human blood for four hours. 
(d) In regard to the clinical application of this procedure it was important to investigate the 
necessity of patient cross matching with the animal. Since no baboon is grouped as 
human group 0 , livers from baboons of groups A, 8 or AB were perfused with human 
blood of group Oto assess the effect of the anti -A and anti -8 antibodies present. 
(i) The liver from a baboon of group B was perfused with group A human blood and 
(ii) one of group AB with group A human blood. 
Since group B human blood was very scarce, perfusion of a group A baboon liver and 
human group B was not performed. 
2) Other conditions 
In the above experiments, the conditions used were those which had given the best results 
143 
in previous work. These included flushing the liver with Krebs Ringer bicarbonate at 38°C, 
using 1, 75 litres through the portal vein and 0,25 litres through the hepatic arte ry. The circuit 
was primed with 0,25 litres of McCoys medium 5A and 1,0 litres of human blood. A constant 
infusion of the hormonal "cocktail" was used, and 15 mmol a KG wa added per litre to the 
flushing solution, the prime and the infusion. 
- The diaphragm was kept mobile. 
- The conditions of dissection were different in these animals in that in each case, the 
anatomy was variable and unfamiliar. Although this was not thought to add to the trauma of 
removal of the liver, the duration of operation was prolonged. In the case of the baboon liver 
dissections, the animals used were very small which complicated the procedure. In addition, 
since no change was made in the volume of the flushing solution, these livers were flushed to a 
relatively greater degree than the larger animal livers. 
(ii) Results: 
A: The results of perfusion of the calf liver with human blood are shown in Figures 33-36. 
Physical and biochemical results : 
Portal resistance was within accepted levels but the total flow rate was much less than the 
arbitrary maximum. Bile flow was slow, especially in view of the large size of the liver, and 
after two hours, frank haemobilia was seen in all three experiments (Figure 33). 
The mean levels of aspartate transaminase were no higher than those noted in perfusions 
of pig liver with human blood, but plasma haemoglobin levels were higher (Figure 34). 
The clearance of the ammonia load was less efficient than that in perfusions of the pig 
liver. The lactate/ pyruvate ratios were much higher throughout perfusion; the increase in 
plasma urea was similar to the results obtained in perfusions of the pig liver with human blood 
(Figure 35). 
Haematological and immunological 
Platelet counts (Figure 36) followed the same pattern as in perfusions of the pig liver with 
human blood. Complement levels decreased by a mean value of 47% within the first 30 
minutes of perfusion. The measurement of antibodies in human blood against calf cells was 
complicated by the inability to prepare lymphocytes and leucocytes by the methods used for 
human and porcine cells. It was found impossible to remove erythrocytes from calf blood, 
which also required longer for defibrination . 
Interpretation: 
No improvement in any factor resulted from the use of the calf liver. In fact, additional 
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Figure 33 : The mean values of portal resistance, total flow and bile flow 
in perfusion of the calf liver with human blood. 
(The inset in all subsequent figures shows the comparative 
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Figure 34 : The mean levels of aspartate transaminase and plasma 
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Figure 35 : The mean levels of ammonia and lactatel pyruvate ratios in 
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Figure 36 : The mean differences in transhepatic platelet counts in 
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damage appeared to result from this form of perfusion, although no comparative studies have 
been made with bovine blood. 
B: The results of perfusion of the lamb liver with human blood are shown in Figures 37-40. 
Physical and biochemical results: 
Portal resistance which was initially high, fell during the first 15 minutes to lower levels 
than those recorded during heterologous porcine liver perfusion. The hepatic arterial 
resistance was also lower, and the total flow rate was a little lower than the arbitrary maxi-
mum. Bile flow was rapid and sustained by the choleretic "cocktail". 
The mean levels of aspartate transaminase were higher than those noted in heterologous 
porcine liver perfusion although the plasma haemoglobin levels were similar (Figure 38). There 
was a rapid clearance of the ammonia and the lactate loads, and urea production was greater 
than was noted in heterologous porcine liver perfusions (Figure 39). 
Haematology and immunology: 
Platelet counts showed a similar marked decline during the first thirty minutes of perfusion 
(Figure 40). Complement levels decreased by 40% within the first 30 minutes of perfusion and 
lymphocytotoxic, leucoagglutinating and heterophile antibodies were reduced within five 
minutes and almost totally absent at 30 minutes. 
Interpretation: 
Thus the lamb liver showed no obvious improvement in the fall in platelets. Other physical 
and biochemical aspects of these experiments gave similar results to heterologous perfusion of 
the calf or pig liver. 
C: Perfusion of the baboon liver with compatible blood: 
The results of these experiments are shown in Figures 41-44. 
Physical and biochemical results: 
It appears that the arbitrary maximum total flow could be more rapidly achieved within 
thirty minutes without excessive rise in portal vascular resistance (Figure 41 ). The hepatic 
arterial pressure was, however, higher than was encountered in other perfusions. This could 
perhaps be related to the fact that the hepatic arterial system could not be directly cannulated 
and an aortic segment had to be used. During this process, the possibility of air embolus was 
greater, but in other perfusions, even if air embolus occurred, the resultant increase in 
resistance resolved within a short period. The arterial resistance in this series of experiments 
remained higher than recommended by others (61 ). The bile flow obtained in all periods of 
perfusion was less than with other livers despite the use of the choleretic solution. It was noted 
that the bile production was less during the operation also, and that the bile was dark green 
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and more viscid than pig bile. 
Figure 42 shows the levels of aspartate transaminase and plasma haemoglobin in 
perfusions of the baboon liver with compatible human blood compared with levels during 
homologous or heterologous perfusion of the pig liver. There was a simi lar rise in aspartate 
transaminase to that occurring in homologous perfusion, but the increase in plasma 
haemoglobin was greater in perfusions of the baboon liver. 
The clearances of ammonia and lactate, appeared similar to those in other experiments. 
(Figure 43). 
Haematological and Immunological: 
The results of the transhepatic platelet study (Figure 44) reveal that there is a marked 
difference in the reduction in platelet counts across the liver. The initial difference of 30% at 
one minute reduces to 10% at 5, 15 and 30 minutes, seventy seven per cent of the original 
platelet level remains at three hours. This level is statistically highly significant when com-
pared with results obtained when pig livers were perfused with human blood (p<0,001 ). 
Mean total complement levels declined 12% over the course of the first thirty minutes of 
perfusion - (cf. in perfusions of the pig liver with human blood, the decline was 28% which is 
significantly different - p<.0,001 ). 
Lymphocytotoxic and leucoagglutinating antibodies were not detected in human blood at 
any stage, and heterophile antibodies against guinea pig, rat, and pig were not reduced. 
Interpretation: 
The use of the baboon liver seemed therefore, to provide the first hope of an improvement 
in the trans-hepatic decrease in platelets. In regard to the other functions measured, these 
seemed to be performed in a manner similar to the homologous perfusions of the pig liver with 
pig blood. 
The question which remained still to be answered concerned the necessity for cross-
matching of the animal and the human blood used. 
D: The results of 
(i) 1 perfusion of the liver from a baboon group A with human blood of group O low titre. 
(2 hours). 
(ii) 1 perfusion of the liver from a baboon group A with human blood of group O high titre. 
(4 hours). 
(iii) 1 perfusion of the liver from a baboon group B with human blood of group A. (1 hour). 
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Figure 37 : The mean values of portal resistance, total flow and bile flow 
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Figure 38 : The mean levels of aspartate transaminase and plasma 
haemoglobin in perfusions of the lamb liver with human blood 
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Figure 39 : The mean levels of ammonia and lactatel pyruvate ratios in 
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Figure 40 : The mean differences in transhepatic platelet counts in 
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Figure 41 : The mean values of portal resistance, total flow and bile 
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Figure 42 : The mean levels of aspartate transaminase and plasma 
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Figure 43 : The mean levels of ammonia and lactatel pyruvate ratios in 
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Figure 44 : The mean differences in transhepatic platelet counts in 
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Physical and biochemical results: 
These are shown in Table XI. It may be seen that values for portal resistance, total flow and 
biie flow were similar to those in section C using compatible blood. The levels of aspartate 
transaminase and plasma haemoglobin and potassium appeared to be higher in these experi -
ments than in those of section B. The clearance of the load of ammonia and lactate as 
completed in one experiment (ii) was similar to the result in perfusions of section B. 
Haematological and Immunological : 
From Table XII it may be seen that there was no difference in the trans-hepatic decline in 
platelets when incompatible blood was used . Complement levels declined by 15% in (i); 11 % in 
(ii) and 12% in (iii). No lymphocytotoxic or leucoagglutinating antibodies were detected, and 
there was no reduction in heterophile antibodies during perfusion. 
Interpretation: 
The conclusion drawn from the platelet counts of these experiments was that there was no 
difference whether compatible or incompatible blood was used, except perhaps in the slightly 
greater damage to liver cells and erythrocytes as shown by greater SGOT and plasma 
haemoglobin. This was not a highly significant difference. (p=0,05). 
The final conclusion drawn was that cross matching of the animal with the blood group of 
a patient with liver failure in whom a hepatic assist was to be performed, was not necessary. 
Table XI : The total flow rates, portal resistance and bile flow rates in 
perfusions of the baboon liver with incompatible blood. 
Table XI : The levels of plasma potassium, haemoglobin and aspartate 
transaminase in perfusions of the baboon liver with incom-
patible blood. 
Total flow rates : ml / g/ min. 
O" 1 .. 5" 15" 30" 1 . 2' 3 ' 3W 3%' 3%' 4' 
( i ) 1 , 1 1 , 1 1 . 1 1,0 
( ii) 0,6 0,6 0,9 
( iii ) 1,0 1 ,0 1,0 1,0 1,0 1,0 
Portal resistance : units 
(i) ,060 ,057 ,066 ,074 ,064 ,066 ,067 
( ii) ,040 ,040 ,041 ,032 ,032 
(iii) ,066 ,066 ,066 ,030 ,030 ,066 
Bile flow ml / hr 
0 2 3 4 
(i) 12 
( ii) 3 15 23 9 11 
(iii ) 2,5 3,5 
Potassium: mE:i/ 1 
O" 1" 5" 15" 30 " 1 . 2· 3' 3~ · 3%' 3%' 4' 
(i) 5 ,2 8,6 7, 1 5, 1 3,6 3,2 6 , 1 10.4 10 .7 12,6 14,2 15 ,7 
(i i) 6 ,0 8,4 7, 1 6, 1 5, 1 5,3 7,2 8.4 9,9 10,4 10,0 10.4 
( i i i) 5,5 8 ,5 7,2 5,9 4,6 4,2 
Haemcglobin : mg/ 100ml 
(i ) 10 22 30 24 39 52 
(ii) 19 17 13 8 21 17 37 56 75 83 98 95 
(ii i) 16 16 15 14 18 21 
Aspartate Transaminase: Karmen units I 
(i) 15 55 50 50 70 110 235 350 440 330 325 300 
(ii) 15 20 15 20 30 30 80 115 140 160 150 200 
(iii ) 10 30 25 30 20 
Table XII : The levels of blood ammonia and urea, and the lactate/ 
pyruvate ratios in perfusions of the baboon liver with in-
compatible blood. 
Table XII : The levels of platelets and leucocytes recorded in transhepa-
tic samples in perfusions of the baboon liver with incompat-
ible blood. (Counts are expressed as a percentage of the 
original). 
O" 1 .. 5" 15" 30 " 1' 2' 3' 3'05 3W 3W 3%' 4' 
Urea mg/ 100ml 
(i) 28 24 26 28 31 42 58 
(ii) 30 24 30 26 26 32 42 46 48 50 52 58 
(iii) 27 25 26 26 26 32 
Ammonia : umols/ 1 
(i) ,56 ,59 ,56 ,53 ,52 ,42 ,36 
(ii) ,26 ,22 ,22 ,18 ,26 ,21 ,20 , 16 1,50 1,56 ,73 ,34 , 19 
(iii) ,32 ,34 ,28 ,26 ,27 ,26 
Lactate/ pyruvate ratio: 
(i) 18 17 6 7 9 8 7 
(ii) 18 18 23 6 3 4 9 4 6 5 7 7 5 
(iii) 20 21 20 17 12 12 
Platelets: 
1" 5" 15" 30" 
(i) 73 / 75 75 / 80 67 / 66 70 / 82 
(ii) 88 / 77 99 / 72 70 / 78 70 / 6D 
(iii) 92 / 85 120 / 89 96 / 78 96 / 72 
Leucocytes: 
(i) 96 / 32 70 / 15 21 / 17 12 / 17 
(ii) 90 / 80 88 I 11 26 / 9 14 / 11 





The objective of this programme of experiments was to find some treatment which would 
improve the mortality from acute hepatic failure. The use of the isolated perfused pig liver as a 
hepatic assist still has great appeal which will continue until an "artificial liver" is designed. As 
the increasing collection of information reveals the complexity of liver metabolism, it is obvious 
that the chaos resulting from total hepatic destruction cannot at present be controlled with any-
thing but another liver. Thus the rationale for continued effort in the field of hepatic assist is 
justified, although to date, no series of patients thus treated is sufficiently large to show a 
significant improvement in survival as a result of the procedure. Indeed, the severity of the 
disease may be such that after a certain point, there is no treatment which could be effective. 
Although this point is, at present, impossible to define, earlier institution of hepatic assist, 
might yet reverse the decline in some patients. 
Thus there is a need for a safe. well-functioning system, which could in fact be used earlier 
without hazard. At pn,:sent, the pig liver cannot be said to fulfill these criteria, but there are 
indications that the baboon liver may prove more successful. However the potential virological 
hazard of the use of these animals must be borne in mind. Several reports exist of human infec-
tion from various primates (209), and a recent review has summarised current opinion (246). 
The hazard of virus infection from African green monkeys was first noted in 1967 when 31 per-
sons from 3 institutions became ill, and 7 died. The incubation period of the illness was 3-9 
days, and a maculo-papular rash developed which was non-irritating but associated with fever. 
There was evidence of involvement of the central nervous and haemopoeitic systems but the 
greatest effect was noted upon the liver with increase in transaminase yet no jaundice or 
coma . Death occurred between the 8th and 16th days of illness, as a result of circulatory 
collapse and coma . Thrombocytopenia was common, and focal encephalitis was noted at 
autopsy in all patients. In an attempt to prevent transmission of virus from animals to 
laboratory workers, an isolation period of a minimum of six weeks was advised for any impor-
ted animals. 
The studies described in this thesis have explored several avenues of investigation of the 
isolated liver; a few questions have been answered and a great many more posed. These may 
be broadly grouped as follows : 
i) Can further improvement be made in the function of the isolated liver? 
ii) Can further contribution be made to solution of the heterograft problem? 
ii i ) How could the use of a satisfactory experimental model of hepatic coma aid further 
improvements in treatment? 
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i) Improvement in liver function: 
Apart from its physiological interest. adequate function of the liver used for hepatic assist 
is essential. Several types of experiment which may further define the effects of poor preserva-
tion of the liver are urgently needed. 
(a) A controlled comparison of a variety of liver functions in the intact awake animal and the 
perfused liver. Studies to date which have explored the metabolism of bromsulphthe !ein and 
alcohol (74) and the elimination of galactose ( 128) have shown a deficit of function in the 
perfused liver. For greater validity, these studies should be performed with the animal 
unanaesthetised, and under various conditions of feeding when an even greater deficit might 
be demonstrated. As an important corollary to the work, attempts should be made to improve 
the function of the isolated organ whilst such comparative studies are under way. In these 
instances, studies should be made of changes across the organ as can be performed in the 
isolated liver, since little information exists in regard to the biochemical effects of the liver 
alone. An associated investigation during which various periods of inflow occ!usion were 
studied would also provide evidence of the trans-hepatic effects of ischaemia. Most studies to 
date have been performed using the dog liver (215) and have included splanchnic as well as 
hepatic ischaemia. 
(b) Since, at present. the only measure of assessment of total liver function involves the com-
plexities of transplantation, a study is required of the liver perfused at normal temperature for 
increasing periods with subsequent re-implantation into a recipient animal. However, it is fully 
recognised that such procedures are complicated by defects in coagulation (127) which claim 
the lives of these animals. Hence intensive further study is needed of the coagulation problems 
resultant upon poor storage of the liver. If the problem is that of failure of synthesis of clotting 
factors, and endothelial damage resulting from poor preservation, an intensive attempt to 
improve storage may solve this . 
(c) A major effort should be made to improve preparation of the liver. Assessment of the 
organ just prior to removal might reveal defects which should be rectified before insertion into 
the perfusion circuit . A period allowed for recovery at that time might improve this "un-
conventional ischaemia", as might the administration of protective drugs such as hydro-
cortisone, dibenzyline or chlorpromazine ( 145). A concerted investigation should be made into 
th e constitution, volume, temperature and form of delivery of the flushing solution, since more 
adequate protection during short term ischaemia is necessary. 
A criticism which might be levelled at the work presented, is that the liver was 
inadequately washed out on some occasions, and that remaining animal blood might initiate 
the immune response. This occurred in only a few experiments where the final effluent was 
174 
still obviously blood stained, - in the remainder, the liver became the uniform beige and the 
effluent clear as reported. It was felt that excessive flushing of the liver might be more harmful. 
Although Judah has suggested previously and has recently reiterated, that ischaemia 
commences with perfusion, the addition of various substrates appeared to reverse many of the 
results of ischaemia (58). In his series of experiments, the addition of aoxoglutarate preserved 
oxidative phosphorylation; in the current studies, livers to which this substrate was 
administered in the flushing solution, the perfusate and the ir.fusing medium appeared to 
function better in those features noted. Certainly the appearance of these organs suggested 
improvement in perfusion. The use of other substrates or substrate precursors as shown by 
Krebs (146) may also result in better function . 
ii) The heterograft: 
Heterologous perfusion of the pig liver gave results suggestive of an acute rejection 
phenomenon. These results were however, not as dramatic as the total cut-off in flow of blood 
and urine which occurs with heterologous perfusion of the kidney. Nonetheless, the effect 
upon cellular constituents was similar and had resulted in the initial clinical observation of 
thrombocytopenia after hepatic assist. The disappearance of platelets and leucocytes 
paralleled the absorption of antibody and hence could be taken as an index of rejection or its 
prevention . None of the methods used in an attempt to prevent heterograft rejection resulted in 
any improvement of the thrombocytopenia , although the use of citrate appeared to prevent the 
aggregation of leucocytes. 
Additional confirmatory evidence of the role of the liver in this response could be obtained 
with the use of more sophisticated immunological techniques. To date, the presence of platelet 
thrombi in the hepatic sinusoids has only been inferred but not proven histologically; electron 
microscopy might reveal these. Also, the use of radio-isotopic labelling of platelets with 
subsequent autoradiographic exposure of the histological specimens, might demonstrate the 
site of adherence. Individual labelling of platelets and leucocytes might aid their differentiation. 
In these particular studies, a partial solution to the problem of thrombocytopenia has been 
achieved by choice of livers from a different species. Due to the relative unavailability of 
baboons especially in other countries, the pig liver would have a place were it not for the acute 
rejection phenomenon which it provokes. In addition, the heterograft phenomenon remains 
one of the most vexed in transplantation biology, and its solution would offer a wide range of 
experiments and therapy. Extra-corporeal organ perfusion with heterologous blood provides a 
valuable tool for further investigation . At present, the most likely solution appears to be the 
fractionation of cells or plasma components in an attempt to remove the participants in the 
response (27), and thereby to prevent the sequelae of the formation of antigen / antibody 
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complexes . When this technique is perfected beyond its present experimental stage, there is 
definite clinical application. 
(iii) Acute hepatic failure - the roles of liver regeneration and an experimental model. 
It is certain that a great deal more knowledge is necessary concerning the nature of the 
biochemical defects resulting from acute hepatic failure, and with further elucidation of these, 
more rational treatment may be undertaken either with pharmacological means, or with 
physical removal of toxins or provision of liver function . 
At this time, the most likely avenue appears to be that of liver regeneration and its control. 
Since this is probably the principal reason why most patients do not recover, elucidation of the 
stimuli and suppressors of liver regeneration may provide a major new means of management. 
Meanwhile since a controlled trial of treatment is not possible, and since it would be diffi -
cult in any one series to collect sufficient patients to provide a convincing demonstration of the 
effect of any particular treatment, a satisfactory experimental model acute hepatic failure is 
required . The use of the rhesus monkey by Trey has provided such a model, but again these 
animals are generally scarce, and the more available pig should be investigated. Once such a 
model is obtained, the relative values of the current forms of treatment could be evaluated and 
the biochemical derangements might be clarified. 
In conclusion, therefore, in regard to this study in particular, at present the pig liver cannot 
safely be offered by this laboratory for the treatment of acute liver failure . Some solution seems 
to lie in the use of the baboon liver as regards the prevention of thrombocytopenia, but the bio-
chemical function of these livers remains to be demonstrated in clinical application. 
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1. Astrup determinations were made on a Radiometer apparatus with derivation of the 
partial pressure of carbon dioxide, the bicarbonate and the base excess from samples 
equilibrated with known concentrations of carbon dioxide (4% and 8%) using the Sig-
gaard Andersen nomogram. The partial pressure of oxygen was measured directly with 
a Clarke electrode. 
2. Oxygen consumption was calculated according to the method of Selkurt and Brecher, 
but several values for pig blood were assumed to be similar to those accepted fer human 
blood - viz. the oxygen carrying capacity of haemoglobin - 1,34ml oxygen / g haemoglobin, 
and oxygen solubility in plasma 0,003ml / mm p0 2• Haemoglobin was measured accord-
ing to the method of Sheard and Sanford using a Leitz photometer, and oxygen satura-
tion was determined using a Radiometer oximeter. The final calculation was as follows: 
Oxygen carried by haemoglobin:-
(Portal vein O 
2 
% saturation x flow/ min + Hepatic artery 0 2 % saturation x flow/ min minus 
Inferior vena cava 0 2 % saturation x flow/ min) x haemoglobin g/ 100ml x 1,34, PLUS 
Oxygen dissolved in plasma:-
(Portal vein p0 2 x flow/ min + Hepatic artery p0 2 x flow/ min - Infer ior vena cava p0 2 
x flow/ min) x 0,003 
The final result was expressed as millilitres of oxygen consumed per kilogram liver wet 
weight. 
3. Sodium and potassium in plasma and bile were measured by flame photometry with 
lithium as internal standard, using a Baird Atomic model KY 1 flame photometer. 
Chloride was determined coulombmetrically on an Aminco Cotlove automatic titrator 
after the design of Cotlove (Cotlove and Nishi). 
4. Glucosewas measured by the alkaline ferricyanide AutoAnalyser method (Hoffman). 
5. Osmolal ity of plasma and bile was calculated from the depression of freezing point using 
an Advanced Instruments or Fiske osmometer. 
6. Lactate determinations were made initially using the method of Blair and Summerson 
as modified by Huckabee (Huckabee) and pyruvate by the enzymatic method of Segal, 
Bla ir and Wyngaarten. Just prior to the experiments described in phase IV, the improved 
methods of Bucher were employed and continued for the remainder of the study. 
7. Total protein and albumin were measured by the biuret method before and after precipita-
tion with sodium sulphite, and the globulin was obtained by difference (Wolfson). 
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8. Alkaline phosphatase determinations used phenolphthalein monophosphate as the 
substrate (Babson) the method being modified for use on a Technicon AutoAnalyser. 
Results were expressed as Shinowara-Jones-Reinhart units. 
9 . Aspartate transaminase was determined according to the method of Karmen. 
10. Cholesterol measurement employed the Liebermann-Burchard reaction (Pearson). 
11 . Bilirubin in plasma and bile was measured by methods of Malloy and Evelyn - using the 
diazo reaction for plasma levels and direct oxidation with hydrogen peroxide for bile. 
12. Urea was measured on an AutoAnalyser using urease and the Berthelot reaction as 
described by Chaney and Marbach. 
13. Plasma haemoglobin was determined spectrophotometrically (Hunter, Grove-Rasmus-
sen and Soutter). 
14. Plasma ammonia was measured using a combination of the methods of Kaplan, Chaney 
and Marbach . Under anaerobic conditions, blood samples were added to equal volumes 
of 15% trichloro-acetic acid for protein precipitation. After centrifugation, 0,5ml superna-
tant was mixed with 0,5ml phenol / sodium nitroprusside reagent, and 1,0ml alkaline 
hypochlorite. (The commercial bleach, Nomisol, was found to contain the correct con-
centration of hypochlorite). After a ten minute incubation period in a water-bath at 
37°C, the absorbance was read spectrophotometrically at 625,-i. Final calculation was 
made from a standard curve. 
Haematological methods: 
15. Platelet and leucocyte counts were made visually using an improved Neubauer counting 
chamber. The diluent for platelet counting was 1 % Ammonium oxalate. Although the 
reported error of this form of counting is 30% it was felt that this was justified when 
compared with the inaccuracy involved in the use of mechanical counting where error 
could arise from particles of the counted size not being platelets but rather fragments 
of cells resulting from trauma . In addition, clumping of cells could be detected visually. 
In an attempt to reduce the error in counting, all samples were counted in duplicate 
and the mean recorded . 
16. Complement was determined according to the method of Kabat and Mayers using 
haemolysis of sensitized sheep erythrocytes. The pH of the diluent buffer used in deter-
mination of pig complement was changed from 7,5 as used for human complement 
estimations to 7,3 to obtain optimal values. 
Immunological methods: 
17. Antibody testing . 
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(a) Preparation of lymphocytes (Kissmeyer-Nielsen and Kjerbye) - from 20ml de-
fibrinated blood, 8ml was added to pre-warmed iron powder and 3ml methyl cellulose . 
This mixture was rotated at 37°C for 30 minutes to allow phagocytosis of iron bv erythro-
cytes. Subsequent sedimentation for 30 minutes resulted in a supernatant fluid free 
from erythrocytes (Coulson and Chalmers). Two millilitres of this supernatant was th en 
layered onto 1,5ml Ficoll lsopaque (Boyum). After centrifugation at 15 000 rpm for 20 
minutes, an isolated layer of lymphocytes could be removed and was washed twice with 
Hanks balanced salt solution. Centrifugation between these two washes was conducted 
at 1 200 rpm for 8 minutes. After draining the Hanks. the cells were resuspended in 
2 drops of Hanks which resulted in a dilution of 12 000 lymphocytes/ mm 3. These cells 
were stored on ice at 4°C until use. For the final assessment of lymphocytotoxicity of 
plasma, 3 drops absorbed rabbit complement (see below) were added to the suspen -
sion of cells . One microlitre of decomplemented test serum was dispensed into Moller-
Coates trays and one microlitre of the lymphocyte/ complement mixture was added . 
After incubation at 37°C for 30 minutes, 0,5ml. 1 % Trypan blue was added to each well 
and the tray re-incubated at 20°C for 30 minutes. Cytotoxicity was determined using 
an inverted vision microscope, and was scored as follows:- Negative = less than ten 
per cent cells which were not capable of excluding the dye; + = 10-20%; ++ = 21-50%; 
+++=51-74%; ++++=75-100%. 
(b) Preparation of leucocytes - from 20ml defibrinated blood, 8ml was added to 3ml 
methyl cellulose and allowed to sediment for 30 minutes at 37°C. One half millilitre 
was removed from the uppermost layer and was dispensed in 2 microlitre aliquots into 
Terasaki trays. Two microlitres of decomplemented test serum was added and the trays 
were incubated for 105 minutes at 37°C. After addition of one microlitre of Toluidine 
blue and further incubation, aggregation was noted and scored in a similar manner to 
that described above. Test sera were prepared by centrifugation of plasma at 4 000 rpm 
for 2 minutes. decomplementation by incubation at 56°C for 30 minutes and further 
centrifugation in a microcentrifuge for 5 minutes. 
Preparation of absorbed rabbit complement: 
Five millilitres of blood from the experimental° animal was collected with 0,5ml Heparin 
without phenol preservative (Thromboloquine - Organon - 50mg/ ml). After centrifugation at 
2 000 rpm for 10 minutes, the buffy coat was removed and added to an equal volume of rabbit 
complement. The mixture was allowed to stand for 120 minutes at 4°C and centrifuged on 




Heterophile antibodies were detected in plasma samples by the method of Rapaport et al. 
Sheep cells were obtained from Karl Bremer Hospital, rat, guinea pig and baboon cells from 
the Animal House, University of Cape Town and human cells were prepared from pooled group 
0 human blood. All cells were washed five times with phosphate-buffered saline, pH 7,2, 
and were diluted to 1 %. Serial dilutions of test plasma samples were made in phosphate 
buffered saline. For the definite test, 0,3ml cell suspension was mixed with 0,3ml plasma 
di1ution, incubated for 2 hours at 22°C, and was then centrifuged and observed microscopi -
cally ior evidence of erythrocyte aggregation. 
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PIG LIVER PERFUSION A Role in Hepatic Assist? 
The pig liver has been used in many institutions as a means of 
treatment of acute liver failure. Since the incidence of this complica-
tion is very high at Groote Schuur Hospital, and because of the associa-
ted mortality of 80 to 90%, the model of pig liver perfusion was developed 
in the laboratory in 1969. 
After physiological studies using human blood in comparison with 
initial perfusion studies which had used pig blood, the procedure was 
applied as hepatic assist to 4 patients in fulminant hepatic failure. 
Although none survived, there was sufficient improvement in their level 
of consciousness to encourage the technique to be pursued. However, all 
clinical applications had been complicated by the development of thrombo-
cytopenia. This problem had not been reported frrom other laboratories 
and hence the clinical programme was terminated while the platelet decline 
was investigated. 
Two possible explanations existed. The incorporation of a bubble 
oxygenator in the circuit was excluded as a cause by experiments using 
blood in the circuit alone without a liver. 
It became evident from estimation of platelets in blood samples taken 
across the liver, that a significantly greater fall occurred when the pig 
liver was perfused with human blood as compared with pig blood. This ob-
servation was interpreted as an acute rejection phenomenon, more especially 
as an associated decrease in levels of complement and antibodies was noted. 
Attempts were made to prevent this acute response, using pharmecolo-
gical means but none was successful. An alternative was to use livers 
from different animals. In comparison ~ith the pig liver, no difference 
was noted with the use of the calf or lamb liver. The baboon liver 
showed a significant improvement in the fall in platelets. In addition, 
no significant decrease occurred in complement levels and no antibodies 
were detected in human blood against baboon tissue. 
In conclusion, it has been decided as a result of these experiments, 
that the baboon liver should be used for hepatic assist when practised 
in this Unit. In order to diminish the hazard of viral spread from 
animals to patient or personnel, baboons to . be used to donate livers, 
will have beeh kept in i~ol~tion for a period of at least six months. 
